[
    {
        "request_id": "3244",
        "lead_investigator": "Vojtech Huser",
        "lead_institution": "National Library of Medicine/NIH",
        "study_title": "Identification of Research Common Data Elements in HIV/AIDS using data science methods",
        "link": "https://vivli.org/identification-of-research-common-data-elements-in-hiv-aids-using-data-science-methods/",
        "year": "2019",
        "study_id": [
            "NCT00358917",
            "NCT00358917",
            "NCT00043966",
            "NCT00043966",
            "NCT00262522",
            "NCT00711009",
            "NCT00962780",
            "NCT00963235"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "3246",
        "lead_investigator": "Dawn Farrell",
        "lead_institution": "Institute of Technology Tralee\u200b",
        "study_title": "Cochrane Review: Interventions for fatigue in inflammatory bowel disease",
        "link": "https://vivli.org/interventions-for-fatigue-in-inflammatory-bowel-disease/",
        "year": "2019",
        "study_id": [
            "NCT01235689",
            "NCT01235689"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "3270",
        "lead_investigator": "Mirjana Stanic Benic",
        "lead_institution": "University Hospital Centre Rijeka\u200b",
        "study_title": "The impact of biological interventions on health\u2010related quality of life in adults with Crohn's disease",
        "link": "https://vivli.org/the-impact-of-biological-interventions-on-health%e2%80%90related-quality-of-life-in-adults-with-crohns-disease/",
        "year": "2019",
        "study_id": [
            "NCT00077779",
            "NCT00077779",
            "NCT00055523",
            "NCT00055523",
            "NCT00055497",
            "NCT00055497",
            "NCT00105300",
            "NCT00105300",
            "NCT00055536",
            "NCT00055536",
            "NCT00032799",
            "NCT00032799",
            "NCT00078611",
            "NCT00078611"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "3287",
        "lead_investigator": "Robert Alexander",
        "lead_institution": "Takeda",
        "study_title": "Identification of biomarkers associated with specific sleep variables",
        "link": "https://vivli.org/identification-of-biomarkers-associated-with-specific-sleep-variables/",
        "year": "2019",
        "study_id": [
            "NCT00992160"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "3288",
        "lead_investigator": "Marc-Antoine Sparfel",
        "lead_institution": "Tours Hospital",
        "study_title": "MIDRA: influence of demographic and environmental factors on anti-tumor necrosis factor efficacy in rheumatoid arthritis a systematic review and meta-analysis of randomized controlled trials",
        "link": "https://vivli.org/midra-influence-of-demographic-and-environmental-factors-on-anti-tumor-necrosis-factor-efficacy-in-rheumatoid-arthritis-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/",
        "year": "2020",
        "study_id": [
            "NCT00647491",
            "NCT00420927",
            "NCT00195663",
            "NCT00195702",
            "NCT00234845",
            "NCT00235859",
            "NCT00647920",
            "NCT00538902",
            "NCT00647270",
            "NCT00870467",
            "NCT00445770",
            "NCT00565409",
            "NCT00858780",
            "NCT00913458",
            "NCT00160602",
            "NCT00152386",
            "NCT00717236",
            "NCT00548834",
            "NCT00175877",
            "NCT00674362",
            "NCT00580840",
            "NCT01235598",
            "NCT01519791",
            "NCT00195650"
        ],
        "number_of_studies": 24
    },
    {
        "request_id": "3320",
        "lead_investigator": "John Frew",
        "lead_institution": "Rockefeller University",
        "study_title": "Analysis of Outcome Measures in Hidradenitis Suppurativa",
        "link": "https://vivli.org/analysis-of-outcome-measures-in-hidradenitis-suppurativa/",
        "year": "2019",
        "study_id": [
            "NCT01468233",
            "NCT01468233",
            "NCT01635764",
            "NCT01635764",
            "NCT01468207",
            "NCT01468207"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "3321",
        "lead_investigator": "Ewa Olech",
        "lead_institution": "IQVIA",
        "study_title": "Study of entry variables to optimize lupus trial design",
        "link": "https://vivli.org/study-of-entry-variables-to-optimize-lupus-trial-design/",
        "year": "2020",
        "study_id": [
            "NCT01484496",
            "NCT00424476",
            "NCT00410384"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "3328",
        "lead_investigator": "Klaus\u00a0Gottlieb",
        "lead_institution": "Eli Lilly USA",
        "study_title": "Mapping of components of the complete blood count and comprehensive metabolic profile to disease-specific clinical and endoscopy endpoints in phase 2 and 3 clinical trials of ulcerative colitis and Crohn\u2019s disease",
        "link": "https://vivli.org/mapping-of-components-of-the-complete-blood-count-and-comprehensive-metabolic-profile-to-disease-specific-clinical-and-endoscopy-endpoints-in-phase-2-and-3-clinical-trials-of-ulcerative-colitis-and-cr/",
        "year": "2019",
        "study_id": [
            "NCT01177228",
            "NCT02039505",
            "NCT00783692",
            "NCT00783692",
            "NCT01224171",
            "NCT01224171",
            "NCT00783718",
            "NCT00783718",
            "NCT02039505",
            "NCT02039505",
            "NCT00655135",
            "NCT00655135"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "3361",
        "lead_investigator": "Gustav Nilsonne",
        "lead_institution": "Karolinska Institutet",
        "study_title": "Distribution of interleukin -6 in human plasma implications for statistical modelling and meta-analysis",
        "link": "https://vivli.org/distribution-of-interleukin-6-in-human-plasma-implications-for-statistical-modelling-and-meta-analysis/",
        "year": "2019",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "3369",
        "lead_investigator": "Michael Ward \n",
        "lead_institution": "NIH",
        "study_title": "Predicting Treatment Response to Tumor Necrosis Factor Inhibitors in Patients with Ankylosing Spondylitis",
        "link": "https://vivli.org/predicting-treatment-response-to-tumor-necrosis-factor-inhibitors-in-patients-with-ankylosing-spondylitis/",
        "year": "2019",
        "study_id": [
            "NCT00265083",
            "NCT01248793",
            "NCT02186873",
            "NCT00202865",
            "NCT00207701",
            "NCT00195819",
            "NCT00085644",
            "NCT01114880",
            "NCT00421915",
            "NCT00418548",
            "NCT00247962"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "3762",
        "lead_investigator": "Lin Wang",
        "lead_institution": "Johns Hopkins Hospital",
        "study_title": "The relative efficacy and safety of apalutamide, enzalutamide, abiraterone, and darolutamide for nonmetastatic castration-resistant prostate cancer",
        "link": "https://vivli.org/the-relative-efficacy-and-safety-of-apalutamide-enzalutamide-abiraterone-and-darolutamide-for-nonmetastatic-castration-resistant-prostate-cancer/",
        "year": "2019",
        "study_id": [
            "NCT00626548",
            "NCT01664923",
            "NCT01664923",
            "NCT01946204",
            "NCT01171898",
            "NCT02003924",
            "NCT01314118",
            "NCT02200614"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "3876",
        "lead_investigator": "Changyu Shen",
        "lead_institution": "Beth Israel Deaconess Medical Center",
        "study_title": "Risk and Benefit Stratification of Treatment Effects in Patients with Atrial Fibrillation",
        "link": "https://vivli.org/risk-and-benefit-stratification-of-treatment-effects-in-patients-with-atrial-fibrillation/",
        "year": "2019",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "4036",
        "lead_investigator": "Akira Kimata",
        "lead_institution": "University of Tsukuba",
        "study_title": "Optimal interruption time of dabigatran per OS to Ablation (O-A time) in patients with atrial fibrillation Integrated analysis of 2 randomized controlled clinical trials",
        "link": "https://vivli.org/optimal-interruption-time-of-dabigatran-per-os-to-ablation-o-a-time-in-patients-with-atrial-fibrillation-integrated-analysis-of-2-randomized-controlled-clinical-trials/",
        "year": "2019",
        "study_id": [
            "NCT02348723",
            "NCT02348723",
            "NCT02348723"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "4037",
        "lead_investigator": "Karl Peace",
        "lead_institution": "Georgia Southern University",
        "study_title": "Assessment of Matching Methods for Causal Analysis",
        "link": "https://vivli.org/assessment-of-matching-methods-for-causal-analysis/",
        "year": "2019",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "4039",
        "lead_investigator": "Claire Daien",
        "lead_institution": "CHU lapeyronie",
        "study_title": "The most appropriate conventional DMARD to combine with tofacitinib in Rheumatoid Arthritis post hoc analysis of ORAL sync study",
        "link": "https://vivli.org/the-most-appropriate-conventional-dmard-to-combine-with-tofacitinib-in-rheumatoid-arthritis-post-hoc-analysis-of-oral-sync-study/",
        "year": "2020",
        "study_id": [
            "NCT00856544",
            "NCT00856544"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "4041",
        "lead_investigator": "Vivek Rudrapatna",
        "lead_institution": "University of California, San Francisco",
        "study_title": "Enhancing inference from real-world data using externally-derived missing data models: a pilot study of Ulcerative Colitis",
        "link": "https://vivli.org/enhancing-inference-from-real-world-data-using-externally-derived-missing-data-models-a-pilot-study-of-ulcerative-colitis/\u201d",
        "year": "2021",
        "study_id": [
            "NCT02497469",
            "NCT00783718",
            "NCT02039505",
            "NCT00853099",
            "NCT00385736",
            "NCT00408629",
            "NCT01863771",
            "NCT00488631",
            "NCT00487539",
            "NCT00036439",
            "NCT00096655",
            "NCT01551290"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "4043",
        "lead_investigator": "Janneke van der Woude",
        "lead_institution": "Erasmus Medical Center",
        "study_title": "Effect of treatment on lipid profiles in patients with inflammatory bowel disease a systematic review and meta-analysis",
        "link": "https://vivli.org/effect-of-treatment-on-lipid-profiles-in-patients-with-inflammatory-bowel-disease-a-systematic-review-and-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT00787202",
            "NCT00787202",
            "NCT01465763",
            "NCT01465763",
            "NCT01458951",
            "NCT01458951",
            "NCT01458574",
            "NCT01458574"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "4047",
        "lead_investigator": "Miriam\u00a0Oron\n",
        "lead_institution": "Skintelligence\u00a0ltd.",
        "study_title": "Test the prospects of expending the\u00a0Skintelligence\u00a0algorithm for predicting response to treatment with Alefacept and\u00a0Ustekinumab\u00a0in psoriatic patients affected with type I diabetes",
        "link": "https://vivli.org/\u202ftest-the-prospects-of-expending-the-skintelligence-algorithm-for-predicting-response-to-treatment-with-alefacept-and-ustekinumab-in-psoriatic-patients-affected-with-type-i/",
        "year": "2019",
        "study_id": [
            "NCT00965458"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4113",
        "lead_investigator": "Lesley Inker",
        "lead_institution": "Tufts Medical Center",
        "study_title": "Chronic Kidney Disease Epidemiology \u2013 Clinical Trials Consortium (CKD-EPI CT)",
        "link": "https://vivli.org/chronic-kidney-disease-epidemiology-clinical-trials-consortium-ckd-epi-ct/",
        "year": "2020",
        "study_id": [
            "NCT00279045",
            "NCT00968708",
            "NCT02465515"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "4115",
        "lead_investigator": "Amir Mahabadi",
        "lead_institution": "University Hospital Essen, West German Heart and Vascular Center",
        "study_title": "Impact of statin therapy on coronary artery calcification volume and density - A meta-analysis of randomized controlled trials",
        "link": "https://vivli.org/impact-of-statin-therapy-on-coronary-artery-calcification-volume-and-density-a-meta-analysis-of-randomized-controlled-trials/",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "4116",
        "lead_investigator": "Sharon Strauss",
        "lead_institution": "St. Michael\u2019s Hospital",
        "study_title": "Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia a systematic review and individual patient data network meta-analysis",
        "link": "https://vivli.org/comparative-safety-and-effectiveness-of-cognitive-enhancers-for-alzheimers-dementia-a-systematic-review-and-individual-patient-data-network-meta-analysis/",
        "year": "2019",
        "study_id": [
            "NCT01018875",
            "NCT01018875",
            "NCT00948909",
            "NCT00948909"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "4117",
        "lead_investigator": "John Frew",
        "lead_institution": "Rockefeller University",
        "study_title": "Predictors of Treatment Response, Adverse Events, Changes in Anaemia status and Assessment of Lesion Count Variability in Hidradenitis Suppurativa",
        "link": "https://vivli.org/predictors-of-treatment-response-adverse-events-changes-in-anaemia-status-and-assessment-of-lesion-count-variability-in-hidradenitis-suppurativa",
        "year": "2019",
        "study_id": [
            "NCT01635764"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4118",
        "lead_investigator": "J. David Spence",
        "lead_institution": "Western University",
        "study_title": "On-Treatment analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial",
        "link": "https://vivli.org/on-treatment-analysis-of-the-stroke-prevention-by-aggressive-reduction-in-cholesterol-levels-sparcl-trial/",
        "year": "2019",
        "study_id": [
            "NCT00147602",
            "NCT00147602"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "4120",
        "lead_investigator": "Merryn Voysey",
        "lead_institution": "University of Oxford",
        "study_title": "The immunogenicity and sero-efficacy of pneumococcal vaccines",
        "link": "https://vivli.org/the-immunogenicity-and-sero-efficacy-of-pneumococcal-vaccines/",
        "year": "2020",
        "study_id": [
            "NCT00366678",
            "NCT00475033",
            "NCT00676091",
            "NCT00384059",
            "NCT00444457",
            "NCT00689351",
            "NCT00688870",
            "NCT00373958",
            "NCT00366899",
            "NCT00366340",
            "NCT01200368",
            "NCT01692886",
            "NCT00474539",
            "NCT00452790",
            "NCT00366548",
            "NCT00508742"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "4121",
        "lead_investigator": "Frederikus Klok",
        "lead_institution": "Leiden University Medical Center",
        "study_title": "Performance of the AF-adapted VTE-BLEED score for predicting major bleeding in patients with atrial fibrillation a post-hoc analysis of the ENGAGE-AF TIMI-48 Study",
        "link": "https://vivli.org/performance-of-the-af-adapted-vte-bleed-score-for-predicting-major-bleeding-in-patients-with-atrial-fibrillation-a-post-hoc-analysis-of-the-engage-af-timi-48-study",
        "year": "2019",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "4275",
        "lead_investigator": "Lisa Stamp",
        "lead_institution": "University of Otago",
        "study_title": "Serum urate as a biomarker in gout Protocol for individual patient data analysis for OMERACT 2020",
        "link": "https://vivli.org/serum-urate-as-a-biomarker-in-gout-protocol-for-individual-patient-data-analysis-for-omeract-2020/",
        "year": "2019",
        "study_id": [
            "NCT00174915",
            "NCT00102440",
            "NCT00430248",
            "NCT00174941",
            "NCT02139046",
            "NCT02128490",
            "NCT01078389",
            "NCT00174967"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "4278",
        "lead_investigator": "Jennifer Quint",
        "lead_institution": "Imperial College London",
        "study_title": "Withdrawing inhaled corticosteroid (ICS) treatment in people with COPD a real world study",
        "link": "https://vivli.org/withdrawing-inhaled-corticosteroid-ics-treatment-in-people-with-copd-a-real-world-study/",
        "year": "2019",
        "study_id": [
            "NCT00975195"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4316",
        "lead_investigator": "Martin Okun",
        "lead_institution": "Fort HealthCare",
        "study_title": "Geospatial and Seasonal Variation in Psoriasis Severity Analysis of Placebo Response Data from Phase 3 placebo-controlled trials in moderate-severe psoriasis",
        "link": "https://vivli.org/geospatial-and-seasonal-variation-in-psoriasis-severity-analysis-of-placebo-response-data-from-phase-3-placebo-controlled-trials-in-moderate-severe-psoriasis/",
        "year": "2020",
        "study_id": [
            "NCT00237887",
            "NCT02684370",
            "NCT02684357"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "4319",
        "lead_investigator": "Maria Alice Franzoi",
        "lead_institution": "Jules Bordet Institut",
        "study_title": "Clinical implications of body mass index and weight in metastatic breast cancer patients receiving abemaciclib. A combined individual patient level data sub-analysis of MONARCH 2 and MONARCH 3 trials.",
        "link": "https://vivli.org/clinical-implications-of-body-mass-index-and-weight-in-metastatic-breast-cancer-patients-receiving-abemaciclib-a-combined-individual-patient-level-data-sub-analysis-of-monarch-2-and-monarch-3-trials/",
        "year": "2019",
        "study_id": [
            "NCT02246621",
            "NCT02107703"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "4324",
        "lead_investigator": "Peng Xie",
        "lead_institution": "Chongqing Medical University",
        "study_title": "Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analys",
        "link": "https://vivli.org/comparative-efficacy-and-tolerability-of-new-generation-antidepressants-for-major-depressive-disorder-in-children-and-adolescents-protocol-of-an-individual-patient-data-meta-analysis/",
        "year": "2021",
        "study_id": [
            "NCT00849693",
            "NCT00849901",
            "NCT00812812",
            "NCT01371734",
            "NCT01372150"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "4326",
        "lead_investigator": "John Markman",
        "lead_institution": "University of Rochester",
        "study_title": "Phenotypic Characterization of Chronic Neuropathic Pain Following Post-Traumatic and Post-Surgical Injury",
        "link": "https://vivli.org/phenotypic-characterization-of-chronic-neuropathic-pain-following-post-traumatic-and-post-surgical-injury/",
        "year": "2020",
        "study_id": [
            "NCT01701362"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4327",
        "lead_investigator": "Michael Szarek",
        "lead_institution": "SUNY Downstate Medical Center",
        "study_title": "Analysis of Total Events and Hospitalizations in the SPARCL Study",
        "link": "https://vivli.org/analysis-of-total-events-and-hospitalizations-in-the-sparcl-study",
        "year": "2019",
        "study_id": [
            "NCT00147602"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4329, 4048",
        "lead_investigator": "Shomron Ben-Horin",
        "lead_institution": "Sun Yatsen 1st affiliated Hospital",
        "study_title": "Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease",
        "link": "https://vivli.org/efficacy-of-biologic-drugs-in-short-duration-versus-long-duration-inflammatory-bowel-disease/",
        "year": "2020",
        "study_id": [
            "NCT00783718",
            "NCT00783692",
            "NCT01224171",
            "NCT00032799",
            "NCT00032786",
            "NCT00078611",
            "NCT00077779",
            "NCT00348283",
            "NCT00445939",
            "NCT00445432",
            "NCT00055497",
            "NCT00055523",
            "NCT00853099",
            "NCT00385736",
            "NCT00408629",
            "NCT00105300",
            "NCT00291668",
            "NCT00552058",
            "NCT00152425",
            "NCT00152490",
            "NCT00487539",
            "NCT00488631",
            "NCT00036439",
            "NCT00096655",
            "NCT00094458",
            "NCT00207662",
            "NCT00537316",
            "NCT01551290"
        ],
        "number_of_studies": 28
    },
    {
        "request_id": "4330",
        "lead_investigator": "Laure Gossec",
        "lead_institution": "Sorbonne Universit\u00e9",
        "study_title": "Domains of health important for Rheumatoid Arthritis patients can be assessed separately: Reliability and Responsiveness of the Rheumatoid Arthritis Impact of Disease Score - 7 items (RAID.7i)",
        "link": "https://vivli.org/domains-of-health-important-for-rheumatoid-arthritis-patients-can-be-assessed-separately-reliability-and-responsiveness-of-the-rheumatoid-arthritis-impact-of-disease-score-7-items-raid-7i/",
        "year": "2020",
        "study_id": [
            "NCT00768053"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4352",
        "lead_investigator": "Stefano Barco",
        "lead_institution": "University Medical Center Mainz",
        "study_title": "Differential effects of long-term treatment with warfarin vs. edoxaban on blood count parameters. A parallel posthoc analysis of the Hokusai VTE and Engage AF-TIMI-48 trials",
        "link": "https://vivli.org/differential-effects-of-long-term-treatment-with-warfarin-vs-edoxaban-on-blood-count-parameters-a-parallel-posthoc-analysis-of-the-hokusai-vte-and-engage-af-timi-48-trials/",
        "year": "2020",
        "study_id": [
            "NCT00781391",
            "NCT00986154"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "4540",
        "lead_investigator": "Chris Gale",
        "lead_institution": "University of Leeds",
        "study_title": "Efficacy and safety of edoxaban versus warfarin in patients with atrial fibrillation and frailty insights from the ENGAGE AF-TIMI 48 trial",
        "link": "https://vivli.org/efficacy-and-safety-of-edoxaban-versus-warfarin-in-patients-with-atrial-fibrillation-and-frailty-insights-from-the-engage-af-timi-48-trial/",
        "year": "2020",
        "study_id": [
            "NCT00781391"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4541",
        "lead_investigator": "C Elizabeth Caldon",
        "lead_institution": "Garvan Institute of Medical Research",
        "study_title": "Therapeutic targeting of dual CDK4/6 inhibitor and endocrine resistant breast cancer",
        "link": "https://vivli.org/therapeutic-targeting-of-dual-cdk4-6-inhibitor-and-endocrine-resistant-breast-cancer/",
        "year": "2020",
        "study_id": [
            "NCT01942135",
            "NCT01942135",
            "NCT01942135"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "4913",
        "lead_investigator": "Susan Halabi",
        "lead_institution": "Duke University",
        "study_title": "Surrogate Endpoints of Overall Survival in Non-Metastatic Renal Clear Cell Carcinoma",
        "link": "https://vivli.org/surrogate-endpoints-of-overall-survival-in-non-metastatic-renal-clear-cell-carcinoma/",
        "year": "2020",
        "study_id": [
            "NCT00326898",
            "NCT00375674",
            "NCT01599754"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "4915",
        "lead_investigator": "Rachel Tomko",
        "lead_institution": "Medical University of South Carolina",
        "study_title": "Predicting Individuals' Probability of Response to Smoking Cessation Pharmacotherapy",
        "link": "https://vivli.org/predicting-individuals-probability-of-response-to-smoking-cessation-pharmacotherapy/",
        "year": "2020",
        "study_id": [
            "NCT01456936"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4917",
        "lead_investigator": "Andrea Cipriani",
        "lead_institution": "University of Oxford",
        "study_title": "Choosing the Right Antidepressant for Depressive Disorder in Adults: Individual Patient Data Network Meta-Analysis",
        "link": "https://vivli.org/choosing-the-right-antidepressant-for-depressive-disorder-in-adults-individual-patient-data-network-meta-analysis",
        "year": "2021",
        "study_id": [
            "NCT01808651",
            "NCT01808612",
            "NCT01070329",
            "NCT01000805",
            "NCT00960986",
            "NCT00896363",
            "NCT00635219",
            "NCT00811252",
            "NCT01140906",
            "NCT01571453",
            "NCT01422213",
            "NCT02191397"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "4918",
        "lead_investigator": "Nina Hilkens",
        "lead_institution": "Radboudmc Nijmegen",
        "study_title": "Association between blood pressure, blood pressure variability and the risk of post-stroke dementia",
        "link": "https://vivli.org/ association-between-blood-pressure-blood-pressure-variability-and-the-risk-of-post-stroke-dementia/",
        "year": "2020",
        "study_id": [
            "NCT00153062"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4919",
        "lead_investigator": "Hendrik Jan Guchelaar",
        "lead_institution": "Leiden University Medical Center (LUMC)",
        "study_title": "Effect of digoxin on survival outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors",
        "link": "https://vivli.org/effect-of-digoxin-on-survival-outcome-in-metastatic-renal-cell-carcinoma-patients-treated-with-tyrosine-kinase-inhibitors/",
        "year": "2019",
        "study_id": [
            "NCT00054886",
            "NCT00077974",
            "NCT00267748",
            "NCT00338884",
            "NCT00137423",
            "NCT00254540",
            "NCT00089648",
            "NCT00835978",
            "NCT00083889",
            "NCT00678392",
            "NCT00474786",
            "NCT00920816",
            "NCT00054886",
            "NCT00077974",
            "NCT00267748",
            "NCT00338884",
            "NCT00137423",
            "NCT00254540",
            "NCT00089648",
            "NCT00835978",
            "NCT00083889",
            "NCT00678392",
            "NCT00474786",
            "NCT00920816"
        ],
        "number_of_studies": 24
    },
    {
        "request_id": "4920",
        "lead_investigator": "Gustavo Turecki",
        "lead_institution": "Douglas Mental Health University Institute",
        "study_title": "Predicting Treatment Efficacy in Individuals with Major Depression -- Deep Neural Networks  for Physiological Patient Parameters",
        "link": "https://vivli.org/predicting-treatment-efficacy-in-individuals-with-major-depression-deep-neural-networks-for-physiological-patient-parameters/",
        "year": "2019",
        "study_id": [
            "NCT00863798",
            "NCT00824291",
            "NCT00406640",
            "NCT00369343",
            "NCT00075257",
            "NCT01309542",
            "NCT00063206",
            "NCT00072774",
            "NCT00073762",
            "NCT00090649",
            "NCT00087737",
            "NCT00092911",
            "NCT00452595",
            "NCT00887224",
            "NCT01432457",
            "NCT01121484",
            "NCT01372150",
            "NCT01371734",
            "NCT00798707",
            "NCT00831415",
            "NCT01371708",
            "NCT01371721",
            "NCT01056289",
            "NCT00277823",
            "NCT00300378",
            "NCT00384033"
        ],
        "number_of_studies": 26
    },
    {
        "request_id": "4921",
        "lead_investigator": "Tim Bru\u0308mmendorf",
        "lead_institution": "University Hospital Aachen",
        "study_title": "Entropy based Biomarkers for individualized response on Bosutinib treatment in chronic phase CML",
        "link": "https://vivli.org/entropy-based-biomarkers-for-individualized-response-on-bosutinib-treatment-in-chronic-phase-cml/",
        "year": "2020",
        "study_id": [
            "NCT00574873"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4922, 3274",
        "lead_investigator": "Diane van der Woude",
        "lead_institution": "Leiden University Medical Center\u200b",
        "study_title": "Effect of rheumatoid factor and anticitrullinated peptide antibody on the efficacy of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis",
        "link": "https://vivli.org/effect-of-rheumatoid-factor-and-anticitrullinated-peptide-antibody-on-the-efficacy-of-biological/",
        "year": "2022",
        "study_id": [
            "NCT00235859",
            "NCT00393471",
            "NCT00195494",
            "NCT00445770"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "4926",
        "lead_investigator": "Eva-Maria Gamper",
        "lead_institution": "Medical University Innsbruck",
        "study_title": "Comparison of the EORTC QLU-C10D with generic utility instruments and development of a comprehensive manual for its use",
        "link": "https://vivli.org/comparison-of-the-eortc-qlu-c10d-with-generic-utility-instruments-and-development-of-a-comprehensive-manual-for-its-use/",
        "year": "2020",
        "study_id": [
            "NCT00949650",
            "NCT01523587",
            "NCT00656136",
            "NCT01085136"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "4931",
        "lead_investigator": "Siddharth Singh",
        "lead_institution": "University of California, San Diego",
        "study_title": "Early changes in inflammatory biomarkers and long-term outcomes in patients with IBD: A pooled post-hoc analyses of clinical trials",
        "link": "https://vivli.org/early-changes-in-inflammatory-biomarkers-and-long-term-outcomes-in-patients-with-ibd-a-pooled-post-hoc-analyses-of-clinical-trials/",
        "year": "2020",
        "study_id": [
            "NCT00055523",
            "NCT00105300",
            "NCT00195715",
            "NCT00348283",
            "NCT00409682",
            "NCT00445432",
            "NCT00445939",
            "NCT00783692",
            "NCT01224171",
            "NCT01235689",
            "NCT01958827",
            "NCT02015793",
            "NCT02499783",
            "NCT02039505",
            "NCT01550965",
            "NCT01177228",
            "NCT00853099",
            "NCT00783718",
            "NCT00619489",
            "NCT00408629",
            "NCT00385736"
        ],
        "number_of_studies": 21
    },
    {
        "request_id": "4933",
        "lead_investigator": "Hongxia Wang",
        "lead_institution": "Shanghai Jiao Tong University School of Medicine",
        "study_title": "Novel predictive biomarker for therapeutic sensitivity of CKD4/6 inhibitor in breast cancer patients",
        "link": "https://vivli.org/novel-predictive-biomarker-for-therapeutic-sensitivity-of-ckd4-6-inhibitor-in-breast-cancer-patients/",
        "year": "2020",
        "study_id": [
            "NCT01740427"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "4949, 3190",
        "lead_investigator": "Vivek Rudrapatna",
        "lead_institution": "University of California San Francisco",
        "study_title": "Efficacy of Crohn\u2019s Disease Treatment Stratified by Disease Phenotype",
        "link": "https://vivli.org/efficacy-of-crohns-disease-treatment-stratified-by-disease-phenotype/",
        "year": "2020",
        "study_id": [
            "NCT02499783",
            "NCT00445432",
            "NCT00055497",
            "NCT00348283",
            "NCT00445939",
            "NCT00077779",
            "NCT00105300",
            "NCT00055523",
            "NCT00078611",
            "NCT00032799",
            "NCT01224171",
            "NCT00032786",
            "NCT00783692",
            "NCT00207662",
            "NCT00094458",
            "NCT01369342",
            "NCT01369329",
            "NCT01190839",
            "NCT00771667",
            "NCT00269854",
            "NCT00207766",
            "NCT01369355",
            "NCT00265122",
            "NCT00152490",
            "NCT00152425",
            "NCT00552058",
            "NCT00291668",
            "NCT00308581"
        ],
        "number_of_studies": 28
    },
    {
        "request_id": "4950",
        "lead_investigator": "John \u201cDevin\u201d Peipert",
        "lead_institution": "Northwestern University",
        "study_title": "Justification of PROMIS (FACIT) Fatigue Short Form 10a scale for FDA Drug Development ToolQualification in Rheumatoid Arthritis",
        "link": "https://vivli.org/justification-of-promis-facit-fatigue-short-form-10a-scale-for-fda-drug-development-toolqualification-in-rheumatoid-arthritis/",
        "year": "2020",
        "study_id": [
            "NCT00234897",
            "NCT00420927"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5073",
        "lead_investigator": "Philip Robinson",
        "lead_institution": "University of Queensland",
        "study_title": "Assessment of treatment outcome using ASAS40 with etanercept in non-radiographic axSpA by baseline CRP - a re-analysis of trial data",
        "link": "https://vivli.org/assessment-of-treatment-outcome-using-asas40-with-etanercept-in-non-radiographic-axspa-by-baseline-crp-a-re-analysis-of-trial-data/",
        "year": "2020",
        "study_id": [
            "NCT01258738"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5074",
        "lead_investigator": "Sebastian Zundler",
        "lead_institution": "University Hospital Erlangen",
        "study_title": "Evaluation of the relationship between vedolizumab peripheral blood serum level at week 6 and binary clinical outcomes at week 10/14 - a meta-analysis",
        "link": "https://vivli.org/evaluation-of-the-relationship-between-vedolizumab-peripheral-blood-serum-level-at-week-6-and-binary-clinical-outcomes-at-week-10-14-a-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT02039505",
            "NCT01224171",
            "NCT00783718",
            "NCT00783692"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "5079",
        "lead_investigator": "Maureen Dubreuil",
        "lead_institution": "Boston University",
        "study_title": "Clinical and MRI predictors of Clinical Response in Axial Spondyloarthritis",
        "link": "https://vivli.org/clinical-and-mri-predictors-of-clinical-response-in-axial-spondyloarthritis/",
        "year": "2020",
        "study_id": [
            "NCT00939003"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5080",
        "lead_investigator": "Joel Skaistis",
        "lead_institution": "Beaumont Health",
        "study_title": "Benefit of Anticoagulation in Cryptogenic Stroke According to Biomarker Level",
        "link": "https://vivli.org/benefit-of-anticoagulation-in-cryptogenic-stroke-according-to-biomarker-level/",
        "year": "2020",
        "study_id": [
            "NCT02239120"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5086",
        "lead_investigator": "Junko Takeshita",
        "lead_institution": "University of Pennsylvania",
        "study_title": "A Systematic Review to Describe the Demographic Diversity of Dermatologic Clinical Trial Participants for Common Dermatologic Diseases",
        "link": "https://vivli.org/a-systematic-review-to-describe-the-demographic-diversity-of-dermatologic-clinical-trial-participants-for-common-dermatologic-diseases/",
        "year": "2020",
        "study_id": [
            "NCT01646177",
            "NCT02718898",
            "NCT02513550",
            "NCT01597245",
            "NCT01474512",
            "NCT02694523",
            "NCT02684370",
            "NCT02684357",
            "NCT02016482",
            "NCT02260986",
            "NCT02277743",
            "NCT02277769"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "5095",
        "lead_investigator": "Mathilde Nijkeuter",
        "lead_institution": "University Medical Center Utrecht",
        "study_title": "Assessing bleeding risk in patients with cancer-associated thrombosis",
        "link": "https://vivli.org/assessing-bleeding-risk-in-patients-with-cancer-associated-thrombosis/",
        "year": "2020",
        "study_id": [
            "NCT02073682"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5096",
        "lead_investigator": "Joo Sang Lee",
        "lead_institution": "Samsung Medical Center, South Korea",
        "study_title": "Harnessing genetic interactions to advance precision cancer medicine",
        "link": "https://vivli.org/harnessing-genetic-interactions-to-advance-precision-cancer-medicine/",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "5098",
        "lead_investigator": "Christopher Baethge",
        "lead_institution": "University of Cologne Medical School",
        "study_title": "Dose-response relationships in antidepressant pharmacotherapy of depressive disorders with (S)SNRI: a systematic review and meta-analysis",
        "link": "https://vivli.org/dose-response-relationships-in-antidepressant-pharmacotherapy-of-depressive-disorders-with-ssnri-a-systematic-review-and-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT00067912"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5099",
        "lead_investigator": "Jorge Hernando",
        "lead_institution": "Vall d \u0301Hebron University Hospital",
        "study_title": "Impact of gender on multikinase inhibitors (MKIs) toxicity in patients (pts) with advanced pancreatic and gastrointestinal neuroendocrine tumors (NETs)",
        "link": "https://vivli.org/ impact-of-gender-on-multikinase-inhibitors-mkis-toxicity-in-patients-pts-with-advanced-pancreatic-and-gastrointestinal-neuroendocrine-tumors-nets/",
        "year": "2020",
        "study_id": [
            "NCT00428597",
            "NCT00056693"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5163",
        "lead_investigator": "Susan Bates",
        "lead_institution": "Columbia University Medical Center",
        "study_title": "Assessing the tumor growth and decay rates in patients with pancreatic cancer treated with Gemcitabine/Abraxane: Comparing real world data with clinical trial data",
        "link": "https://vivli.org/assessing-the-tumor-growth-and-decay-rates-in-patients-with-pancreatic-cancer-treated-with-gemcitabine-abraxane-comparing-real-world-data-with-clinical-trial-data",
        "year": "2020",
        "study_id": [
            "NCT00844649",
            "NCT00844649"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5165",
        "lead_investigator": "Byeongzu Ghang",
        "lead_institution": "Jeju National University Hospital",
        "study_title": "Reanalysis of CARES study to investigate the incidence of cardiovascular events and death after initiation and discontinuation of allopurinol and febuxostat",
        "link": "https://vivli.org/reanalysis-of-cares-study-to-investigate-the-incidence-of-cardiovascular-events-and-death-after-initiation-and-discontinuation-of-allopurinol-and-febuxostat/",
        "year": "2020",
        "study_id": [
            "NCT01101035"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5166",
        "lead_investigator": "Thomas Metkus",
        "lead_institution": "Johns Hopkins University School of Medicine",
        "study_title": "Severe sepsis in the cardiac intensive care unit: management strategies and outcomes",
        "link": "https://vivli.org/severe-sepsis-in-the-cardiac-intensive-care-unit-management-strategies-and-outcomes/",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "5207",
        "lead_investigator": "Fasihul Khan",
        "lead_institution": "University of Nottingham",
        "study_title": "A systematic review and individual patient data meta-analysis of physiological biomarkers in idiopathic pulmonary fibrosis",
        "link": "https://vivli.org/a-systematic-review-and-individual-patient-data-meta-analysis-of-physiological-biomarkers-in-idiopathic-pulmonary-fibrosis/",
        "year": "2020",
        "study_id": [
            "NCT00514683",
            "NCT01335477",
            "NCT01335464",
            "NCT00903331",
            "NCT00391443",
            "NCT00071461",
            "NCT00957242",
            "NCT00650091",
            "NCT00287716",
            "NCT00287729",
            "NCT01366209"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "5209",
        "lead_investigator": "Bruce Perkins",
        "lead_institution": "University of Toronto",
        "study_title": "TRIAL-INFORMED DKA MITIGATION EDUCATIONAL TOOL",
        "link": "https://vivli.org/trial-informed-dka-mitigation-educational-tool/",
        "year": "2020",
        "study_id": [
            "NCT02580591",
            "NCT02414958"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5276",
        "lead_investigator": "Yan Luo",
        "lead_institution": "Kyoto University",
        "study_title": "Predicting the Treatment Response of Certolizumab for Individual Patients with Rheumatoid Arthritis: An Individual Participant Data Meta-Analysis",
        "link": "https://vivli.org/predicting-the-treatment-response-of-certolizumab-for-individual-patients-with-rheumatoid-arthritis-an-individual-participant-data-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT00544154",
            "NCT00160602",
            "NCT00152386",
            "NCT00717236",
            "NCT00674362",
            "NCT00580840",
            "NCT01521923",
            "NCT01519791",
            "NCT01235598"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "5290",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Predictors of therapeutic and adverse effects of medicines used in the treatment of gastrointestinal cancers",
        "link": "https://vivli.org/predictors-of-therapeutic-and-adverse-effects-of-medicines-used-in-the-treatment-of-gastrointestinal-cancers/",
        "year": "2020",
        "study_id": [
            "NCT01183780",
            "NCT02314117",
            "NCT01170663",
            "NCT00917384",
            "NCT01041404",
            "NCT00548548",
            "NCT00652366",
            "NCT00700102",
            "NCT00112918",
            "NCT01641939",
            "NCT01214720",
            "NCT00069121",
            "NCT00069108",
            "NCT00069095",
            "NCT00887822",
            "NCT00388206",
            "NCT00109226",
            "NCT00109070",
            "NCT01004003",
            "NCT00987935",
            "NCT01258608",
            "NCT00674973",
            "NCT02149108",
            "NCT00115765",
            "NCT01001377",
            "NCT01412957",
            "NCT00364013",
            "NCT00113763",
            "NCT00339183"
        ],
        "number_of_studies": 29
    },
    {
        "request_id": "5291",
        "lead_investigator": "Sarah Nevitt",
        "lead_institution": "University of Liverpool",
        "study_title": "Antiepileptic drug monotherapy for epilepsy: an updated Cochrane review and individual participant data network meta-analysis",
        "link": "https://vivli.org/antiepileptic-drug-monotherapy-for-epilepsy-an-updated-cochrane-review-and-individual-participant-data-network-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT01498822",
            "NCT01243177",
            "NCT01954121"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5292",
        "lead_investigator": "D\u00e9sir\u00e9e van der Heijde",
        "lead_institution": "Leiden University Medical Center",
        "study_title": "Measurement properties of the instruments used in the outcome assessment of axial spondyloarthritis",
        "link": "https://vivli.org/measurement-properties-of-the-instruments-used-in-the-outcome-assessment-of-axial-spondyloarthritis/",
        "year": "2020",
        "study_id": [
            "NCT01087762"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5294",
        "lead_investigator": "Daniel Caldeira",
        "lead_institution": "University of Lisbon/CCUL",
        "study_title": "The clinical impact of dabigratran in patients with non-valvular atrial fibrillation who had a fall or head injury: a retrospective analysis of RE-LY",
        "link": "https://vivli.org/the-clinical-impact-of-dabigratran-in-patients-with-non-valvular-atrial-fibrillation-who-had-a-fall-or-head-injury-a-retrospective-analysis-of-re-ly /",
        "year": "2020",
        "study_id": [
            "NCT00262600"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5325, 5324",
        "lead_investigator": "Daniel Goldenholz",
        "lead_institution": "Beth Israel Deaconess Medical Center",
        "study_title": "Retrospective analysis of placebo arm data in clinical epilepsy trials",
        "link": "https://vivli.org/retrospective-analysis-of-placebo-arm-data-in-clinical-epilepsy-trials/",
        "year": "2020",
        "study_id": [
            "NCT00783692",
            "NCT00220415",
            "NCT00160550",
            "NCT00490035",
            "NCT00464269",
            "NCT01261325",
            "NCT00104416",
            "NCT00113165",
            "NCT00043875",
            "NCT00232596",
            "NCT00235755",
            "NCT01648101",
            "NCT00141258"
        ],
        "number_of_studies": 13
    },
    {
        "request_id": "5330",
        "lead_investigator": "Laura Bonnett",
        "lead_institution": "University of Liverpool",
        "study_title": "Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs",
        "link": "https://vivli.org/modelling-seizure-rates-rather-than-time-to-an-event-within-clinical-trials-of-antiepileptic-drugs/",
        "year": "2020",
        "study_id": [
            "NCT00150735",
            "NCT01243177"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5352",
        "lead_investigator": "Elena Myasoedova",
        "lead_institution": "Mayo Clinic",
        "study_title": "Individualized Prediction of Treatment Response to Methotrexate in Patients with Rheumatoid Arthritis: A Machine Learning Approach",
        "link": "https://vivli.org/individualized-prediction-of-treatment-response-to-methotrexate-in-patients-with-rheumatoid-arthritis-a-machine-learning-approach/",
        "year": "2020",
        "study_id": [
            "NCT00544154",
            "NCT00160602",
            "NCT00717236",
            "NCT01521923",
            "NCT01519791",
            "NCT00266227",
            "NCT00106548",
            "NCT00106535",
            "NCT00109408",
            "NCT00106522",
            "NCT01007435",
            "NCT00468546",
            "NCT00299130",
            "NCT00299104",
            "NCT00406419",
            "NCT00673920",
            "NCT00485589"
        ],
        "number_of_studies": 17
    },
    {
        "request_id": "5435",
        "lead_investigator": "Matthew Gilbert",
        "lead_institution": "University of Vermont",
        "study_title": "Effect of Albiglutide on Cardiovascular Outcomes in Older Adults with Type 2 Diabetes: a Post Hoc Analysis of a Randomized Controlled Trial",
        "link": "https://vivli.org/effect-of-albiglutide-on-cardiovascular-outcomes-in-older-adults-with-type-2-diabetes-a-post-hoc-analysis-of-a-randomized-controlled-trial/",
        "year": "2020",
        "study_id": [
            "NCT02465515",
            "NCT02465515"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5436",
        "lead_investigator": "Adrian Wagg",
        "lead_institution": "University of Alberta",
        "study_title": "A pooled analysis of the efficacy and tolerability of tolterodine for the treatment of Overactive Bladder (OAB) in patients over the age of 65 years of age",
        "link": "https://vivli.org/a-pooled-analysis-of-the-efficacy-and-tolerability-of-tolterodine-for-the-treatment-of-overactive-bladder-oab-in-patients-over-the-age-of-65-years-of-age/",
        "year": "2021",
        "study_id": [
            "NCT00143481"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5456",
        "lead_investigator": "Ramona Belfiore-Oshan",
        "lead_institution": "Critical Path Institute",
        "study_title": "Validation of a Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Design of Studies to Investigate Efficacy of Potential Therapies for Duchenne Muscular Dystrophy",
        "link": "https://vivli.org/validation-of-a-model-based-clinical-trial-simulation-tool-to-optimize-clinical-trial-design-of-studies-to-investigate-efficacy-of-potential-therapies-for-duchenne-muscular-dystrophy/",
        "year": "2020",
        "study_id": [
            "NCT01753804",
            "NCT01254019",
            "NCT01153932",
            "NCT01462292"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "5483",
        "lead_investigator": "David McAllister",
        "lead_institution": "University of Glasgow",
        "study_title": "Assessing heterogeneity in relative treatment efficacy by age, sex and comorbidity.",
        "link": "https://vivli.org/assessing-heterogeneity-in-relative-treatment-efficacy-by-age-sex-and-comorbidity/\u201d",
        "year": "2021",
        "study_id": [
            "NCT00240435",
            "NCT00168844",
            "NCT00168831",
            "NCT00479401",
            "NCT00402233",
            "NCT00472199",
            "NCT00466167",
            "NCT00321854",
            "NCT00926289",
            "NCT00525512",
            "NCT00563381",
            "NCT00274612",
            "NCT00153023",
            "NCT00034840",
            "NCT00153088",
            "NCT00274599",
            "NCT00168857",
            "NCT00239408",
            "NCT00274014",
            "NCT00239421",
            "NCT00274547",
            "NCT00274053",
            "NCT00274560",
            "NCT00277264",
            "NCT00274573",
            "NCT02177344",
            "NCT02175355",
            "NCT02177461",
            "NCT02177396",
            "NCT02181998",
            "NCT02172287",
            "NCT00321984",
            "NCT00627016",
            "NCT00255190",
            "NCT00251693",
            "NCT00251719",
            "NCT00255164",
            "NCT00255151",
            "NCT00321737",
            "NCT00251745",
            "NCT00251758",
            "NCT00783718",
            "NCT01087762",
            "NCT01087788",
            "NCT00782509",
            "NCT00782210",
            "NCT00793624",
            "NCT02200640",
            "NCT02200653",
            "NCT00274079",
            "NCT01164501",
            "NCT01370005",
            "NCT02183064",
            "NCT01191944",
            "NCT02242318",
            "NCT01126437",
            "NCT01694771",
            "NCT01335464",
            "NCT01335477",
            "NCT00174915",
            "NCT00102440",
            "NCT00175019",
            "NCT00430248",
            "NCT00152984",
            "NCT02172586",
            "NCT00776984",
            "NCT00772538",
            "NCT00552058",
            "NCT00490035",
            "NCT00464269",
            "NCT00975195",
            "NCT01719003",
            "NCT00856284",
            "NCT01075282",
            "NCT01474512",
            "NCT01597245",
            "NCT01646177",
            "NCT00125918",
            "NCT00861757",
            "NCT00384930",
            "NCT00827242",
            "NCT00855582",
            "NCT00848081",
            "NCT00970632",
            "NCT01769378",
            "NCT01624259",
            "NCT01191268",
            "NCT01126580",
            "NCT01064687",
            "NCT00734474",
            "NCT00968708",
            "NCT00051558",
            "NCT00670501",
            "NCT00670319",
            "NCT00591578",
            "NCT00760214",
            "NCT00696436",
            "NCT00696384",
            "NCT00591253",
            "NCT00591266",
            "NCT00591773",
            "NCT00696241",
            "NCT01209702",
            "NCT00106535",
            "NCT01119859",
            "NCT01007435",
            "NCT01232569",
            "NCT01287117",
            "NCT01292473",
            "NCT01264939"
        ],
        "number_of_studies": 110
    },
    {
        "request_id": "5567",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "McMaster University",
        "study_title": "Impact of Ulcer Size and Extent of Inflammation On Ability To Achieve Endoscopic Healing In Crohns Disease: An EXTEND Post-Hoc Analysis",
        "link": "https://vivli.org/impact-of-ulcer-size-and-extent-of-inflammation-on-ability-to-achieve-endoscopic-healing-in-crohns-disease-an-extend-post-hoc-analysis/",
        "year": "2020",
        "study_id": [
            "NCT00348283"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5812",
        "lead_investigator": "Yougen Wu",
        "lead_institution": "The Fifth People's Hospital of Shanghai, Fudan University",
        "study_title": "Development and validation of nomograms for predicting efficacy and toxicity in cancer patients treated with immune checkpoint inhibitors",
        "link": "https://vivli.org/development-and-validation-of-nomograms-for-predicting-efficacy-and-toxicity-in-cancer-patients-treated-with-immune-checkpoint-inhibitors/",
        "year": "2020",
        "study_id": [
            "NCT02951767",
            "NCT02302807",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01903993",
            "NCT01846416",
            "NCT01984242"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "5813",
        "lead_investigator": "Phillip Garfin",
        "lead_institution": "Seattle Genetics Inc.",
        "study_title": "Effectiveness of cytotoxic chemotherapy for the treatment metastatic breast cancer subtypes",
        "link": "https://vivli.org/effectiveness-of-cytotoxic-chemotherapy-for-the-treatment-metastatic-breast-cancer-subtypes/",
        "year": "2020",
        "study_id": [
            "NCT00109239",
            "NCT00333775",
            "NCT00262067",
            "NCT01663727",
            "NCT00281697"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "5852",
        "lead_investigator": "Marliese Alexander",
        "lead_institution": "Peter MacCallum Cancer Centre",
        "study_title": "Infective outcomes in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: an individual patient data meta-analysis",
        "link": "https://vivli.org/infective-outcomes-in-cancer-patients-treated-with-subcutaneous-versus-intravenous-trastuzumab-and-rituximab-an-individual-patient-data-meta-analysis",
        "year": "2020",
        "study_id": [
            "NCT00930514",
            "NCT01200758",
            "NCT01292603",
            "NCT01649856",
            "NCT01724021",
            "NCT00950300",
            "NCT01401166"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "5853",
        "lead_investigator": "Florian Naudet",
        "lead_institution": "CHU Rennes",
        "study_title": "Data-sharing and re-analysis for main studies assessed by the European Medicines Agency - a cross-sectional study on European Public Assessment Reports",
        "link": "https://vivli.org/data-sharing-and-re-analysis-for-main-studies-assessed-by-the-european-medicines-agency-a-cross-sectional-study-on-european-public-assessment-reports/",
        "year": "2021",
        "study_id": [
            "NCT02636595"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5869",
        "lead_investigator": "Alexandra Freeman",
        "lead_institution": "University of Cambridge",
        "study_title": "Meta-analysis of the adverse effects of trastuzumab in women with breast cancer",
        "link": "https://vivli.org/meta-analysis-of-the-adverse-effects-of-trastuzumab-in-women-with-breast-cancer",
        "year": "2020",
        "study_id": [
            "NCT00045032"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5871",
        "lead_investigator": "Nobuhisa Kanahara",
        "lead_institution": "Chiba University Center for Forensic Mental Health",
        "study_title": "Determination of dopamine supersensitivity psychosis in randomized controlled studies of long-acting injectable vs. oral agents of the same atypical antipsychotic in schizophrenia subjects",
        "link": "https://vivli.org/determination-of-dopamine-supersensitivity-psychosis-in-randomized-controlled-studies-of-long-acting-injectable-vs-oral-agents-of-the-same-atypical-antipsychotic-in-schizophrenia-subjects/",
        "year": "2020",
        "study_id": [
            "NCT00088491",
            "NCT00320489"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5872",
        "lead_investigator": "Yaw Nyame",
        "lead_institution": "University of Washington Medical Center",
        "study_title": "Representation of Low-Grade Prostate Cancer in Metastatic Prostate Cancer Trials",
        "link": "https://vivli.org/representation-of-low-grade-prostate-cancer-in-metastatic-prostate-cancer-trials/",
        "year": "2020",
        "study_id": [
            "NCT01212991"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5880",
        "lead_investigator": "Benjamin Schneider",
        "lead_institution": "Iowa State University",
        "study_title": "Optimal Scheduling of First-Line Therapeutics in Non-Small Cell Lung Cancer",
        "link": "https://vivli.org/optimal-scheduling-of-first-line-therapeutics-in-non-small-cell-lung-cancer/",
        "year": "2021",
        "study_id": [
            "NCT00762034",
            "NCT01004250",
            "NCT00480831",
            "NCT00806923",
            "NCT00700180",
            "NCT00800202",
            "NCT00312728",
            "NCT02596958",
            "NCT01364012",
            "NCT00388206",
            "NCT02031458",
            "NCT01984242",
            "NCT02008227",
            "NCT01846416",
            "NCT01903993"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "5894",
        "lead_investigator": "Takashi Sozu",
        "lead_institution": "Tokyo University of Science",
        "study_title": "Matrix Decomposition in Meta-Analysis for Extraction of Adverse Event Pattern and Patient-Level Safety Profile",
        "link": "https://vivli.org/matrix-decomposition-in-meta-analysis-for-extraction-of-adverse-event-pattern-and-patient-level-safety-profile/",
        "year": "2020",
        "study_id": [
            "NCT02314117",
            "NCT01183780",
            "NCT01170663",
            "NCT01168973",
            "NCT00917384",
            "NCT00703326"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "5897",
        "lead_investigator": "John Peipert",
        "lead_institution": "Northwestern University",
        "study_title": "Justification of PROMIS (FACIT) Fatigue Short Form 10a scale for FDA Drug Development Tool Qualification in Rheumatoid Arthritis",
        "link": "https://vivli.org/justification-of-promis-facit-fatigue-short-form-10a-scale-for-fda-drug-development-tool-qualification-in-rheumatoid-arthritis/",
        "year": "2022",
        "study_id": [
            "NCT00847613",
            "NCT00814307",
            "NCT00960440",
            "NCT01039688",
            "NCT00853385",
            "NCT00853385",
            "NCT00856544",
            "NCT00856544",
            "NCT02187055",
            "NCT02187055",
            "NCT00413699",
            "NCT00413699"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "5901",
        "lead_investigator": "Junhao Hu",
        "lead_institution": "Chinese Academy of Science",
        "study_title": "Vessel pericytes NO-sGC signaling in COVID-19",
        "link": "https://vivli.org/vessel-pericytes-no-sgc-signaling-in-covid-19/",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "5902",
        "lead_investigator": "Thrasyvoulos Tzellos",
        "lead_institution": "Norland University Hospital",
        "study_title": "Development and validation of a IHS4 dichotomous outcome for assessing anti-inflammatory treatment efficacy for the treatment of hidradenitis suppurativa",
        "link": "https://vivli.org/development-and-validation-of-a-ihs4-dichotomous-outcome-for-assessing-anti-inflammatory-treatment-efficacy-for-the-treatment-of-hidradenitis-suppurativa/",
        "year": "2020",
        "study_id": [
            "NCT01468207",
            "NCT01468233"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5904",
        "lead_investigator": "Saskia Middeldorp",
        "lead_institution": "Amsterdam UMC",
        "study_title": "Hokusai post VTE study: long-term outcome after heparin plus edoxaban versus heparin plus vitamin K antagonists for acute deep vein thrombosis and pulmonary embolism",
        "link": "https://vivli.org/hokusai-post-vte-study-long-term-outcome-after-heparin-plus-edoxaban-versus-heparin-plus-vitamin-k-antagonists-for-acute-deep-vein-thrombosis-and-pulmonary-embolism/",
        "year": "2020",
        "study_id": [
            "NCT00986154"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5921",
        "lead_investigator": "Paul Schulz",
        "lead_institution": "University of Texas Health Science Center",
        "study_title": "Identification of biomarkers associated with Alzheimer\u2019s disease progression that correlate with responses to medications",
        "link": "https://vivli.org/identification-of-biomarkers-associated-with-alzheimers-disease-progression-that-correlate-with-responses-to-medications/",
        "year": "2021",
        "study_id": [
            "NCT00762411",
            "NCT00594568",
            "NCT01035138"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5924",
        "lead_investigator": "Iris Sommer",
        "lead_institution": "University Medical Center Groningen",
        "study_title": "Meta-analysis of efficacy of cholinesterase inhibitors on individual neuropsychiatric symptoms in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies",
        "link": "https://vivli.org/meta-analysis-of-efficacy-of-cholinesterase-inhibitors-on-individual-neuropsychiatric-symptoms-in-alzheimers-disease-parkinsons-disease-and-dementia-with-lewy-bodies/",
        "year": "2021",
        "study_id": [
            "NCT00428090",
            "NCT00253227",
            "NCT00253214"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5925",
        "lead_investigator": "Min Hwan Kim",
        "lead_institution": "Yonsei University College of Medicine",
        "study_title": "Analysis of neutrophil to lymphocyte ratio (NLR) in ER+ breast cancer patients to predict palbociclib clinical response",
        "link": "https://vivli.org/analysis-of-neutrophil-to-lymphocyte-ratio-nlr-in-er-breast-cancer-patients-to-predict-palbociclib-clinical-response/",
        "year": "2020",
        "study_id": [
            "NCT01740427",
            "NCT01942135"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5930",
        "lead_investigator": "Youssef Zeidan",
        "lead_institution": "American University of Beirut Medical Center",
        "study_title": "Evaluation of Radiotherapy Boost in Women with HER-2 positive Breast Cancer",
        "link": "https://vivli.org/evaluation-of-radiotherapy-boost-in-women-with-her-2-positive-breast-cancer/",
        "year": "2020",
        "study_id": [
            "NCT00045032"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5931",
        "lead_investigator": "Youssef Zeidan",
        "lead_institution": "American University of Beirut Medical Center",
        "study_title": "Evaluation of Radiotherapy in Triple Negative Breast Cancer: Analysis of the BEATRICE trial",
        "link": "https://vivli.org/evaluation-of-radiotherapy-in-triple-negative-breast-cancer-analysis-of-the-beatrice-trial/",
        "year": "2020",
        "study_id": [
            "NCT00052856"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5933, 5208",
        "lead_investigator": "Ahmad Abuhelwa",
        "lead_institution": "University of South Australia",
        "study_title": "Predictors of exposure, therapeutic and adverse effects of certolizumab pegol and baricitinib used in the treatment of rheumatoid arthritis",
        "link": "https://vivli.org/predictors-of-exposure-therapeutic-and-adverse-effects-of-certolizumab-pegol-and-baricitinib-used-in-the-treatment-of-rheumatoid-arthritis/",
        "year": "2020",
        "study_id": [
            "NCT00544154",
            "NCT00160602",
            "NCT00152386",
            "NCT00717236",
            "NCT00548834",
            "NCT00175877",
            "NCT00160641",
            "NCT01500278",
            "NCT01521923",
            "NCT01519791",
            "NCT00160693",
            "NCT01255761",
            "NCT01721044",
            "NCT01721057",
            "NCT01711359",
            "NCT01710358",
            "NCT01469013",
            "NCT01185353",
            "NCT00106548",
            "NCT00106535",
            "NCT00109408",
            "NCT00106522",
            "NCT00106574",
            "NCT00721123",
            "NCT00720798",
            "NCT01232569",
            "NCT01007435",
            "NCT01194414",
            "NCT01119859",
            "NCT00531817"
        ],
        "number_of_studies": 30
    },
    {
        "request_id": "5940",
        "lead_investigator": "Aziz Mezlini",
        "lead_institution": "Massachusetts General Hospital",
        "study_title": "A novel statistical approach to detect the efficacy of drugs that have heterogeneous treatment effects",
        "link": "https://vivli.org/a-novel-statistical-approach-to-detect-the-efficacy-of-drugs-that-have-heterogeneous-treatment-effects/",
        "year": "2021",
        "study_id": [
            "NCT00428090",
            "NCT01255787",
            "NCT00195663",
            "NCT00321984",
            "NCT00635219",
            "NCT00672958",
            "NCT02389816",
            "NCT01313676",
            "NCT00144339",
            "NCT00299104",
            "NCT00531817",
            "NCT00216476",
            "NCT01262365",
            "NCT01261793",
            "NCT00679627"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "5944",
        "lead_investigator": "Pietro Spitali",
        "lead_institution": "Leiden University Medical Center",
        "study_title": "Prediction of disease progression in Duchenne muscular dystrophy",
        "link": "https://vivli.org/prediction-of-disease-progression-in-duchenne-muscular-dystrophy/",
        "year": "2020",
        "study_id": [
            "NCT01753804",
            "NCT01462292",
            "NCT01254019",
            "NCT01153932"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "5945",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "McMaster University",
        "study_title": "Predictors of Mucosal Healing in Ulcerative Colitis: A Post-hoc Analysis of VARSITY",
        "link": "https://vivli.org/predictors-of-mucosal-healing-in-ulcerative-colitis-a-post-hoc-analysis-of-varsity/",
        "year": "2020",
        "study_id": [
            "NCT02497469"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5948",
        "lead_investigator": "Georgia Salanti",
        "lead_institution": "University of Bern",
        "study_title": "Making real world predictions for clinical outcomes in Relapsing-Remitting Multiple Sclerosis",
        "link": "https://vivli.org/making-real-world-predictions-for-clinical-outcomes-in-relapsing-remitting-multiple-sclerosis/",
        "year": "2020",
        "study_id": [
            "NCT01332019",
            "NCT01064401",
            "NCT00027300"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5950",
        "lead_investigator": "Shirley Wang",
        "lead_institution": "Brigham and Women's Hospital",
        "study_title": "Understanding effectiveness of new drugs in older adults shortly after market entry",
        "link": "https://vivli.org/understanding-effectiveness-of-new-drugs-in-older-adults-shortly-after-market-entry/",
        "year": "2020",
        "study_id": [
            "NCT00262600",
            "NCT00680186"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5951, 4543",
        "lead_investigator": "Mathilde Nijkeuter",
        "lead_institution": "UMC Utrecht",
        "study_title": "Individualized prediction of recurrence risk reduction and risk of bleeding with extended anticoagulation in patients with venous thromboembolism",
        "link": "https://vivli.org/individualized-prediction-of-recurrence-risk-reduction-and-risk-of-bleeding-with-extended-anticoagulation-in-patients-with-venous-thromboembolism/",
        "year": "2020",
        "study_id": [
            "NCT00986154",
            "NCT00329238",
            "NCT00558259"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5959",
        "lead_investigator": "John Dennis",
        "lead_institution": "University of Exeter Medical School",
        "study_title": "Stratification of SGLT2 inhibitor glucose lowering therapy in Type 2 diabetes",
        "link": "https://vivli.org/stratification-of-sglt2-inhibitor-glucose-lowering-therapy-in-type-2-diabetes/",
        "year": "2020",
        "study_id": [
            "NCT00736099",
            "NCT01159600",
            "NCT01164501",
            "NCT01210001",
            "NCT01177813",
            "NCT00641043",
            "NCT00621140",
            "NCT00601250",
            "NCT00602472",
            "NCT01289990",
            "NCT01167881",
            "NCT00622284",
            "NCT00968708",
            "NCT00856284"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "5960",
        "lead_investigator": "Matt Linnik",
        "lead_institution": "Hannover Medical School",
        "study_title": "Covid-19 Pulmonary Gene Expression Analysis",
        "link": "https://vivli.org/covid-19-pulmonary-gene-expression-analysis",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "5963",
        "lead_investigator": "Elyse Katz",
        "lead_institution": "USSAMMDA",
        "study_title": "A secondary Data-Analysis to determine treatment effectiveness in Post-Traumatic Stress Disorder",
        "link": "https://vivli.org/a-secondary-data-analysis-to-determine-treatment-effectiveness-in-post-traumatic-stress-disorder/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "5968",
        "lead_investigator": "Mehul Patel",
        "lead_institution": "King's College Hospital NHS Foundation Trust",
        "study_title": "Methods for Staging disease activity In ulcerative colitis; A comparison of endoscopy and Histology (MESIAH)",
        "link": "https://vivli.org/methods-for-staging-disease-activity-in-ulcerative-colitis-a-comparison-of-endoscopy-and-histology-mesiah/",
        "year": "2022",
        "study_id": [
            "NCT02497469",
            "NCT00783718",
            "NCT00488631",
            "NCT00487539"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "5974",
        "lead_investigator": "Robert Schoevers",
        "lead_institution": "University of Groningen",
        "study_title": "Prescriber effects on outcome of psychopharmacological treatment of Major Depressive Disorder (MDD)",
        "link": "https://vivli.org/prescriber-effects-on-outcome-of-psychopharmacological-treatment-of-major-depressive-disorder-mdd/",
        "year": "2020",
        "study_id": [
            "NCT00036335",
            "NCT00073411",
            "NCT00406848"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "5981",
        "lead_investigator": "Mark Peterson",
        "lead_institution": "Vertex Pharmaceuticals",
        "study_title": "Identifying and quantifying predictors of disease progression in common measures of physical function among boys with Duchenne Muscular Dystrophy (DMD)",
        "link": "https://vivli.org/identifying-and-quantifying-predictors-of-disease-progression-in-common-measures-of-physical-function-among-boys-with-duchenne-muscular-dystrophy-dmd/",
        "year": "2021",
        "study_id": [
            "NCT01753804",
            "NCT01462292",
            "NCT01254019",
            "NCT01153932"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "5982",
        "lead_investigator": "Matthew Baker",
        "lead_institution": "Stanford University",
        "study_title": "Investigating the effects of rituximab on specific cell subsets and cytokine levels in systemic lupus erythematosus patients and constructing a prediction model of treatment response",
        "link": "https://vivli.org/investigating-the-effects-of-rituximab-on-specific-cell-subsets-and-cytokine-levels-in-systemic-lupus-erythematosus-patients-and-constructing-a-prediction-model-of-treatment-response/",
        "year": "2020",
        "study_id": [
            "NCT00282347",
            "NCT00137969"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5984",
        "lead_investigator": "David Baker",
        "lead_institution": "Queen Mary University of London",
        "study_title": "Exploring possibilities to improve the riskbenefit balance through anlaysis of the ocrelizumab phase II extension study",
        "link": "https://vivli.org/exploring-possibilities-to-improve-the-risk:benefit-balance-through-analysis-of-the-ocrelizumab-phase-ii-extension-study/",
        "year": "2020",
        "study_id": [
            "NCT00676715"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "5985, 5327",
        "lead_investigator": "Jose Antonio Pereira da Silva",
        "lead_institution": "Universidade de Coimbra, Portugal",
        "study_title": "Long-term predictive value of patient global assessment regarding radiographic damage and physical function in patients with Rheumatoid Arthritis: individual patient data meta-analysis",
        "link": "https://vivli.org/long-term-predictive-value-of-patient-global-assessment-regarding-radiographic-damage-and-physical-function-in-patients-with-rheumatoid-arthritis-individual-patient-data-meta-analysis/",
        "year": "2020",
        "study_id": [
            "NCT00195663",
            "NCT00195702",
            "NCT00160602",
            "NCT00152386",
            "NCT00175877",
            "NCT00160641",
            "NCT00393471",
            "NCT00195494",
            "NCT00106535",
            "NCT01232569",
            "NCT01007435",
            "NCT00468546",
            "NCT02097745",
            "NCT00299104"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "5987, 8728",
        "lead_investigator": "Glen Hazlewood",
        "lead_institution": "University of Calgary",
        "study_title": "Disease\u2010modifying anti\u2010rheumatic drugs for rheumatoid arthritis: A network meta-analysis incorporating individual patient data",
        "link": "https://vivli.org/disease\u2010modifying-anti\u2010rheumatic-drugs-for-rheumatoid-arthritis-a-network-meta-analysis-incorporating-individual-patient-data/",
        "year": "2022",
        "study_id": [
            "NCT01962974",
            "NCT01721057",
            "NCT01721044",
            "NCT01500278",
            "NCT01469013",
            "NCT01248780",
            "NCT01232569",
            "NCT01194414",
            "NCT01185353",
            "NCT01119859",
            "NCT00973479",
            "NCT00960440",
            "NCT00847613",
            "NCT00814307",
            "NCT00810199",
            "NCT00717236",
            "NCT00674362",
            "NCT00647920",
            "NCT00647491",
            "NCT00647270",
            "NCT00550446",
            "NCT00538902",
            "NCT00535782",
            "NCT00531817",
            "NCT00468546",
            "NCT00413660",
            "NCT00361335",
            "NCT00299546",
            "NCT00299130",
            "NCT00282308",
            "NCT00269867",
            "NCT00264550",
            "NCT00235859",
            "NCT00207714",
            "NCT00202852",
            "NCT00195702",
            "NCT00160602",
            "NCT00152386",
            "NCT00106574",
            "NCT00106548",
            "NCT00106535",
            "NCT00106522",
            "NCT00074438",
            "NCT00036387",
            "NCT01710358",
            "NCT01960855",
            "NCT01004432",
            "NCT00317538",
            "NCT01768572",
            "NCT01768572",
            "NCT01709578",
            "NCT01709578",
            "NCT01061736",
            "NCT01061736",
            "NCT01295151",
            "NCT01147341",
            "NCT01000441"
        ],
        "number_of_studies": 57
    },
    {
        "request_id": "5988",
        "lead_investigator": "Elad Sharon",
        "lead_institution": "National Cancer Institute",
        "study_title": "The Role of Targeted Agents and Their Effects on Lymphocytes and Patient Outcomes",
        "link": "https://vivli.org/the-role-of-targeted-agents-and-their-effects-on-lymphocytes-and-patient-outcomes/",
        "year": "2020",
        "study_id": [
            "NCT00679211",
            "NCT00509769",
            "NCT01006980",
            "NCT00833417",
            "NCT00528567",
            "NCT02596958",
            "NCT00467779",
            "NCT00739661",
            "NCT01201915",
            "NCT00607724",
            "NCT01641939",
            "NCT00063154",
            "NCT01286753",
            "NCT01378975",
            "NCT01248936",
            "NCT00949910",
            "NCT02774278",
            "NCT02013206",
            "NCT02271139"
        ],
        "number_of_studies": 19
    },
    {
        "request_id": "5989",
        "lead_investigator": "Alexandre Betourne",
        "lead_institution": "Critical Path Institute",
        "study_title": "Sharing of Progressive Supranuclear Palsy (PSP) data with the Rare Disease Cures Accelerator - Data and Analytics Platform for Analysis of Outcome Measures and Other Purposes",
        "link": "https://vivli.org/sharing-of-progressive-supranuclear-palsy-(psp)-data-with-the-rare-disease-cures-accelerator-data-and-analytics-platform-for-analysis-of-outcome-measures-and-other-purposes/",
        "year": "2020",
        "study_id": [
            "NCT03391765",
            "NCT02985879"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "5990",
        "lead_investigator": "Yan Luo",
        "lead_institution": "Kyoto University",
        "study_title": "Predicting the Treatment Response of Biologics for Individual Patients with Rheumatoid Arthritis: An Individual Participant Data Meta-Analysis",
        "link": "https://vivli.org/predicting-the-treatment-response-of-biologics-for-individual-patients-with-rheumatoid-arthritis-an-individual-participant-data-meta-analysis/",
        "year": "2021",
        "study_id": [
            "NCT01752855",
            "NCT01712178",
            "NCT01561313",
            "NCT01502423",
            "NCT01185301",
            "NCT01185288",
            "NCT01163617",
            "NCT00870467",
            "NCT00650390",
            "NCT00650026",
            "NCT00649545",
            "NCT00647920",
            "NCT00647491",
            "NCT00647270",
            "NCT00603993",
            "NCT00538902",
            "NCT00448383",
            "NCT00420927",
            "NCT00235872",
            "NCT00235859",
            "NCT00235833",
            "NCT00234845",
            "NCT00233571",
            "NCT00195702",
            "NCT00195663",
            "NCT00195650",
            "NCT01232569",
            "NCT01194414",
            "NCT01119859",
            "NCT01007435",
            "NCT00810199",
            "NCT00721123",
            "NCT00720798",
            "NCT00535782",
            "NCT00531817",
            "NCT00109408",
            "NCT00106574",
            "NCT00106548",
            "NCT00106535",
            "NCT00106522",
            "NCT02097745",
            "NCT02093026",
            "NCT00468546",
            "NCT00443651",
            "NCT00422383",
            "NCT00299130",
            "NCT00299104",
            "NCT00282308",
            "NCT00266227",
            "NCT00074438"
        ],
        "number_of_studies": 50
    },
    {
        "request_id": "6003",
        "lead_investigator": "Andrea Quattrone",
        "lead_institution": "Magna Graecia University of Catanzaro",
        "study_title": "Evaluation of disease progression rate in progressive supranuclear palsy using MRI biomarkers: new implications for clinical trials",
        "link": "https://vivli.org/evaluation-of-disease-progression-rate-in-progressive-supranuclear-palsy-using-mri-biomarkers-new-implications-for-clinical-trials",
        "year": "2021",
        "study_id": [
            "NCT02985879",
            "NCT02985879"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6004",
        "lead_investigator": "Lily Lim",
        "lead_institution": "University of Manitoba",
        "study_title": "Identifying Trajectories of Disease Activity States in Juvenile Idiopathic Arthritis (JIA) Early After Treatment: Shortening Time to Decision to Change Treatment",
        "link": "https://vivli.org/identifying-trajectories-of-disease-activity-states-in-juvenile-idiopathic-arthritis-jia-early-after-treatment-shortening-time-to-decision-to-change-treatment/",
        "year": "2020",
        "study_id": [
            "NCT00988221"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6006",
        "lead_investigator": "Nicholas White",
        "lead_institution": "Mahidol University",
        "study_title": "A Multiple-Dose Study to Assess the Effects of Azithromycin plus Chloroquine on Electrocardiograms in Healthy Subjects - COVID-19",
        "link": "https://vivli.org/a-multiple-dose-study-to-assess-the-effects-of-azithromycin-plus-chloroquine-on-electrocardiograms-in-healthy-subjects-covid-19/",
        "year": "2020",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "6007",
        "lead_investigator": "Judith Goldstein",
        "lead_institution": "Johns Hopkins School of Medicine",
        "study_title": "National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) Calibrations for Low Vision Patients with age-related macular degeneration (AMD)",
        "link": "https://vivli.org/national-eye-institute-visual-function-questionnaire-25-nei-vfq-25-calibrations-for-low-vision-patients-with-age-related-macular-degeneration-amd/",
        "year": "2020",
        "study_id": [
            "NCT00473330",
            "NCT00473382",
            "NCT00891735",
            "NCT00056836",
            "NCT00090623",
            "NCT00379795",
            "NCT00251459",
            "NCT00486018",
            "NCT00485836",
            "NCT00061594",
            "NCT01277302"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "6008",
        "lead_investigator": "David Hsieh",
        "lead_institution": "University of Texas Southwestern Medical Center",
        "study_title": "Patterns of outcomes and the relevance surrogate endpoints in patients treated with immune checkpoint inhibitors.",
        "link": "https://vivli.org/patterns-of-outcomes-and-the-relevance-surrogate-endpoints-in-patients-treated-with-immune-checkpoint-inhibitors",
        "year": "2021",
        "study_id": [
            "NCT02951767",
            "NCT02420821",
            "NCT02302807",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01984242",
            "NCT01903993",
            "NCT01846416"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "6041",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Histologic Predictors of Endoscopic Healing in Crohn's Disease",
        "link": "https://vivli.org/histologic-predictors-of-endoscopic-healing-in-crohns-disease/",
        "year": "2020",
        "study_id": [
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT00348283"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6050",
        "lead_investigator": "Paul Cinciripini",
        "lead_institution": "UT MD Anderson Cancer Center",
        "study_title": "Safety and efficacy of smoking cessation treatments in smokers with and without depression",
        "link": "https://vivli.org/safety-and-efficacy-of-smoking-cessation-treatments-in-smokers-with-and-without-depression",
        "year": "2021",
        "study_id": [
            "NCT01456936",
            "NCT01456936"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6062",
        "lead_investigator": "Alex Meisel",
        "lead_institution": "University Hospital of Zurich",
        "study_title": "Neutrophils, Neutrophil-to-Lymphocyte Ratio (NLR) and Neutropenia as Predictors of Treatment Efficacy of Atezolizumab Monotherapy and Atezolizumab-Chemotherapy-Combinations",
        "link": "https://vivli.org/neutrophils-neutrophil-to-lymphocyte-ratio-nlr-and-neutropenia-as-predictors-of-treatment-efficacy-of-atezolizumab-monotherapy-and-atezolizumab-chemotherapy-combinations",
        "year": "2021",
        "study_id": [
            "NCT02008227",
            "NCT02366143",
            "NCT02367781"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6063",
        "lead_investigator": "Wiesje van der Flier",
        "lead_institution": "Amsterdam UMC, VUmc",
        "study_title": "Optimizing Trial design to Achieve Personalized prevention of Alzheimer\u2019s disease",
        "link": "https://vivli.org/optimizing-trial-design-to-achieve-personalized-prevention-of-alzheimers-disease/",
        "year": "2021",
        "study_id": [
            "NCT01424436",
            "NCT00459550",
            "NCT01035138",
            "NCT00762411",
            "NCT00594568",
            "NCT02337907",
            "NCT00575055",
            "NCT00574132",
            "NCT02240693"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "6064",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Comparative Effectiveness of Vedolizumab vs. Infliximab in Ulcerative Colitis",
        "link": "https://vivli.org/comparative-effectiveness-of-vedolizumab-vs-infliximab-in-ulcerative-colitis/",
        "year": "2021",
        "study_id": [
            "NCT00036439",
            "NCT00096655",
            "NCT00783718",
            "NCT02497469",
            "NCT00783718",
            "NCT00036439",
            "NCT00096655"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "6066",
        "lead_investigator": "Vivek Sharma",
        "lead_institution": "University of Louisville",
        "study_title": "EVALUATING THE ASSOCIATION BETWEEN PROTEINURIA AND THROMBOSIS AND ITS PREDICTORS IN PATIENTS TREATED WITH BEVACIZUMAB",
        "link": "https://vivli.org/evaluating-the-association-between-proteinuria-and-thrombosis-and-its-predictors-in-patients-treated-with-bevacizumab/",
        "year": "2022",
        "study_id": [
            "NCT00069095",
            "NCT00130728",
            "NCT00257608",
            "NCT00095225",
            "NCT00112918",
            "NCT00262067",
            "NCT00281697",
            "NCT00312728",
            "NCT00333775",
            "NCT00345163",
            "NCT00388206",
            "NCT00391092",
            "NCT00403403",
            "NCT00434642",
            "NCT00528567",
            "NCT00531960",
            "NCT00548548",
            "NCT00700102",
            "NCT00700180",
            "NCT00738530",
            "NCT00762034",
            "NCT00800202",
            "NCT00806923",
            "NCT00904839",
            "NCT00943826",
            "NCT00948675",
            "NCT00976911",
            "NCT01004250",
            "NCT01214720",
            "NCT01663727",
            "NCT02596958",
            "NCT01984242"
        ],
        "number_of_studies": 32
    },
    {
        "request_id": "6068",
        "lead_investigator": "Youssef Zeidan",
        "lead_institution": "American University of Beirut Medical Center",
        "study_title": "Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated with Radiation Therapy and Trastuzumaby",
        "link": "https://vivli.org/evaluation-of-cardiotoxicity-in-her-2-positive-breast-cancer-patients-treated-with-radiation-therapy-and-trastuzumab/",
        "year": "2021",
        "study_id": [
            "NCT00045032"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6104",
        "lead_investigator": "Pratik Sinha",
        "lead_institution": "Washington University",
        "study_title": "Heterogeneous treatment effects in molecular phenotypes of sepsis",
        "link": "https://vivli.org/heterogeneous-treatment-effects-in-molecular-phenotypes-of-sepsis",
        "year": "2021",
        "study_id": [
            "NCT00604214"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6115",
        "lead_investigator": "David McAllister",
        "lead_institution": "University of Glasgow",
        "study_title": "Real-world treatment effectiveness of novel anti-diabetic agents in people with type 2 diabetes: Maximising the applicability of clinical trials",
        "link": "https://vivli.org/real-world-treatment-effectiveness-of-novel-anti-diabetic-agents-in-people-with-type-2-diabetes-maximising-the-applicability-of-clinical-trials/",
        "year": "2021",
        "study_id": [
            "NCT02683746",
            "NCT02597049",
            "NCT02465515",
            "NCT02152371",
            "NCT01890122",
            "NCT01792518",
            "NCT01778049",
            "NCT01769378",
            "NCT01734785",
            "NCT01733758",
            "NCT01719003",
            "NCT01708902",
            "NCT01624259",
            "NCT01621178",
            "NCT01438814",
            "NCT01422876",
            "NCT01370005",
            "NCT01368081",
            "NCT01306214",
            "NCT01215097",
            "NCT01214239",
            "NCT01210001",
            "NCT01204294",
            "NCT01191268",
            "NCT01177813",
            "NCT01164501",
            "NCT01159600",
            "NCT01128894",
            "NCT01126580",
            "NCT01098539",
            "NCT01075282",
            "NCT01064687",
            "NCT01023581",
            "NCT00976391",
            "NCT00968708",
            "NCT00954447",
            "NCT00856284",
            "NCT00849056",
            "NCT00849017",
            "NCT00839527",
            "NCT00838916",
            "NCT00838903",
            "NCT00798161",
            "NCT00734474",
            "NCT00707993",
            "NCT00654381",
            "NCT00641043",
            "NCT00622284",
            "NCT00621140",
            "NCT00602472",
            "NCT00601250",
            "NCT00432276",
            "NCT00395512",
            "NCT00328627",
            "NCT00306384",
            "NCT00286494",
            "NCT00286468",
            "NCT00286455",
            "NCT00286442",
            "NCT00286429",
            "NCT00915772",
            "NCT01167881",
            "NCT02489968",
            "NCT01318083",
            "NCT01318070",
            "NCT02681094",
            "NCT02471404",
            "NCT02284893",
            "NCT02229227",
            "NCT01606007",
            "NCT01217892",
            "NCT01289119"
        ],
        "number_of_studies": 72
    },
    {
        "request_id": "6464",
        "lead_investigator": "Michael Wiese",
        "lead_institution": "University of South Australia",
        "study_title": "Individualisation of gout flare prophylaxis when initiating urate-lowering therapy",
        "link": "https://vivli.org/individualisation-of-gout-flare-prophylaxis-when-initiating-urate-lowering-therapy/",
        "year": "2021",
        "study_id": [
            "NCT01101035",
            "NCT02139046",
            "NCT02128490",
            "NCT01082640",
            "NCT01078389",
            "NCT00430248",
            "NCT00175019",
            "NCT00174967",
            "NCT00174941",
            "NCT00174915",
            "NCT00102440"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "6471",
        "lead_investigator": "Floris Bosch",
        "lead_institution": "University of Amsterdam Academic Medical Center",
        "study_title": "Risk of recurrent venous thromboembolism and bleeding in cancer patients an individual patient data meta-analysis",
        "link": "https://vivli.org/risk-of-recurrent-venous-thromboembolism-and-bleeding-in-cancer-patients-an-individual-patient-data-meta-analysis",
        "year": "2021",
        "study_id": [
            "NCT01130025",
            "NCT03045406",
            "NCT02585713",
            "NCT02583191",
            "NCT02073682",
            "NCT02744092"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "6472",
        "lead_investigator": "Soong June Bae",
        "lead_institution": "Yonsei University Health System",
        "study_title": "Impact of neutrophil to lymphocyte ratio on prognosis in patients with HER2-positive breast cancer regarding the HER2-targeted therapy",
        "link": "https://vivli.org/impact-of-neutrophil-to-lymphocyte-ratio-on-prognosis-in-patients-with-her2-positive-breast-cancer-regarding-the-her2-targeted-therapy",
        "year": "2022",
        "study_id": [
            "NCT01358877",
            "NCT00045032"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6475",
        "lead_investigator": "Tobias Polak",
        "lead_institution": "Erasmus Medical Center",
        "study_title": "Combining data from expanded access programs and conventional clinical trials: a statistical application to vemurafenib",
        "link": "https://vivli.org/combining-data-from-expanded-access-programs-and-conventional-clinical-trials-a-statistical-application-to-vemurafenib/",
        "year": "2022",
        "study_id": [
            "NCT01248936",
            "NCT00949702",
            "NCT01006980",
            "NCT01378975"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6477",
        "lead_investigator": "Tobias Polak",
        "lead_institution": "Erasmus Medical Center",
        "study_title": "Tositumomab: statistical modeling of expanded access programs and conventional trials",
        "link": "https://vivli.org/tositumomab-statistical-modeling-of-expanded-access-programs-and-conventional-trials",
        "year": "2021",
        "study_id": [
            "NCT00268203",
            "NCT00996593",
            "NCT00989664",
            "NCT01573000",
            "NCT00268983"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "6482",
        "lead_investigator": "Andreas Monsch",
        "lead_institution": "University of Basel",
        "study_title": "Analyses of available cognitive data from 200 healthy, German-speaking individuals to be used to examine potential patients",
        "link": "https://vivli.org/analyses-of-available-cognitive-data-from-200-healthy-german-speaking-individuals-to-be-used-to-examine-potential-patients/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "6483",
        "lead_investigator": "Bharati Kumar",
        "lead_institution": "University of Bath",
        "study_title": "Evaluation of available statistical methods performance under non-proportional hazards",
        "link": "https://vivli.org/evaluation-of-available-statistical-methods-performance-under-non-proportional-hazards/",
        "year": "2021",
        "study_id": [
            "NCT01170663",
            "NCT00322452",
            "NCT00322452"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6484",
        "lead_investigator": "Ari Rosenberg",
        "lead_institution": "University of Chicago",
        "study_title": "Developing predictive and prognostic Artificial Intelligent (AI) digital biomarkers for soft tissue sarcoma",
        "link": "https://vivli.org/developing-predictive-and-prognostic-artificial-intelligent-ai-digital-biomarkers-for-soft-tissue-sarcoma/",
        "year": "2021",
        "study_id": [
            "NCT02451943"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6489",
        "lead_investigator": "Line Uhrenholt",
        "lead_institution": "Aalborg University Hospital",
        "study_title": "Tapering strategies of biological and targeted synthetic disease-modifying antirheumatic drugs for patients with inflammatory arthritis: a systematic review of randomised controlled trials",
        "link": "https://vivli.org/tapering-strategies-of-biological-and-targeted-synthetic-disease-modifying-antirheumatic-drugs-for-patients-with-inflammatory-arthritis-a-systematic-review-of-randomised-controlled-trials/",
        "year": "2021",
        "study_id": [
            "NCT00420927"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6494",
        "lead_investigator": "Maria Alice Franzoi",
        "lead_institution": "Jules Bordet Institute",
        "study_title": "Implications of body mass index on the biological and clinical effects of endocrine therapy and abemaciclib in the neoadjuvant setting",
        "link": "https://vivli.org/implications-of-body-mass-index-on-the-biological-and-clinical-effects-of-endocrine-therapy-and-abemaciclib-in-the-neoadjuvant-setting/",
        "year": "2021",
        "study_id": [
            "NCT02441946"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6495, 5485",
        "lead_investigator": "G\u00fcnter H\u00f6glinger",
        "lead_institution": "Hanover Medical School",
        "study_title": "Application of improved statistical methodologies for clinical trials in Progressive Supranuclear Palsy",
        "link": "https://vivli.org/prediction-model-for-individual-disease-progression-in-patients-with-progressive-supranuclear-palsy/",
        "year": "2020",
        "study_id": [
            "NCT02985879"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6496",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Endoscopic Disease Severity and Patient Reported Outcomes in Crohns Disease",
        "link": "https://vivli.org/endoscopic-disease-severity-and-patient-reported-outcomes-in-crohns-disease/",
        "year": "2021",
        "study_id": [
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT00348283"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6498",
        "lead_investigator": "Timo Uphaus",
        "lead_institution": "University Medical Center Mainz",
        "study_title": "Identifying patients with unknown stroke etiology who may benefit from a blood thining medication with Dabigatran by a clinically based scoring system",
        "link": "https://vivli.org/identifying-patients-with-unknown-stroke-etiology-who-may-benefit-from-a-blood-thining-medication-with-dabigatran-by-a-clinically-based-scoring-system/",
        "year": "2021",
        "study_id": [
            "NCT02239120"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6499, 5323, 5289",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer",
        "link": "https://vivli.org/predictors-of-therapeutic-and-adverse-effects-of-medicines-used-in-the-treatment-of-breast-cancer",
        "year": "2020",
        "study_id": [
            "NCT02246621",
            "NCT02107703",
            "NCT02102490",
            "NCT00721409",
            "NCT00721409",
            "NCT01663727",
            "NCT01419197",
            "NCT01401166",
            "NCT01120184",
            "NCT00950300",
            "NCT00829166",
            "NCT00545688",
            "NCT00528567",
            "NCT00391092",
            "NCT00333775",
            "NCT00089479",
            "NCT00045032",
            "NCT01125566",
            "NCT00567190",
            "NCT00281697",
            "NCT00262067",
            "NCT02441946",
            "NCT01674062",
            "NCT00976989",
            "NCT00679341",
            "NCT00679211",
            "NCT00509769",
            "NCT01441596",
            "NCT00109239",
            "NCT00022672",
            "NCT00006459",
            "NCT02675231",
            "NCT01566721",
            "NCT01250379",
            "NCT00703326",
            "NCT00448591",
            "NCT01740427",
            "NCT01942135",
            "NCT02747004",
            "NCT02308020",
            "NCT01358877",
            "NCT02924883",
            "NCT01152606",
            "NCT01196052",
            "NCT01026142",
            "NCT01772472",
            "NCT00099437"
        ],
        "number_of_studies": 47
    },
    {
        "request_id": "6515",
        "lead_investigator": "Leire Leache",
        "lead_institution": "Navarre Health Service",
        "study_title": "Cochrane Systematic Review Pharmacotherapy for hypertension induced left ventricular hypertrophy",
        "link": "https://vivli.org/cochrane-systematic-review-pharmacotherapy-for-hypertension-induced-left-ventricular-hypertrophy/",
        "year": "2021",
        "study_id": [
            "NCT00153062",
            "NCT00153101"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6520",
        "lead_investigator": "Thomas Schnitzer",
        "lead_institution": "Northwestern University",
        "study_title": "Development of model to predict pain response in clinical trials of chronic pain conditions",
        "link": "https://vivli.org/development-of-model-to-predict-pain-response-in-clinical-trials-of-chronic-pain-conditions",
        "year": "2022",
        "study_id": [
            "NCT00830063",
            "NCT00733902",
            "NCT00744471"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6521",
        "lead_investigator": "Ethan Alt",
        "lead_institution": "University of North Carolina at Chapel Hill",
        "study_title": "Bayesian probability of success for multivariate generalized linear models",
        "link": "https://vivli.org/bayesian-probability-of-success-for-multivariate-generalized-linear-models/",
        "year": "2021",
        "study_id": [
            "NCT01597297"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6532",
        "lead_investigator": "Odelia Cooper",
        "lead_institution": "Cedars-Sinai Medical Center",
        "study_title": "A study of how growth hormone treatment affects health outcomes in patients with noncancerous craniopharyngioma tumors",
        "link": "https://vivli.org/a-study-of-how-growth-hormone-treatment-affects-health-outcomes-in-patients-with-noncancerous-craniopharyngioma-tumors/",
        "year": "2021",
        "study_id": [
            "NCT01088399"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6534",
        "lead_investigator": "Diego Tosi",
        "lead_institution": "Institut du Cancer de Montpellier",
        "study_title": "Analysis of breast cancer molecular adaptation to drugs in order to predict relapse after curative treatment",
        "link": "https://vivli.org/analysis-of-breast-cancer-molecular-adaptation-to-drugs-in-order-to-predict-relapse-after-curative-treatment/",
        "year": "2021",
        "study_id": [
            "NCT02441946"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6541",
        "lead_investigator": "Dipak Kotecha",
        "lead_institution": "University of Birmingham",
        "study_title": "Big data and meta-analytic approaches for better phenotyping in atrial fibrillation and heart failure",
        "link": "https://vivli.org/big-data-and-meta-analytic-approaches-for-better-phenotyping-in-atrial-fibrillation-and-heart-failure/",
        "year": "2021",
        "study_id": [
            "NCT04396418",
            "NCT02348723",
            "NCT00808067",
            "NCT00262600"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6543",
        "lead_investigator": "Andreas Meid",
        "lead_institution": "Heidelberg University Hospital",
        "study_title": "Reproducible Machine Learning (ML) for Tumor Growth Inhibition (TGI) - can ML methods support the validity of conventional TGI metrics?",
        "link": "https://vivli.org/reproducible-machine-learning-ml-for-tumor-growth-inhibition-tgi-can-ml-methods-support-the-validity-of-conventional-tgi-metrics/",
        "year": "2021",
        "study_id": [
            "NCT02008227"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6544",
        "lead_investigator": "Angela Wu",
        "lead_institution": "University of Oxford",
        "study_title": "Investigating the association between smoking cessation and mental health in people with and without psychiatric disorders",
        "link": "https://vivli.org/investigating-the-association-between-smoking-cessation-and-mental-health-in-people-with-and-without-psychiatric-disorders/",
        "year": "2021",
        "study_id": [
            "NCT01456936"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6550",
        "lead_investigator": "James Brorson",
        "lead_institution": "The University of Chicago",
        "study_title": "Examination of survivor functions from SOCRATES and THALES trials for kinetics of stroke recurrence",
        "link": "https://vivli.org/examination-of-survivor-functions-from-socrates-and-thales-trials-for-kinetics-of-stroke-recurrence/",
        "year": "2021",
        "study_id": [
            "NCT01994720",
            "NCT01994720",
            "NCT03354429",
            "NCT03354429"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6551",
        "lead_investigator": "Siddharth Singh",
        "lead_institution": "University of California San Diego",
        "study_title": "Predicting the short- and long-term risk of serious infections in patients with Crohn\u2019s disease: Analysis of the PYRAMID Registry",
        "link": "https://vivli.org/predicting-the-short-and-long-term-risk-of-serious-infections-in-patients-with-crohns-disease-analysis-of-the-pyramid-registry/",
        "year": "2022",
        "study_id": [
            "NCT01235689",
            "NCT00524537",
            "NCT00524537"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6593",
        "lead_investigator": "Matthieu Roustit",
        "lead_institution": "Grenoble Alpes University Hospital",
        "study_title": "Exploration of regional heterogeneity in trials assessing the efficacy of recent non-insulin glucose lowering drugs on cardiovascular outcomes",
        "link": "https://vivli.org/exploration-of-regional-heterogeneity-in-trials-assessing-the-efficacy-of-recent-non-insulin-glucose-lowering-drugs-on-cardiovascular-outcomes/",
        "year": "2022",
        "study_id": [
            "NCT01144338",
            "NCT01144338"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6594",
        "lead_investigator": "Manju Subramanian",
        "lead_institution": "Boston Medical Center",
        "study_title": "The Impact of Race on Short Term Treatment Response to Intravitreal anti-Vascular Endothelial Growth Factor in Diabetic Macular Edema: A Pooled Analysis",
        "link": "https://vivli.org/the-impact-of-race-on-short-term-treatment-response-to-intravitreal-anti-vascular-endothelial-growth-factor-in-diabetic-macular-edema-a-pooled-analysis/",
        "year": "2021",
        "study_id": [
            "NCT00473382",
            "NCT00473330"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6601",
        "lead_investigator": "Dan Turner",
        "lead_institution": "Shaare Zedek Medical Center",
        "study_title": "Adaptation and validation of the Mucosal Inflammation Non-invasive (MINI) Index for Crohn's disease in adults using the SERENE clinical trial data",
        "link": "https://vivli.org/adaptation-and-validation-of-the-mucosal-inflammation-non-invasive-mini-index-for-crohns-disease-in-adults-using-the-serene-clinical-trial-data/",
        "year": "2021",
        "study_id": [
            "NCT02065570"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6632",
        "lead_investigator": "Luca Valerio",
        "lead_institution": "University Medical Center of the Johannes Gutenberg-University Mainz",
        "study_title": "Healthcare resource utilization and economic burden related to pulmonary embolism. An analysis of the PREFER in venous thromboembolism (VTE) study",
        "link": "https://vivli.org/healthcare-resource-utilization-and-economic-burden-related-to-pulmonary-embolism-an-analysis-of-the-prefer-in-venous-thromboembolism-vte-study/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "6633",
        "lead_investigator": "Luca Valerio",
        "lead_institution": "University Medical Center Mainz",
        "study_title": "Performance status and long-term clinical outcomes in pulmonary embolism patients with cancer. An analysis of Hokusai VTE Cancer study",
        "link": "https://vivli.org/performance-status-and-long-term-clinical-outcomes-in-pulmonary-embolism-patients-with-cancer-an-analysis-of-hokusai-vte-cancer-study/",
        "year": "2021",
        "study_id": [
            "NCT02073682"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6641",
        "lead_investigator": "Anna Feeney",
        "lead_institution": "Massachusetts General Hospital",
        "study_title": "Antidepressants in children and adolescents with Major Depressive Disorder and the influence of placebo response: a meta-analysis",
        "link": "https://vivli.org/antidepressants-in-children-and-adolescents-with-major-depressive-disorder-and-the-influence-of-placebo-response-a-meta-analysis/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "6642",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Modified Multiplier SES-CD (MM-SES-CD) on Predicting Endoscopic Remission in Crohns Disease",
        "link": "https://vivli.org/modified-multiplier-ses-cd-mm-ses-cd-on-predicting-endoscopic-remission-in-crohns-disease/",
        "year": "2021",
        "study_id": [
            "NCT00348283",
            "NCT02425111",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT00094458"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "6686",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Extended Validation of an Ulcerative Colitis Vedolizumab Decision Support Tool",
        "link": "https://vivli.org/extended-validation-of-an-ulcerative-colitis-vedolizumab-decision-support-tool/",
        "year": "2021",
        "study_id": [
            "NCT02497469"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6710",
        "lead_investigator": "Gus Slotman",
        "lead_institution": "Inspira Health Network",
        "study_title": "Identifying Patients in the PROWESS SHOCK Clinical Trial Among Whom Drotrecogin Alfa (DrottAA) Reduced Mortality",
        "link": "https://vivli.org/identifying-patients-in-the-prowess-shock-clinical-trial-among-whom-drotrecogin-alfa-drottaa-reduced-mortality/",
        "year": "2021",
        "study_id": [
            "NCT00604214"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6712",
        "lead_investigator": "Yeon-Mok Oh",
        "lead_institution": "Asan Medical Center",
        "study_title": "Development and validation of a prediction model for the indication of inhaled corticosteroid (ICS) in patients with chronic obstructive pulmonary disease (COPD)",
        "link": "https://vivli.org/development-and-validation-of-a-prediction-model-for-the-indication-of-inhaled-corticosteroid-ics-in-patients-with-chronic-obstructive-pulmonary-disease-copd/",
        "year": "2021",
        "study_id": [
            "NCT02164513"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6716",
        "lead_investigator": "Nigam Shah",
        "lead_institution": "Stanford University",
        "study_title": "Applying machine learning tools to personalize dabigatran treatment decisions",
        "link": "https://vivli.org/applying-machine-learning-tools-to-personalize-dabigatran-treatment-decisions/",
        "year": "2021",
        "study_id": [
            "NCT00262600",
            "NCT00808067"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6732",
        "lead_investigator": "Yung-Chuan Huang",
        "lead_institution": "Fu Jen Catholic University Hospital",
        "study_title": "Decision Tree Model for Dose Selection of Dabigatran in Non-valvular Atrial Fibrillation Patients",
        "link": "https://vivli.org/decision-tree-model-for-dose-selection-of-dabigatran-in-non-valvular-atrial-fibrillation-patients/",
        "year": "2021",
        "study_id": [
            "NCT01227629",
            "NCT00262600",
            "NCT00808067"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6734",
        "lead_investigator": "Andreas Suhrbier",
        "lead_institution": "QIMR Berghofer Medical Research institute",
        "study_title": "The K18 mouse model recapitulates the transcriptomic response to acute COVID-19 Acute Respiratory Distress syndrome (ARDS) in humans",
        "link": "https://vivli.org/the-k18-mouse-model-recapitulates-the-transcriptomic-response-to-acute-covid-19-acute-respiratory-distress-syndrome-ards-in-humans/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "6739",
        "lead_investigator": "Rifaquat Rahman",
        "lead_institution": "Dana Farber Cancer Institute",
        "study_title": "Evaluation of Differences in Trial and Non-Trial Patients and Leveraging of External Data for More Efficient Clinical Trial Designs in Newly Diagnosed Glioblastoma",
        "link": "https://vivli.org/evaluation-of-differences-in-trial-and-non-trial-patients-and-leveraging-of-external-data-for-more-efficient-clinical-trial-designs-in-newly-diagnosed-glioblastoma/",
        "year": "2021",
        "study_id": [
            "NCT00943826",
            "NCT00813943",
            "NCT00689221"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6740",
        "lead_investigator": "Georgios Paliouras",
        "lead_institution": "National Centre for Scientific Research 'Demokritos' (NCSR-D)",
        "study_title": "in-silico DMD: Developing computational predictive models for the progression of Duchenne Muscular Dystrophy",
        "link": "https://vivli.org/in-silico-dmd-developing-computational-predictive-models-for-the-progression-of-duchenne-muscular-dystrophy/",
        "year": "2021",
        "study_id": [
            "NCT01753804"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6758",
        "lead_investigator": "Qian Chen",
        "lead_institution": "Hubei Cancer Hospital",
        "study_title": "Retrospective analysis of the effect of first-line bevacizumab treatment on survival and prognosis of patients with advanced non-small cell lung cancer treated with second-line immunotherapy",
        "link": "https://vivli.org/retrospective-analysis-of-the-effect-of-first-line-bevacizumab-treatment-on-survival-and-prognosis-of-patients-with-advanced-non-small-cell-lung-cancer-treated-with-second-line-immunotherapy/",
        "year": "2021",
        "study_id": [
            "NCT02008227",
            "NCT01903993",
            "NCT02031458"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "6759, 5936",
        "lead_investigator": "Zhi Xiao",
        "lead_institution": "Xiangya Hospital, Central-South University",
        "study_title": "Roles of neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in prognosis and in differentiation of potential beneficiaries in HER2-positive breast cancer with trastuzumab therapy",
        "link": "https://vivli.org/roles-of-neutrophil-lymphocyte-ratio-nlr-and-platelet-lymphocyte-ratio-plr-in-prognosis-and-in-differentiation-of-potential-beneficiaries-in-her2-positive-breast-cancer-with-trastuzumab-therapy/",
        "year": "2020",
        "study_id": [
            "NCT00045032",
            "NCT00567190"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6762, 5935",
        "lead_investigator": "Jian-Guo Zhou\n",
        "lead_institution": "The Second Affiliated Hospital of Zunyi Medical University",
        "study_title": "Longitudinal peripheral blood markers as dynamic predictors to identify efficacy and safety of patients treated with immune checkpoint inhibitors (ICIs)",
        "link": "https://vivli.org/longitudinal-peripheral-blood-markers-as-dynamic-predictors-to-identify-efficacy-and-safety-of-patients-treated-with-immune-checkpoint-inhibitors-icis",
        "year": "2021",
        "study_id": [
            "NCT02302807",
            "NCT01846416",
            "NCT02951767",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01984242",
            "NCT01903993",
            "NCT02366143",
            "NCT03041311",
            "NCT02924883",
            "NCT02420821",
            "NCT02367781",
            "NCT02367794",
            "NCT02322814",
            "NCT01621490",
            "NCT01621490",
            "NCT01621490",
            "NCT02041533"
        ],
        "number_of_studies": 19
    },
    {
        "request_id": "6764",
        "lead_investigator": "Johnathan Bartlett",
        "lead_institution": "London School of Hygiene & Tropical Medicine",
        "study_title": "Hypothetical estimand in clinical trials: an application of causal inference and missing data methods",
        "link": "https://vivli.org/hypothetical-estimand-in-clinical-trials-an-application-of-causal-inference-and-missing-data-methods/",
        "year": "2021",
        "study_id": [
            "NCT02471404"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "6765",
        "lead_investigator": "Dan Hanley",
        "lead_institution": "Johns Hopkins University",
        "study_title": "Pandemic response COVID-19 Research Collaboration Platform",
        "link": "https://vivli.org/pandemic-response-covid-19-research-collaboration-platform/",
        "year": "2021",
        "study_id": [
            "NCT04369742",
            "NCT04329832",
            "NCT04341727",
            "NCT04328012",
            "NCT04328012",
            "NCT04345692",
            "NCT04335552",
            "NCT04344444",
            "NCT04369742",
            "NCT04329832",
            "NCT04341727",
            "NCT04328012",
            "NCT04328012",
            "NCT04345692",
            "NCT04335552",
            "NCT04344444"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "6836",
        "lead_investigator": "Alana Rojewski",
        "lead_institution": "Medical University of South Carolina",
        "study_title": "Smoking Cessation Pharmacotherapy Efficacy in Comorbid Medical Populations: Secondary Analysis of the EAGLES Randomized Clinical Trial",
        "link": "https://vivli.org/smoking-cessation-pharmacotherapy-efficacy-in-comorbid-medical-populations-secondary-analysis-of-the-eagles-randomized-clinical-trial/",
        "year": "2021",
        "study_id": [
            "NCT01456936",
            "NCT01456936"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6860",
        "lead_investigator": "Nicholas Lange",
        "lead_institution": "Columbia University",
        "study_title": "Belatacept in obese kidney transplant recipients",
        "link": "https://vivli.org/belatacept-in-obese-kidney-transplant-recipients/",
        "year": "2022",
        "study_id": [
            "NCT00114777",
            "NCT00114777",
            "NCT00256750",
            "NCT00256750"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "6866",
        "lead_investigator": "Andy Lim",
        "lead_institution": "Monash University",
        "study_title": "Meta-analysis of early stroke recurrence rate in minor stroke",
        "link": "https://vivli.org/meta-analysis-of-early-stroke-recurrence-rate-in-minor-stroke/\u201d",
        "year": "2021",
        "study_id": [
            "NCT01994720",
            "NCT01994720"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "6869",
        "lead_investigator": "Zhen Lin",
        "lead_institution": "Robot Bacon Corporation",
        "study_title": "Evaluating Clinical Trial Data Conventions for the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM)",
        "link": "https://vivli.org/evaluating-clinical-trial-data-conventions-for-the-observational-medical-outcomes-partnership-common-data-model-omop-cdm/",
        "year": "2022",
        "study_id": [
            "NCT04386616",
            "NCT02425111",
            "NCT02343458",
            "NCT04026750",
            "NCT03337477",
            "NCT03034967",
            "NCT02798978",
            "NCT01755598",
            "NCT02485301"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "6881, 5484",
        "lead_investigator": "Stefan Leucht",
        "lead_institution": "Technical University of Munich",
        "study_title": "Individual-patient-data (IPD) meta-analysis of the efficacy of clozapine versus second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia",
        "link": "https://vivli.org/individual-patient-data-ipd-meta-analysis-of-the-efficacy-of-clozapine-versus-second-generation-antipsychotic-drugs-in-patients-with-treatment-resistant-schizophrenia/",
        "year": "2020",
        "study_id": [
            "NCT00649844"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7062",
        "lead_investigator": "Julien Edeline",
        "lead_institution": "Centre Eugene Marquis",
        "study_title": "PATIENT REPORTED OUTCOME (PRO) AS A PROGNOSTIC MARKER IN PATIENTS TREATED WITH TARGETED THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA (PRO\u00b2-HCC)",
        "link": "https://vivli.org/patient-reported-outcome-pro-as-a-prognostic-marker-in-patients-treated-with-targeted-therapies-for-advanced-hepatocellular-carcinoma-pro\u00b2-hcc/",
        "year": "2021",
        "study_id": [
            "NCT00858871",
            "NCT00858871"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7070",
        "lead_investigator": "Georgios Tsakonas",
        "lead_institution": "Karolinska Institutet",
        "study_title": "Anaplastic Lymphoma Kinase- Brain Prognostic Index (ALK-BPI) a novel prognostic score for brain metastasized ALK+ Non Small Cell Lung Cancer (NSCLC)",
        "link": "https://vivli.org/anaplastic-lymphoma-kinase-brain-prognostic-index-alk-bpi-a-novel-prognostic-score-for-brain-metastasized-alk-non-small-cell-lung-cancer-nsclc/",
        "year": "2021",
        "study_id": [
            "NCT02075840"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7072",
        "lead_investigator": "James Signorovitch",
        "lead_institution": "Analysis Group",
        "study_title": "Development of natural history controls to contextualize clinical trial outcomes of boys with Duchenne muscular dystrophy treated with DS-5141B",
        "link": "https://vivli.org/development-of-natural-history-controls-to-contextualize-clinical-trial-outcomes-of-boys-with-duchenne-muscular-dystrophy-treated-with-ds-5141b/",
        "year": "2021",
        "study_id": [
            "NCT01753804",
            "NCT01753804"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7074",
        "lead_investigator": "Gregory YH Lip",
        "lead_institution": "University of Liverpool",
        "study_title": "Impact of atrial fibrillation and the effects of comorbidities and treatment on disease progression and outcomes",
        "link": "https://vivli.org/impact-of-atrial-fibrillation-and-the-effects-of-comorbidities-and-treatment-on-disease-progression-and-outcomes/",
        "year": "2021",
        "study_id": [
            "NCT01468701",
            "NCT01671007",
            "NCT01937377"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7076",
        "lead_investigator": "Elias Eriksson",
        "lead_institution": "University of Gothenburg",
        "study_title": "Post hoc patient-level analysis of the impact of amitriptyline, selective serotonin reuptake inhibitors, and placebo of individual items of the Hamilton Depression Rating Scale",
        "link": "https://vivli.org/post-hoc-patient-level-analysis-of-the-impact-of-amitriptyline-selective-serotonin-reuptake-inhibitors-and-placebo-of-individual-items-of-the-hamilton-depression-rating-scale/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7077",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Dominant Patient Reported Outcomes on Predicting Mucosal Healing in Crohns Disease",
        "link": "https://vivli.org/dominant-patient-reported-outcomes-on-predicting-mucosal-healing-in-crohns-disease/",
        "year": "2021",
        "study_id": [
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT00348283"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7078",
        "lead_investigator": "Alberto Martini\n",
        "lead_institution": "University of Cincinnati",
        "study_title": "Role of body mass index and Beta Blockers in metastatic urothelial carcinoma",
        "link": "https://vivli.org/role-of-body-mass-index-and-beta-blockers-in-metastatic-urothelial-carcinoma/",
        "year": "2021",
        "study_id": [
            "NCT02302807",
            "NCT02108652"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7101",
        "lead_investigator": "Jason Luke",
        "lead_institution": "University of Pittsburgh",
        "study_title": "Analysis of gene expression profiles in melanoma tumors exhibiting differential lactate dehydrogenase biomarker levels and correlation with immunotherapy response",
        "link": "https://vivli.org/analysis-of-gene-expression-profiles-in-melanoma-tumors-exhibiting-differential-lactate-dehydrogenase-biomarker-levels-and-correlation-with-immunotherapy-response/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7104",
        "lead_investigator": "Jakob N\u00e4slund",
        "lead_institution": "University of Gothenburg",
        "study_title": "Item-level effects of adjuvant olanzapine and/or olanzapine monotherapy in treatment-resistant depression",
        "link": "https://vivli.org/item-level-effects-of-adjuvant-olanzapine-and-or-olanzapine-monotherapy-in-treatment-resistant-depression/",
        "year": "2022",
        "study_id": [
            "NCT00035321"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7126",
        "lead_investigator": "Alessio Cortellini",
        "lead_institution": "Imperial College London",
        "study_title": "The predictive role of inflammation indices in patients treated with immunotherapy or chemotherapy for advanced non-small cell lung cancer.",
        "link": "https://vivli.org/the-predictive-role-of-inflammation-indices-in-patients-treated-with-immunotherapy-or-chemotherapy-for-advanced-non-small-cell-lung-cancer/",
        "year": "2021",
        "study_id": [
            "NCT02008227"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7127",
        "lead_investigator": "Alexa Kimball",
        "lead_institution": "Beth Israel Deaconess Medical Center",
        "study_title": "Effects of adalimumab on inflammation-associated abnormal hematologic patterns in patients with Hidradenitis Suppurativa",
        "link": "https://vivli.org/effects-of-adalimumab-on-inflammation-associated-abnormal-hematologic-patterns-in-patients-with-hidradenitis-suppurativa/",
        "year": "2022",
        "study_id": [
            "NCT01468207",
            "NCT01468233",
            "NCT00918255"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7136",
        "lead_investigator": "Shou-Ching TANG",
        "lead_institution": "University of Mississippi Medical Center (UMMC) Cancer Center and Research Inst.",
        "study_title": "Validation of trastuzumab-emtansine (T-DM1) Toxicity Score to predict response to T-DM1 treatment in metastatic breast cancer",
        "link": "https://vivli.org/validation-of-trastuzumab-emtansine-t-dm1-toxicity-score-to-predict-response-to-t-dm1-treatment-in-metastatic-breast-cancer/",
        "year": "2021",
        "study_id": [
            "NCT00829166",
            "NCT01120184",
            "NCT01419197"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7140",
        "lead_investigator": "Michael J. Sorich",
        "lead_institution": "Flinders University of South Australia",
        "study_title": "Early markers of clinical outcome to ipilimumab therapy for advanced melanoma",
        "link": "https://vivli.org/early-markers-of-clinical-outcome-to-ipilimumab-therapy-for-advanced-melanoma/",
        "year": "2021",
        "study_id": [
            "NCT00094653",
            "NCT00261365",
            "NCT00135408",
            "NCT00289627",
            "NCT00077532",
            "NCT00289640",
            "NCT00324155",
            "NCT00623766"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "7142",
        "lead_investigator": "Sara Tedeschi",
        "lead_institution": "Brigham and Women\u2019s Hospital",
        "study_title": "Causal inference cohort re-analysis of the 'CARES' trial to better understand the roles of colchicine, allopurinol, and febuxostat on cardiovascular events among patients with gout",
        "link": "https://vivli.org/causal-inference-cohort-re-analysis-of-the-cares-trial-to-better-understand-the-roles-of-colchicine-allopurinol-and-febuxostat-on-cardiovascular-events-among-patients-with-gout/",
        "year": "2022",
        "study_id": [
            "NCT01101035"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7143",
        "lead_investigator": "Chaim Singal",
        "lead_institution": "experiMind",
        "study_title": "The effects of systemic anti-infective concomitant medications on progression of neurological diseases",
        "link": "https://vivli.org/the-effects-of-systemic-anti-infective-concomitant-medications-on-progression-of-neurological-diseases/",
        "year": "2021",
        "study_id": [
            "NCT00256893",
            "NCT00233025",
            "NCT00673452",
            "NCT00965081",
            "NCT02614196",
            "NCT02614261",
            "NCT00479401",
            "NCT00466167",
            "NCT00381472",
            "NCT00321854",
            "NCT00244387",
            "NCT01262365",
            "NCT01261793",
            "NCT00410384",
            "NCT00348309",
            "NCT00594568",
            "NCT02337907",
            "NCT01710358",
            "NCT01521923",
            "NCT01519791",
            "NCT00428090",
            "NCT00240630",
            "NCT00240617",
            "NCT00843024",
            "NCT00712933",
            "NCT01705977",
            "NCT01484496",
            "NCT00424476",
            "NCT01695239",
            "NCT01087788"
        ],
        "number_of_studies": 30
    },
    {
        "request_id": "7144",
        "lead_investigator": "Timothy Perk",
        "lead_institution": "AIQ Solutions",
        "study_title": "External validation of the AIQ predictive score of clinical benefit using Sodium Fluoride (NaF) position emission tomography/computed tomography (PET/CT) images in metastatic prostate cancer (mPC)",
        "link": "https://vivli.org/external-validation-of-the-aiq-predictive-score-of-clinical-benefit-using-sodium-fluoride-naf-position-emission-tomography-computed-tomography-pet-ct-images-in-metastatic-prostate-cancer-mpc/",
        "year": "2021",
        "study_id": [
            "NCT02384382",
            "NCT02384382"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7145",
        "lead_investigator": "Joan Busner",
        "lead_institution": "Signant Health",
        "study_title": "Psychometric evaluation of Positive and Negative Syndrome Scale (PANSS) in adolescent schizophrenia trials",
        "link": "https://vivli.org/psychometric-evaluation-of-positive-and-negative-syndrome-scale-panss-in-adolescent-schizophrenia-trials/",
        "year": "2021",
        "study_id": [
            "NCT00102063"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7147",
        "lead_investigator": "Carmela Tartaglia",
        "lead_institution": "University of Toronto",
        "study_title": "Exploring the heterogeneity of cognitive profile in patients with Progressive Supranuclear Palsy (PSP) enrolled in the ABBV-8E12 trial and the relationship to brain volumes",
        "link": "https://vivli.org/exploring-the-heterogeneity-of-cognitive-profile-in-patients-with-progressive-supranuclear-palsy-psp-enrolled-in-the-abbv-8e12-trial-and-the-relationship-to-brain-volumes/",
        "year": "2021",
        "study_id": [
            "NCT02985879",
            "NCT03391765"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7156",
        "lead_investigator": "Angelina Tjokrowidjaja",
        "lead_institution": "University of Sydney",
        "study_title": "Concordance between disease progression by Cancer Antigen 125 and computerized tomography (CT) progression in patients with relapsed advanced ovarian cancer treated with poly(adenosine diphosphate [ADP]\u2013ribose) polymerase inhibitor: a pooled analysis",
        "link": "https://vivli.org/concordance-between-disease-progression-by-cancer-antigen-125-and-computerized-tomography-ct-progression-in-patients-with-relapsed-advanced-ovarian-cancer-treated-with-polyadenosine-diphosphate-ad/",
        "year": "2022",
        "study_id": [
            "NCT00753545"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7158",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Patient Reported Symptoms as Predictors of Endoscopic Improvement in Ulcerative Colitis",
        "link": "https://vivli.org/patient-reported-symptoms-as-predictors-of-endoscopic-improvement-in-ulcerative-colitis/",
        "year": "2021",
        "study_id": [
            "NCT02497469",
            "NCT02497469"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7159, 6634",
        "lead_investigator": "James Signorovitch",
        "lead_institution": "Analysis Group, Inc.",
        "study_title": "Associations between steroid treatment, functional outcomes and disease milestones among non-ambulatory patients with Duchenne muscular dystrophy (DMD)",
        "link": "https://vivli.org/associations-between-steroid-treatment-functional-outcomes-and-disease-milestones-among-non-ambulatory-patients-with-duchenne-muscular-dystrophy-dmd/",
        "year": "2021",
        "study_id": [
            "NCT01753804",
            "NCT01254019"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7161",
        "lead_investigator": "Wesley Kerr",
        "lead_institution": "University of California, Los Angeles",
        "study_title": "Real time monitoring of individual response to antiseizure medication treatment during clinical trials",
        "link": "https://vivli.org/real-time-monitoring-of-individual-response-to-antiseizure-medication-treatment-during-clinical-trials/",
        "year": "2022",
        "study_id": [
            "NCT01261325",
            "NCT00504881",
            "NCT00490035",
            "NCT00464269",
            "NCT00355082",
            "NCT00160550",
            "NCT00150735",
            "NCT01243177",
            "NCT01921205",
            "NCT00236756",
            "NCT01648101",
            "NCT01498822",
            "NCT01229735",
            "NCT00236704",
            "NCT00232596",
            "NCT00230698",
            "NCT00220415",
            "NCT00210782",
            "NCT00136019",
            "NCT00113815",
            "NCT00113165",
            "NCT00104416",
            "NCT00043901",
            "NCT02100644",
            "NCT01777139",
            "NCT01431976",
            "NCT01431963",
            "NCT01336621",
            "NCT00516139",
            "NCT00310388",
            "NCT00310375",
            "NCT00264615",
            "NCT00235755",
            "NCT00043914"
        ],
        "number_of_studies": 34
    },
    {
        "request_id": "7162",
        "lead_investigator": "Andrew Bottomley",
        "lead_institution": "European Organisation for Research and Treatment of Cancer (EORTC)",
        "study_title": "Cancer Clinical Trials Pooling of Quality Life Data (CATAPULT) initiative",
        "link": "https://vivli.org/cancer-clinical-trials-pooling-of-quality-life-data-catapult-initiative/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7163",
        "lead_investigator": "Laura Mezquita",
        "lead_institution": "Hospital Clinic and the Translational Genomics Group at IDIBAPS",
        "study_title": "Prospective validation of the Lung Immune Prognostic Index in patients with non-small cell and small cell lung cancers",
        "link": "https://vivli.org/prospective-validation-of-the-lung-immune-prognostic-index-in-patients-with-non-small-cell-and-small-cell-lung-cancers/",
        "year": "2021",
        "study_id": [
            "NCT02008227",
            "NCT03041311",
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02031458",
            "NCT01903993",
            "NCT01846416"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "7164",
        "lead_investigator": "J\u00f6rg Ellinger",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Evaluation of CRP (c-reactive protein) flare phenomena as an early predictor of response to the Atezolizumab + Bevacizumab therapy in renal cell carcinoma",
        "link": "https://vivli.org/evaluation-of-crp-c-reactive-protein-flare-phenomena-as-an-early-predictor-of-response-to-the-atezolizumab-bevacizumab-therapy-in-renal-cell-carcinoma/\u201d",
        "year": "2021",
        "study_id": [
            "NCT02420821"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7224",
        "lead_investigator": "Keiichi Fujiwara",
        "lead_institution": "Gynecologic Oncology Trial and Investigation Consortium (GOTIC)",
        "study_title": "Early prediction of survival outcome of large-scale randomized clinical trials using artificial intelligence technology",
        "link": "https://vivli.org/early-prediction-of-survival-outcome-of-large-scale-randomized-clinical-trials-using-artificial-intelligence-technology/",
        "year": "2021",
        "study_id": [
            "NCT00976911",
            "NCT00434642",
            "NCT02149108",
            "NCT01183780",
            "NCT00700102"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7225",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Early vs. Delayed Response to Vedolizumab in Ulcerative Colitis",
        "link": "https://vivli.org/early-vs-delayed-response-to-vedolizumab-in-ulcerative-colitis/",
        "year": "2021",
        "study_id": [
            "NCT02497469"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7227",
        "lead_investigator": "Catrin Tudur-Smith",
        "lead_institution": "University of Liverpool",
        "study_title": "Add-on treatment for refractory focal-onset epilepsy: Individual Participant Data Network Meta-analysis",
        "link": "https://vivli.org/add-on-treatment-for-refractory-focal-onset-epilepsy-individual-participant-data-network-meta-analysis/",
        "year": "2022",
        "study_id": [
            "NCT00464269",
            "NCT01261325",
            "NCT00490035",
            "NCT00136019",
            "NCT00220415",
            "NCT00113165",
            "NCT00044278",
            "NCT00236860",
            "NCT00236730",
            "NCT00236873",
            "NCT00236847",
            "NCT00504881",
            "NCT01921205",
            "NCT01229735"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "7232",
        "lead_investigator": "Neil Oxtoby",
        "lead_institution": "University College London",
        "study_title": "Identification of heterogeneity in Alzheimer\u2019s disease clinical trials using computational modelling",
        "link": "https://vivli.org/identification-of-heterogeneity-in-alzheimers-disease-clinical-trials-using-computational-modelling/",
        "year": "2021",
        "study_id": [
            "NCT01931566"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7241",
        "lead_investigator": "Frederick Reimherr",
        "lead_institution": "Psychiatric and Behavioral Solutions, LLC",
        "study_title": "Retrospective Analysis of Emotional Symptoms in Adults with ADHD and Improvement Produced by Brexpiprazole",
        "link": "https://vivli.org/retrospective-analysis-of-emotional-symptoms-in-adults-with-adhd-and-improvement-produced-by-brexpiprazole/",
        "year": "2021",
        "study_id": [
            "NCT01074294"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7243",
        "lead_investigator": "Emanual Maverakis",
        "lead_institution": "University of California Davis",
        "study_title": "Developing Models from Existing Atopic Dermatitis Outcome Data",
        "link": "https://vivli.org/developing-models-from-existing-atopic-dermatitis-outcome-data/",
        "year": "2022",
        "study_id": [
            "NCT02564055"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7245",
        "lead_investigator": "Manabu Takaki",
        "lead_institution": "Okayama University",
        "study_title": "Clinical moderators of response to nalmefene in alcohol dependence: Results from a randomized controlled trial in Japan.",
        "link": "https://vivli.org/clinical-moderators-of-response-to-nalmefene-in-alcohol-dependence-results-from-a-randomized-controlled-trial-in-japan/",
        "year": "2021",
        "study_id": [
            "NCT02364947"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7274",
        "lead_investigator": "Jun Chen",
        "lead_institution": "West China Hospital, Sichuan University",
        "study_title": "Efficacy comparison of biologics (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) in treatment of severe eosinophilic asthma \u2014 a network meta-analysis",
        "link": "https://vivli.org/efficacy-comparison-of-biologics-benralizumab-dupilumab-mepolizumab-omalizumab-and-reslizumab-in-treatment-of-severe-eosinophilic-asthma-a-network-meta-analysis/",
        "year": "2022",
        "study_id": [
            "NCT01691521",
            "NCT01691508",
            "NCT02281318",
            "NCT01000506"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7277",
        "lead_investigator": "David Carter",
        "lead_institution": "MMS Holdings",
        "study_title": "International COVID-19 Data Alliance COVID-19 Workbench",
        "link": "https://vivli.org/international-covid-19-data-alliance-covid-19-workbench/",
        "year": "2021",
        "study_id": [
            "NCT04320615",
            "NCT04372186",
            "NCT04372186",
            "NCT04320615"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7283",
        "lead_investigator": "Franziska Michor",
        "lead_institution": "Dana Farber Cancer Institute",
        "study_title": "Large-scale public data reuse to model immunotherapy response and resistance",
        "link": "https://vivli.org/large-scale-public-data-reuse-to-model-immunotherapy-response-and-resistance/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7288",
        "lead_investigator": "Vipual Jairath",
        "lead_institution": "Alimentiv Inc.",
        "study_title": "Placebo Rates in Inflammatory Bowel Disease: An Individual Patient Data Meta-analysis of Randomized Controlled Trials",
        "link": "https://vivli.org/placebo-rates-in-inflammatory-bowel-disease-an-individual-patient-data-meta-analysis-of-randomized-controlled-trials/",
        "year": "2022",
        "study_id": [
            "NCT00445939",
            "NCT00445432",
            "NCT02499783",
            "NCT00385736",
            "NCT00408629",
            "NCT00853099",
            "NCT00783718",
            "NCT00783692",
            "NCT01224171",
            "NCT02039505",
            "NCT02038920",
            "NCT00487539",
            "NCT00488631",
            "NCT01863771",
            "NCT00488774",
            "NCT01551290",
            "NCT00771667",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355"
        ],
        "number_of_studies": 20
    },
    {
        "request_id": "7289",
        "lead_investigator": "Gianluca Rigatelli",
        "lead_institution": "Rovigo General Hospital",
        "study_title": "Outcomes of Left Main Purcutaneous Coronary Intervention across age classes",
        "link": "https://vivli.org/outcomes-of-left-main-purcutaneous-coronary-intervention-across-age-classes/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7312",
        "lead_investigator": "Marianna Kruithof-de Julio",
        "lead_institution": "University of Bern",
        "study_title": "Machine learning for personalized drug response prediction for bladder and prostate cancer patients",
        "link": "https://vivli.org/machine-learning-for-personalized-drug-response-prediction-for-bladder-and-prostate-cancer-patients/",
        "year": "2021",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7317",
        "lead_investigator": "Emanual Maverakis",
        "lead_institution": "University of California Davis",
        "study_title": "Developing Efficacy Assessment Tools from Existing Psoriasis Clinical Trial Outcome Data",
        "link": "https://vivli.org/developing-efficacy-assessment-tools-from-existing-psoriasis-clinical-trial-outcome-data/",
        "year": "2022",
        "study_id": [
            "NCT01646177",
            "NCT02718898",
            "NCT02561806",
            "NCT02513550",
            "NCT01777191",
            "NCT01695239",
            "NCT01624233",
            "NCT01597245",
            "NCT01474512",
            "NCT01107457"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "7321",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "A Comparison of the Rapidity of Clinical Response between Infliximab and Tofacitinib for Ulcerative Colitis",
        "link": "https://vivli.org/a-comparison-of-the-rapidity-of-clinical-response-between-infliximab-and-tofacitinib-for-ulcerative-colitis/",
        "year": "2022",
        "study_id": [
            "NCT01465763",
            "NCT01458951",
            "NCT00787202",
            "NCT00036439",
            "NCT00096655"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7322",
        "lead_investigator": "Zhengfei Zhu",
        "lead_institution": "Fudan University Shanghai Cancer Center",
        "study_title": "Clinical value and optimal candidate of cranial radiotherapy in atezolizumab-treated advanced non-small cell lung cancer with baseline brain metastasis",
        "link": "https://vivli.org/clinical-value-and-optimal-candidate-of-cranial-radiotherapy-in-atezolizumab-treated-advanced-non-small-cell-lung-cancer-with-baseline-brain-metastasis/",
        "year": "2021",
        "study_id": [
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02031458",
            "NCT02008227",
            "NCT01903993",
            "NCT01846416"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7323",
        "lead_investigator": "Toshifumi Kishimoto",
        "lead_institution": "Nara Medical University",
        "study_title": "Development of the optimal treatment of Nalmefene in patients with alcohol dependence",
        "link": "https://vivli.org/development-of-the-optimal-treatment-of-nalmefene-in-patients-with-alcohol-dependence/",
        "year": "2021",
        "study_id": [
            "NCT02364947"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7325",
        "lead_investigator": "Andreas Artemiou",
        "lead_institution": "Cardiff University",
        "study_title": "Predicting outcomes (death, improvement, survival) of COVID-19 patients on Standard of Care (SoC)",
        "link": "https://vivli.org/predicting-outcomes-death-improvement-survival-of-covid-19-patients-on-standard-of-care-soc/\u201d",
        "year": "2021",
        "study_id": [
            "NCT04320615",
            "NCT04363736",
            "NCT04372186",
            "NCT04386616",
            "NCT04369742",
            "NCT04344444",
            "NCT04409262"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7379",
        "lead_investigator": "Michele Romoli",
        "lead_institution": "Bufalini Hospital",
        "study_title": "Antithrombotics in patent formane ovale (PFO)-related stroke: a meta-analysis stratified for the risk of paradoxical embolism score (RoPE)",
        "link": "https://vivli.org/antithrombotics-in-patent-formane-ovale-pfo-related-stroke-a-meta-analysis-stratified-for-the-risk-of-paradoxical-embolism-score-rope/",
        "year": "2021",
        "study_id": [
            "NCT02239120"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7381",
        "lead_investigator": "Tomoya Hirota",
        "lead_institution": "University of California San Francisco",
        "study_title": "Early Prediction of Treatment Response to Antipsychotics for Irritability and Aggression in Autism Spectrum Disorder",
        "link": "https://vivli.org/early-prediction-of-treatment-response-to-antipsychotics-for-irritability-and-aggression-in-autism-spectrum-disorder/",
        "year": "2022",
        "study_id": [
            "NCT00337571",
            "NCT00332241",
            "NCT00261508",
            "NCT00576732"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7384",
        "lead_investigator": "Ulrich Mansmann",
        "lead_institution": "Ludwig-Maximilian\u2019s University M\u00fcnchen",
        "study_title": "Application of Estimands and Causal Reasoning in the Reanalysis of Endpoint Measures in Advanced/Metastatic Non-Small Cell Lung Cancer Clinical Trials",
        "link": "https://vivli.org/application-of-estimands-and-causal-reasoning-in-the-reanalysis-of-endpoint-measures-in-advanced-metastatic-non-small-cell-lung-cancer-clinical-trials/",
        "year": "2022",
        "study_id": [
            "NCT02737501",
            "NCT02367794",
            "NCT02367781",
            "NCT02075840",
            "NCT01544179"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7387",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn\u2019s Disease",
        "link": "https://vivli.org/comparative-effectiveness-of-biologics-for-endoscopic-healing-of-the-ileum-and-colon-in-crohns-disease/",
        "year": "2022",
        "study_id": [
            "NCT02425111",
            "NCT00348283",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7388",
        "lead_investigator": "Byeongzu Ghang",
        "lead_institution": "Jeju National University Hospital",
        "study_title": "Reanalysis of CARES study to investigate the changes of estimated glomerular filtration rate after long-term febuxostat or allopurinol treatment in gout patients",
        "link": "https://vivli.org/reanalysis-of-cares-study-to-investigate-the-changes-of-estimated-glomerular-filtration-rate-after-long-term-febuxostat-or-allopurinol-treatment-in-gout-patients/",
        "year": "2021",
        "study_id": [
            "NCT01101035"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7394, 6117, 5895",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Predictors of exposure, therapeutic and adverse effects of atezolizumab used in the treatment of advanced cancers",
        "link": "https://vivli.org/predictors-of-exposure-therapeutic-and-adverse-effects-of-atezolizumab-used-in-the-treatment-of-advanced-cancers/",
        "year": "2020",
        "study_id": [
            "NCT02008227",
            "NCT01903993",
            "NCT02031458",
            "NCT01846416",
            "NCT02951767",
            "NCT02108652",
            "NCT02302807",
            "NCT01984242",
            "NCT02420821",
            "NCT02367794",
            "NCT02367781",
            "NCT02322814",
            "NCT02924883",
            "NCT03434379",
            "NCT02366143",
            "NCT02763579",
            "NCT02908672"
        ],
        "number_of_studies": 17
    },
    {
        "request_id": "7395",
        "lead_investigator": "Xiaoling Shang",
        "lead_institution": "Shandong University",
        "study_title": "Survival analysis of advanced lung adenocarcinoma harboring epidermal growth factor receptor gene mutation receiving the combination treatment of atezolizumab, Bevacizumab,carboplatin and Paclitaxel",
        "link": "https://vivli.org/survival-analysis-of-advanced-lung-adenocarcinoma-harboring-epidermal-growth-factor-receptor-gene-mutation-receiving-the-combination-treatment-of-atezolizumab-bevacizumabcarboplatin-and-paclitaxel/",
        "year": "2021",
        "study_id": [
            "NCT02366143"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7396",
        "lead_investigator": "Mary Ann Lukas",
        "lead_institution": "GSK",
        "study_title": "Modeling and Simulation of ambrisentan pharmacokinetics in young children",
        "link": "https://vivli.org/modeling-and-simulation-of-ambrisentan-pharmacokinetics-in-young-children/",
        "year": "2021",
        "study_id": [
            "NCT02080637"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7399",
        "lead_investigator": "Yoichi Naito",
        "lead_institution": "National Cancer Center Hospital East",
        "study_title": "Correlation of doxorubicin dose and survival in patients with soft tissue sarcoma; Data from two studies (a larger phase III study and a smaller phase II study) will be combined and analyzed.",
        "link": "https://vivli.org/correlation-of-doxorubicin-dose-and-survival-in-patients-with-soft-tissue-sarcoma-data-from-two-studies-a-larger-phase-iii-study-and-a-smaller-phase-ii-study-will-be-combined-and-analyzed/",
        "year": "2022",
        "study_id": [
            "NCT02451943",
            "NCT01185964"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7400",
        "lead_investigator": "Aryelly Rodriguez",
        "lead_institution": "The University of Edinburgh",
        "study_title": "What are the re-identification risk scores of publicly available anonymised clinical trial datasets?",
        "link": "https://vivli.org/what-are-the-re-identification-risk-scores-of-publicly-available-anonymised-clinical-trial-datasets/",
        "year": "2022",
        "study_id": [
            "NCT01198756",
            "NCT01573767",
            "NCT01313676",
            "NCT00400855",
            "NCT01498822"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7401",
        "lead_investigator": "Scott Garrison",
        "lead_institution": "University of Alberta",
        "study_title": "Randomized Controlled Trial Data Availability and Re-Analysis Project",
        "link": "https://vivli.org/randomized-controlled-trial-data-availability-and-re-analysis-project/",
        "year": "2023",
        "study_id": [
            "NCT04320615",
            "NCT04372186",
            "NCT04328961",
            "NCT03349060",
            "NCT03720470",
            "NCT03052608"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "7404",
        "lead_investigator": "Reena Khanna",
        "lead_institution": "Lawson Health Research Institute",
        "study_title": "A Study to Assess the Correlation Between Harvey Bradshaw Index and Patient Reported Outcome 2 in Crohn's Disease Patients Enrolled in Large Scale Randomized Controlled Trials",
        "link": "https://vivli.org/a-study-to-assess-the-correlation-between-harvey-bradshaw-index-and-patient-reported-outcome-2-in-crohns-disease-patients-enrolled-in-large-scale-randomized-controlled-trials/",
        "year": "2022",
        "study_id": [
            "NCT00783692",
            "NCT00790933"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7414",
        "lead_investigator": "Nobuyuki Horita",
        "lead_institution": "Yokohama City University Hospital",
        "study_title": "Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Trials Evaluating Atezolizumab Regimens for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung Carcinoma: Independent-Patient-Data Analysis.",
        "link": "https://vivli.org/progression-free-survival-response-rate-and-disease-control-rate-as-predictors-of-overall-survival-in-trials-evaluating-atezolizumab-regimens-for-advanced-locally-advanced-and-recurrent-non-small/",
        "year": "2022",
        "study_id": [
            "NCT02367781",
            "NCT02366143",
            "NCT02367794",
            "NCT02031458",
            "NCT02008227",
            "NCT01903993",
            "NCT01846416"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7427",
        "lead_investigator": "Joachim Tan",
        "lead_institution": "Monash University",
        "study_title": "Dose reduction and discontinuation of disease modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis",
        "link": "https://vivli.org/dose-reduction-and-discontinuation-of-disease-modifying-anti-rheumatic-drugs-dmards-for-juvenile-idiopathic-arthritis/",
        "year": "2022",
        "study_id": [
            "NCT00048542",
            "NCT01230827",
            "NCT00988221"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7435",
        "lead_investigator": "Noah Goldfarb",
        "lead_institution": "University of Minnesota",
        "study_title": "Decision tool for the use of adalimumab for hidradenitis suppurativa",
        "link": "https://vivli.org/decision-tool-for-the-use-of-adalimumab-for-hidradenitis-suppurativa/",
        "year": "2022",
        "study_id": [
            "NCT01468233",
            "NCT01468207"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7445",
        "lead_investigator": "Catherine Thieblemont",
        "lead_institution": "Inserm",
        "study_title": "Evaluation of surrogate markers in marginal zone lymphoma",
        "link": "https://vivli.org/evaluation-of-surrogate-markers-in-marginal-zone-lymphoma/",
        "year": "2022",
        "study_id": [
            "NCT01332968"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7462",
        "lead_investigator": "Junjie Zhuo",
        "lead_institution": "Hainan University",
        "study_title": "Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles with Clinical Profiles in the Progression of Alzheimer\u2019s Disease",
        "link": "https://vivli.org/associations-of-amyloid-tau-and-neurodegeneration-biomarker-profiles-with-clinical-profiles-in-the-progression-of-alzheimers-disease/",
        "year": "2021",
        "study_id": [
            "NCT02245737",
            "NCT02972658",
            "NCT02783573"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7492",
        "lead_investigator": "Yang Zhao",
        "lead_institution": "Nanjing Medical University",
        "study_title": "An Investigation on the Role of Blood Biomarkers as Predictors for Individualized Treatment Regimen Selection in Non-Small Cell Lung Cancer.",
        "link": "https://vivli.org/an-investigation-on-the-role-of-blood-biomarkers-as-predictors-for-individualized-treatment-regimen-selection-in-non-small-cell-lung-cancer/",
        "year": "2022",
        "study_id": [
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02008227"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7493",
        "lead_investigator": "Nina Hilkens",
        "lead_institution": "Radboudumc Nijmegen",
        "study_title": "Blood pressure variability and progression of white matter hyperintensities after ischemic strokes",
        "link": "https://vivli.org/blood-pressure-variability-and-progression-of-white-matter-hyperintensities-after-ischemic-stroke/",
        "year": "2022",
        "study_id": [
            "NCT00153062"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7495",
        "lead_investigator": "Thomas Antalffy",
        "lead_institution": "Smart Respiratory Products Ltd",
        "study_title": "Analysing Clinical Applicability of CompEx Endpoints",
        "link": "https://vivli.org/analysing-clinical-applicability-of-compex-endpoints/",
        "year": "2021",
        "study_id": [
            "NCT01238861",
            "NCT01704495",
            "NCT00242775",
            "NCT00839800"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7498",
        "lead_investigator": "Riccardo Polosa",
        "lead_institution": "Center of Excellence for the Acceleration of Harm Reduction (CoEHAR)",
        "study_title": "A Machine Learning approach to improve smoking cessation trials",
        "link": "https://vivli.org/a-machine-learning-approach-to-improve-smoking-cessation-trials/",
        "year": "2022",
        "study_id": [
            "NCT01456936"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7501",
        "lead_investigator": "Min-Gul Kim",
        "lead_institution": "Jeonbuk National University Hospital",
        "study_title": "COVID-19 clinical trial data utilization to develop external control datasets in COVID-19 therapeutics development",
        "link": "https://vivli.org/covid-19-clinical-trial-data-utilization-to-develop-external-control-datasets-in-covid-19-therapeutics-development/",
        "year": "2022",
        "study_id": [
            "NCT04463264",
            "NCT04322682",
            "NCT04312009",
            "NCT04311177",
            "NCT04421027",
            "NCT04409262",
            "NCT04386616",
            "NCT04372186",
            "NCT04322123",
            "NCT04320615"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "7503, 6635",
        "lead_investigator": "Leslie Padrnos",
        "lead_institution": "Mayo Clinic",
        "study_title": "Efficacy and safety of anticoagulants for the treatment of acute venous thromboembolism (VTE) in patients with hematologic malignancies a systematic review and individual patient level data meta-analysis",
        "link": "https://vivli.org/efficacy-and-safety-of-anticoagulants-for-the-treatment-of-acute-venous-thromboembolism-vte-in-patients-with-hematologic-malignancies-a-systematic-review-and-individual-patient-level-data-meta-analy/",
        "year": "2021",
        "study_id": [
            "NCT00291330",
            "NCT00329238",
            "NCT00680186",
            "NCT00558259",
            "NCT02073682"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7518",
        "lead_investigator": "Lucio Manenti",
        "lead_institution": "University Hospital of Parma",
        "study_title": "Role of persistent and isolated reduced serum complement 3 (sC3) in lupus nephritis",
        "link": "https://vivli.org/role-of-persistent-and-isolated-reduced-serum-complement-3-sc3-in-lupus-nephritis",
        "year": "2022",
        "study_id": [
            "NCT00282347"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7520",
        "lead_investigator": "Malathi Ram",
        "lead_institution": "Johns Hopkins University",
        "study_title": "ACEi/ARB medications for hospitalized patients with COVID-19 \u2013 an individual patient data (IPD) based pooled analysis",
        "link": "https://vivli.org/acei-arb-medications-for-hospitalized-patients-with-covid-19-an-individual-patient-data-ipd-based-pooled-analysis/",
        "year": "2021",
        "study_id": [
            "NCT04335123",
            "NCT04340557",
            "NCT04312009",
            "NCT04328012",
            "NCT04328012"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7535",
        "lead_investigator": "Joshua Drago",
        "lead_institution": "Memorial Sloan Kettering Cancer Center",
        "study_title": "Statin use and clinical outcomes on ado-trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer",
        "link": "https://vivli.org/statin-use-and-clinical-outcomes-on-ado-trastuzumab-emtansine-t-dm1-in-her2-positive-metastatic-breast-cancer/",
        "year": "2022",
        "study_id": [
            "NCT01702571"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7539",
        "lead_investigator": "Amit Etkin",
        "lead_institution": "Alto Neuroscience, Inc.",
        "study_title": "Clinical and demographic predictors of antidepressant treatment in patients with major depressive disorder with agomelatine versus vortioxetine",
        "link": "https://vivli.org/clinical-and-demographic-predictors-of-antidepressant-treatment-in-patients-with-major-depressive-disorder-with-agomelatine-versus-vortioxetine/",
        "year": "2022",
        "study_id": [
            "NCT01488071"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7541",
        "lead_investigator": "Amit Etkin",
        "lead_institution": "Alto Neuroscience, Inc",
        "study_title": "Role of clinical, historical and demographic factors in the response to antidepressants versus placebo",
        "link": "https://vivli.org/role-of-clinical-historical-and-demographic-factors-in-the-response-to-antidepressants-versus-placebo/",
        "year": "2022",
        "study_id": [
            "NCT00406848",
            "NCT02389816",
            "NCT01808612",
            "NCT01564862",
            "NCT01355081",
            "NCT01255787",
            "NCT01179516",
            "NCT01163266",
            "NCT01153009",
            "NCT00849901",
            "NCT00849693",
            "NCT00735709",
            "NCT00672958",
            "NCT00672620",
            "NCT00536471",
            "NCT00062673"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "7542",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Vedolizumab vs. Adalimumab in Ulcerative Colitis: Validation of Indirect Comparisons",
        "link": "https://vivli.org/vedolizumab-vs-adalimumab-in-ulcerative-colitis-validation-of-indirect-comparisons/",
        "year": "2022",
        "study_id": [
            "NCT00385736",
            "NCT00408629",
            "NCT00783718",
            "NCT02497469",
            "NCT00385736",
            "NCT00408629",
            "NCT00783718",
            "NCT02497469"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "7543",
        "lead_investigator": "Margaret Salisbury",
        "lead_institution": "Vanderbilt University Medical Center",
        "study_title": "Defining the physiologic trajectory of presymptomatic through advanced pulmonary fibrosis",
        "link": "https://vivli.org/defining-the-physiologic-trajectory-of-presymptomatic-through-advanced-pulmonary-fibrosis/",
        "year": "2022",
        "study_id": [
            "NCT01366209",
            "NCT00287729",
            "NCT02999178",
            "NCT00287716",
            "NCT01335464",
            "NCT01335477",
            "NCT02788474"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7544",
        "lead_investigator": "Abhimanyu Mahajan",
        "lead_institution": "Rush University Medical Center",
        "study_title": "Sensory trick and benefit from botulinum toxin in cervical dystonia",
        "link": "https://vivli.org/sensory-trick-and-benefit-from-botulinum-toxin-in-cervical-dystonia/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7549",
        "lead_investigator": "Vipul Jairath",
        "lead_institution": "Alimentiv Inc",
        "study_title": "Responsiveness of the UC-100 Score in Patients with Moderately to Severely Active Ulcerative Colitis",
        "link": "https://vivli.org/responsiveness-of-the-uc-100-score-in-patients-with-moderately-to-severely-active-ulcerative-colitis",
        "year": "2022",
        "study_id": [
            "NCT00385736",
            "NCT00408629",
            "NCT00853099",
            "NCT00783718",
            "NCT02039505",
            "NCT00487539",
            "NCT00488631",
            "NCT01863771",
            "NCT00488774",
            "NCT01551290",
            "NCT02407236"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "7552",
        "lead_investigator": "Anna van Eijk",
        "lead_institution": "Liverpool School of Tropical Medicine",
        "study_title": "Impact of Malaria in Pregnancy on Infants",
        "link": "https://vivli.org/impact-of-malaria-in-pregnancy-on-infants",
        "year": "2023",
        "study_id": [
            "NCT01103063"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7581",
        "lead_investigator": "Rustam Al-Shahi Salman",
        "lead_institution": "University of Edinburgh",
        "study_title": "Collaboration Of Controlled Randomised trials of Oral Antithrombotic agents after intraCranial Haemorrhage (COCROACH)",
        "link": "https://vivli.org/collaboration-of-controlled-randomised-trials-of-oral-antithrombotic-agents-after-intracranial-haemorrhage-cocroach/",
        "year": "2022",
        "study_id": [
            "NCT02801669"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7583, 5932",
        "lead_investigator": "Youssef Zeidan",
        "lead_institution": "American University of Beirut Medical Center",
        "study_title": "Evaluation of Radiotherapy after Complete Response to Neoadjuvant Chemotherapy in HER-2 Positive Breast Cancer Patients",
        "link": "https://vivli.org/evaluation-of-radiotherapy-after-complete-response-to-neoadjuvant-chemotherapy-in-her-2-positive-breast-cancer-patients",
        "year": "2020",
        "study_id": [
            "NCT00976989",
            "NCT00545688"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7587",
        "lead_investigator": "Yashmin Karten",
        "lead_institution": "Critical Path Institute",
        "study_title": "Development of model-informed drug development tools for Alzheimer's Disease",
        "link": "https://vivli.org/development-of-model-informed-drug-development-tools-for-alzheimers-disease/",
        "year": "2022",
        "study_id": [
            "NCT02791191",
            "NCT00594568",
            "NCT00762411",
            "NCT01035138",
            "NCT03518073"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7590",
        "lead_investigator": "No\u00e9mie Lang",
        "lead_institution": "University Hospitals of Geneva",
        "study_title": "FRILLY: a retrospective single center study on Fractionated Rituximab to avoid Lysis Syndrome in Aggressive B-Lymphoma",
        "link": "https://vivli.org/frilly-a-retrospective-single-center-study-on-fractionated-rituximab-to-avoid-lysis-syndrome-in-aggressive-b-lymphoma/",
        "year": "2022",
        "study_id": [
            "NCT01287741",
            "NCT01649856",
            "NCT00118209"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7591, 7392",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Predictors of Placebo Response and Remission in Ulcerative Colitis and Crohn\u2019s Disease",
        "link": "https://vivli.org/predictors-of-placebo-response-and-remission-in-ulcerative-colitis-and-crohns-disease/",
        "year": "2022",
        "study_id": [
            "NCT00055523",
            "NCT00783718",
            "NCT00783692",
            "NCT00036439",
            "NCT00096655",
            "NCT01369342",
            "NCT01369355",
            "NCT01224171",
            "NCT01369329",
            "NCT00488631",
            "NCT00408629",
            "NCT01465763",
            "NCT01458951",
            "NCT01458574"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "7592",
        "lead_investigator": "Alexandre Betourne",
        "lead_institution": "Critical Path Institute",
        "study_title": "Integration of Biogen Rare Disease Data into the Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP)",
        "link": "https://vivli.org/integration-of-biogen-rare-disease-data-into-the-rare-diseases-cures-accelerator-data-and-analytics-platform-rdca-dap",
        "year": "2024",
        "study_id": [
            "NCT03068468",
            "NCT03068468"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7595",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Predicting therapeutic and adverse outcomes to immune checkpoint inhibitors used in cancer treatment",
        "link": "https://vivli.org/predicting-therapeutic-and-adverse-outcomes-to-immune-checkpoint-inhibitors-used-in-cancer-treatment",
        "year": "2022",
        "study_id": [
            "NCT03434379",
            "NCT02951767",
            "NCT02924883",
            "NCT02908672",
            "NCT02763579",
            "NCT02420821",
            "NCT02367794",
            "NCT02367781",
            "NCT02322814",
            "NCT02302807",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01984242",
            "NCT01903993",
            "NCT01846416",
            "NCT02657434"
        ],
        "number_of_studies": 17
    },
    {
        "request_id": "7597",
        "lead_investigator": "Junko Takeshita",
        "lead_institution": "University of Pennsylvania",
        "study_title": "Evaluating Racial and Ethnic Differences in the Quality-of-Life Impact of Atopic Dermatitis",
        "link": "https://vivli.org/evaluating-racial-and-ethnic-differences-in-the-quality-of-life-impact-of-atopic-dermatitis/",
        "year": "2022",
        "study_id": [
            "NCT02277743",
            "NCT02277769",
            "NCT02260986",
            "NCT03345914",
            "NCT03054428",
            "NCT02118766",
            "NCT02118792",
            "NCT03435081"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "7598",
        "lead_investigator": "Harry Southworth",
        "lead_institution": "Data Clarity Consulting Ltd",
        "study_title": "Exploration of ailments related to back pain in the medical history data from clinical studies of healthy subjects using formal hypothesis testing and data mining",
        "link": "https://vivli.org/exploration-of-ailments-related-to-back-pain-in-the-medical-history-data-from-clinical-studies-of-healthy-subjects-using-formal-hypothesis-testing-and-data-mining/",
        "year": "2022",
        "study_id": [
            "NCT01165177",
            "NCT01165229",
            "NCT00753272",
            "NCT00239681",
            "NCT00153101",
            "NCT01165177",
            "NCT01165229",
            "NCT00753272",
            "NCT00239681"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "7599",
        "lead_investigator": "Hwanhee Hong",
        "lead_institution": "Duke University",
        "study_title": "Combining data sources to identify effect moderation for personalized mental health treatment",
        "link": "https://vivli.org/combining-data-sources-to-identify-effect-moderation-for-personalized-mental-health-treatment/",
        "year": "2022",
        "study_id": [
            "NCT00604279",
            "NCT00589914",
            "NCT00210717",
            "NCT01153009",
            "NCT01140906",
            "NCT00672620",
            "NCT00635219"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7601",
        "lead_investigator": "Guru Sonpavde",
        "lead_institution": "AdventHealth Cancer Institute",
        "study_title": "Mathematical prognostic model utilizing multi-platform dynamics in patients with metastatic urothelial carcinoma receiving post-platinum PD1/L1 inhibitors",
        "link": "https://vivli.org/mathematical-prognostic-model-utilizing-multi-platform-dynamics-in-patients-with-metastatic-urothelial-carcinoma-receiving-post-platinum-pd1-l1-inhibitors/",
        "year": "2022",
        "study_id": [
            "NCT02302807"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7606",
        "lead_investigator": "Amber Salter",
        "lead_institution": "University of Texas Southwestern Medical Center",
        "study_title": "Comorbidity and Clinical Trials of Disease-Modifying Therapies in Multiple Sclerosis",
        "link": "https://vivli.org/comorbidity-and-clinical-trials-of-disease-modifying-therapies-in-multiple-sclerosis/",
        "year": "2022",
        "study_id": [
            "NCT01247324",
            "NCT01412333",
            "NCT01194570"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7609",
        "lead_investigator": "Joao Pedro Ferreira",
        "lead_institution": "Porto University",
        "study_title": "The impact of albiglutide on heart failure outcomes among patients with type 2 diabetes with and without heart failure at baseline",
        "link": "https://vivli.org/the-impact-of-albiglutide-on-heart-failure-outcomes-among-patients-with-type-2-diabetes-with-and-without-heart-failure-at-baseline/",
        "year": "2022",
        "study_id": [
            "NCT02465515",
            "NCT02465515"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7620",
        "lead_investigator": "Emilie Sbidian",
        "lead_institution": "University Paris Est Creteil (UPEC)",
        "study_title": "Systemic pharmacological treatments for chronic plaque psoriasis A Systematic Review and an Individual-Patient Data Network Meta-Analysis of Randomized Controlled Trials",
        "link": "https://vivli.org/systemic-pharmacological-treatments-for-chronic-plaque-psoriasis-a-systematic-review-and-an-individual-patient-data-network-meta-analysis-of-randomized-controlled-trials",
        "year": "2023",
        "study_id": [
            "NCT03000075",
            "NCT03255382",
            "NCT02694523",
            "NCT02684370",
            "NCT02684357",
            "NCT02672852",
            "NCT02634801",
            "NCT02561806",
            "NCT02513550",
            "NCT02054481",
            "NCT02016482",
            "NCT01646177",
            "NCT01646073",
            "NCT01597245",
            "NCT01474512",
            "NCT01107457",
            "NCT00237887",
            "NCT00235820",
            "NCT00936065",
            "NCT00245960",
            "NCT00691964",
            "NCT00710580",
            "NCT03478787",
            "NCT03875482",
            "NCT03573323",
            "NCT00338754",
            "NCT00333034",
            "NCT01483599",
            "NCT01008995",
            "NCT00454584",
            "NCT00320216",
            "NCT00307437",
            "NCT00267969",
            "NCT00723528",
            "NCT00747344",
            "NCT01550744",
            "NCT02203032",
            "NCT01059773",
            "NCT02326298",
            "NCT02326272",
            "NCT02346240",
            "NCT03051217",
            "NCT00106834",
            "NCT00230529",
            "NCT02207231",
            "NCT02207244",
            "NCT02905331",
            "NCT02325219",
            "NCT02951533",
            "NCT03090100"
        ],
        "number_of_studies": 50
    },
    {
        "request_id": "7621",
        "lead_investigator": "Adam Boxer",
        "lead_institution": "University of California San Francisco",
        "study_title": "Bayesian Disease Progression Modeling and Clinical Trial Design for Progressive Supranuclear Palsy - Richardson's Syndrome",
        "link": "https://vivli.org/bayesian-disease-progression-modeling-and-clinical-trial-design-for-progressive-supranuclear-palsy-richardsons-syndrome/",
        "year": "2022",
        "study_id": [
            "NCT02985879",
            "NCT03391765"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7654",
        "lead_investigator": "Shirley Yu",
        "lead_institution": "University of Sydney",
        "study_title": "Update of individual data meta-analysis of intra-articular corticosteroids in knee and hip osteoarthritis",
        "link": "https://vivli.org/update-of-individual-data-meta-analysis-of-intra-articular-corticosteroids-in-knee-and-hip-osteoarthritis/",
        "year": "2022",
        "study_id": [
            "NCT00139295"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7656",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Impact of Steroid Weaning Regimens on Outcomes in Clinical Trials of Ulcerative Colitis",
        "link": "https://vivli.org/impact-of-steroid-weaning-regimens-on-outcomes-in-clinical-trials-of-ulcerative-colitis/",
        "year": "2022",
        "study_id": [
            "NCT00036439",
            "NCT00096655",
            "NCT00408629",
            "NCT00783718",
            "NCT02497469",
            "NCT00488631",
            "NCT01465763",
            "NCT01458951",
            "NCT01458574",
            "NCT00036439",
            "NCT00096655",
            "NCT00408629",
            "NCT00783718",
            "NCT02497469",
            "NCT00488631",
            "NCT01465763",
            "NCT01458951",
            "NCT01458574"
        ],
        "number_of_studies": 18
    },
    {
        "request_id": "7658",
        "lead_investigator": "Arman Sabbaghi",
        "lead_institution": "Purdue University",
        "study_title": "Tripartite Estimands for Adherence Causal Inference in Clinical Trials, With Applications for the Development of COVID-19 Treatments",
        "link": "https://vivli.org/tripartite-estimands-for-adherence-causal-inference-in-clinical-trials-with-applications-for-the-development-of-covid-19-treatments/",
        "year": "2022",
        "study_id": [
            "NCT01517412"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7660",
        "lead_investigator": "Shirley Yu",
        "lead_institution": "University of Sydney",
        "study_title": "Predictors of placebo response to local (intra-articular) therapy in osteoarthritis: an individual patient data meta-analysis",
        "link": "https://vivli.org/predictors-of-placebo-response-to-local-intra-articular-therapy-in-osteoarthritis-an-individual-patient-data-meta-analysis/",
        "year": "2022",
        "study_id": [
            "NCT00131352"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7661",
        "lead_investigator": "Baocheng Chang",
        "lead_institution": "Tianjin Medical University",
        "study_title": "Effects of Lixisenatide on the primary prevention of diabetic kidney disease in population with high risk",
        "link": "https://vivli.org/effects-of-lixisenatide-on-the-primary-prevention-of-diabetic-kidney-disease-in-population-with-high-risk/",
        "year": "2022",
        "study_id": [
            "NCT01147250"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7662",
        "lead_investigator": "Benoit You",
        "lead_institution": "Universit\u00e9 Claude Bernard Lyon",
        "study_title": "Prognostic And Predictive Value Of The Modeled PSA Kinetics Parameters In Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel Or Cabazitaxel (Phase III Trial \u2014 FIRSTANA)",
        "link": "https://vivli.org/prognostic-and-predictive-value-of-the-modeled-psa-kinetics-parameters-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-docetaxel-or-cabazitaxel-phase-iii-trial/",
        "year": "2022",
        "study_id": [
            "NCT01308567"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7663, 7385",
        "lead_investigator": "Amit Etkin",
        "lead_institution": "Alto Neuroscience, Inc.",
        "study_title": "Cognitive predictors of antidepressant treatment outcome in patients with major depressive disorder",
        "link": "https://vivli.org/cognitive-predictors-of-antidepressant-treatment-outcome-in-patients-with-major-depressive-disorder/\u201d",
        "year": "2021",
        "study_id": [
            "NCT00811252",
            "NCT01422213",
            "NCT01564862",
            "NCT00406848",
            "NCT02389816",
            "NCT02279966",
            "NCT02279953",
            "NCT02272517",
            "NCT00062673"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "7667",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Summarising the therapeutic and adverse effects of anticancer medicines according to race and sex: pooled analysis of clinical trials of contemporary treatments for solid tumours",
        "link": "https://vivli.org/summarising-the-therapeutic-and-adverse-effects-of-anticancer-medicines-according-to-race-and-sex-pooled-analysis-of-clinical-trials-of-contemporary-treatments-for-solid-tumours/",
        "year": "2022",
        "study_id": [
            "NCT02296125",
            "NCT02151981",
            "NCT00525148",
            "NCT01121393",
            "NCT00949650",
            "NCT01523587",
            "NCT02371369",
            "NCT03248492",
            "NCT01170663",
            "NCT01168973",
            "NCT02246621",
            "NCT00917384",
            "NCT01183780",
            "NCT00982111",
            "NCT00981058",
            "NCT02102490",
            "NCT02107703",
            "NCT00567190",
            "NCT00976989",
            "NCT00545688",
            "NCT01358877",
            "NCT01772472",
            "NCT02367781",
            "NCT02075840",
            "NCT02366143",
            "NCT01689519",
            "NCT02951767",
            "NCT02763579",
            "NCT02008227",
            "NCT00829166",
            "NCT03434379",
            "NCT02908672",
            "NCT00833417",
            "NCT01006980",
            "NCT00949702",
            "NCT01378975",
            "NCT01740427",
            "NCT01942135",
            "NCT00678392",
            "NCT00410761",
            "NCT02737501",
            "NCT02094573",
            "NCT01970865",
            "NCT02928224",
            "NCT01154140",
            "NCT00932893",
            "NCT01909453",
            "NCT01774721",
            "NCT02603432",
            "NCT01945775",
            "NCT00561470",
            "NCT01715285",
            "NCT00887198",
            "NCT00638690",
            "NCT01343277",
            "NCT02000622",
            "NCT00753545",
            "NCT01078662",
            "NCT01874353",
            "NCT01774344",
            "NCT02200614"
        ],
        "number_of_studies": 61
    },
    {
        "request_id": "7743",
        "lead_investigator": "Caroline Quach",
        "lead_institution": "CHU Sainte-Justine",
        "study_title": "Is there a Difference in the Immune Response, Efficacy, and Safety of Seasonal Influenza Vaccine in Males and Females? - A Meta-Analysis",
        "link": "https://vivli.org/is-there-a-difference-in-the-immune-response-efficacy-and-safety-of-seasonal-influenza-vaccine-in-males-and-females-a-meta-analysis/",
        "year": "2022",
        "study_id": [
            "NCT01712984",
            "NCT01481454",
            "NCT02550197",
            "NCT01218646",
            "NCT02451358"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7744, 6055",
        "lead_investigator": "Florian Naudet",
        "lead_institution": "CHU Rennes",
        "study_title": "Inferential reproducibility of therapeutic research: a registered report for a cross-sectional study of RCTs available on major data-sharing platforms",
        "link": "https://vivli.org/inferential-reproducibility-of-therapeutic-research-a-registered-report-for-a-cross-sectional-study-of-rcts-available-on-major-data-sharing-platforms/",
        "year": "2021",
        "study_id": [
            "NCT00558428",
            "NCT00621140",
            "NCT00387088",
            "NCT00474786",
            "NCT00798967",
            "NCT01549964",
            "NCT00782210",
            "NCT00286455",
            "NCT00756002",
            "NCT01341782",
            "NCT00798161",
            "NCT00950300",
            "NCT00673920",
            "NCT00349752",
            "NCT00836693",
            "NCT02314117",
            "NCT01634139",
            "NCT01468233",
            "NCT02164864",
            "NCT00105989",
            "NCT00333775",
            "NCT01126580",
            "NCT01215097",
            "NCT00870467",
            "NCT01194414",
            "NCT01519791",
            "NCT00286442",
            "NCT01120184",
            "NCT02058160",
            "NCT01074944"
        ],
        "number_of_studies": 30
    },
    {
        "request_id": "7758",
        "lead_investigator": "Nahid Sultana",
        "lead_institution": "University of Sheffield",
        "study_title": "Indirect comparisons of time-to-event outcomes using single-arm studies in health technology assessment (Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma)",
        "link": "https://vivli.org/indirect-comparisons-of-time-to-event-outcomes-using-single-arm-studies-in-health-technology-assessment-mepolizumab-treatment-in-patients-with-severe-eosinophilic-asthma/",
        "year": "2022",
        "study_id": [
            "NCT01000506"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7759",
        "lead_investigator": "Tamar Oostrom",
        "lead_institution": "The Ohio State University",
        "study_title": "Heterogenous Effects in Diabetes Mellitus Clinical Trials and Implications for Physician Prescriptions",
        "link": "https://vivli.org/heterogenous-effects-in-diabetes-mellitus-clinical-trials-and-implications-for-physician-prescriptions",
        "year": "2023",
        "study_id": [
            "NCT01596504",
            "NCT00299871",
            "NCT00975286",
            "NCT01768559",
            "NCT00688701",
            "NCT00866658",
            "NCT00707031",
            "NCT00713830",
            "NCT00763451",
            "NCT00715624",
            "NCT00712673",
            "NCT00976937",
            "NCT00763815",
            "NCT01147250",
            "NCT01632163",
            "NCT01960179",
            "NCT01940965",
            "NCT01169779",
            "NCT00679939",
            "NCT00879970",
            "NCT00551564",
            "NCT00279045",
            "NCT00500955",
            "NCT00379769",
            "NCT00306644",
            "NCT00306696",
            "NCT00329225",
            "NCT00499707",
            "NCT00069836",
            "NCT00333723",
            "NCT00501020",
            "NCT00044460",
            "NCT00197132",
            "NCT00386100",
            "NCT00067951"
        ],
        "number_of_studies": 35
    },
    {
        "request_id": "7760",
        "lead_investigator": "John (Devin) Peipert",
        "lead_institution": "Northwestern University",
        "study_title": "Study of Functional Assessment of Chronic Illness Therapy (FACIT) GP5 Item as a Measure of Treatment Tolerability in Advanced Cancer Patients across Multiple Tumour Sites and Treatment Types",
        "link": "https://vivli.org/study-of-functional-assessment-of-chronic-illness-therapy-facit-gp5-item-as-a-measure-of-treatment-tolerability-in-advanced-cancer-patients-across-multiple-tumour-sites-and-treatment-types/",
        "year": "2022",
        "study_id": [
            "NCT01120184",
            "NCT00762034",
            "NCT00678392",
            "NCT00920816",
            "NCT01740427",
            "NCT02420821",
            "NCT00567190"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "7772",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Combined Histologic and Endoscopic Endpoints in Ulcerative Colitis",
        "link": "https://vivli.org/combined-histologic-and-endoscopic-endpoints-in-ulcerative-colitis/",
        "year": "2022",
        "study_id": [
            "NCT02497469"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7776",
        "lead_investigator": "Stefan Leucht",
        "lead_institution": "Technical University of Munich",
        "study_title": "Antipsychotic drugs versus placebo in the treatment of antipsychotic na\u00efve and/or first episode children or adolescents with psychosis: A systematic review and meta-analysis of double-blind randomized controlled",
        "link": "https://vivli.org/antipsychotic-drugs-versus-placebo-in-the-treatment-of-antipsychotic-naive-and-or-first-episode-children-or-adolescents-with-psychosis-a-systematic-review-and-meta-analysis-of-double-blind-randomized/",
        "year": "2022",
        "study_id": [
            "NCT00051298",
            "NCT00102063"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7777",
        "lead_investigator": "Paul Ayuk",
        "lead_institution": "Newcastle-upon-Tyne Hospitals NHS Trust",
        "study_title": "Using Dabigatran etexilate to prevent blood clots in women after childbirth",
        "link": "https://vivli.org/using-dabigatran-etexilate-to-prevent-blood-clots-in-women-after-childbirth/",
        "year": "2022",
        "study_id": [
            "NCT02170701",
            "NCT01225822",
            "NCT01227629",
            "NCT01136408",
            "NCT00262600"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7779",
        "lead_investigator": "Lu\u00eds In\u00eas",
        "lead_institution": "University of Beira Interior",
        "study_title": "Derivation and validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) severe disease activity category: post-hoc analysis of the anifrolumab clinical trials in active systemic lupus erythematosus.",
        "link": "https://vivli.org/derivation-and-validation-of-the-systemic-lupus-erythematosus-disease-activity-score-sle-das-severe-disease-activity-category-post-hoc-analysis-of-the-anifrolumab-clinical-trials-in-active-systemic/",
        "year": "2022",
        "study_id": [
            "NCT01438489",
            "NCT02446912",
            "NCT02446899",
            "NCT02446912",
            "NCT02446899",
            "NCT01438489"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "7782",
        "lead_investigator": "Yang Li",
        "lead_institution": "Renmin University of China",
        "study_title": "A new covariate randomization method for multi-arm randomized controlled trials",
        "link": "https://vivli.org/a-new-covariate-randomization-method-for-multi-arm-randomized-controlled-trials",
        "year": "2022",
        "study_id": [
            "NCT03034915",
            "NCT02924688",
            "NCT02301975"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7785",
        "lead_investigator": "Christian Jonasson",
        "lead_institution": "NordicRWE",
        "study_title": "Using Norwegian real world data to emulate and reproduce results from oncology clinical trials",
        "link": "https://vivli.org/using-norwegian-real-world-data-to-emulate-and-reproduce-results-from-oncology-clinical-trials/",
        "year": "2022",
        "study_id": [
            "NCT02763579",
            "NCT02604342",
            "NCT02366143",
            "NCT02008227",
            "NCT02367794",
            "NCT02367781"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "7794",
        "lead_investigator": "Joan Carles",
        "lead_institution": "Vall D'Hebron Institute of Oncology",
        "study_title": "Co Medication (aspirin, statins and metformin) analysis in patients with metastatic Castration Resistant Prostate Cancer treated with Chemotherapy",
        "link": "https://vivli.org/co-medication-aspirin-statins-and-metformin-analysis-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-chemotherapy/",
        "year": "2022",
        "study_id": [
            "NCT00417079",
            "NCT01308580",
            "NCT01308567"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7797",
        "lead_investigator": "J\u00f6rg Ellinger",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Evaluation of the performance of the modified Glasgow prognostic score in urothelial carcinoma, non-small cell lung cancer and renal cell carcinoma",
        "link": "https://vivli.org/evaluation-of-the-performance-of-the-modified-glasgow-prognostic-score-in-urothelial-carcinoma-non-small-cell-lung-cancer-and-renal-cell-carcinoma/",
        "year": "2022",
        "study_id": [
            "NCT02008227",
            "NCT02302807",
            "NCT02008227",
            "NCT00375674",
            "NCT00326898",
            "NCT01984242",
            "NCT02951767",
            "NCT02108652"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "7801, 6864",
        "lead_investigator": "Yoshie Omachi",
        "lead_institution": "National Center of Neurology and Psychiatry",
        "study_title": "Elucidation of the predictive factors for active and placebo drug response on social functioning and quality of life (QOL) in psychiatric illnesses including developmental disorders",
        "link": "https://vivli.org/elucidation-of-the-predictive-factors-for-active-and-placebo-drug-response-on-social-functioning-and-quality-of-life-qol-in-psychiatric-illnesses-including-developmental-disorders/",
        "year": "2022",
        "study_id": [
            "NCT01323192",
            "NCT00962104",
            "NCT02305134",
            "NCT00191295"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7804",
        "lead_investigator": "Qingyun Li",
        "lead_institution": "Genecast Biotechnology Co., Ltd",
        "study_title": "An exploratory study of the fusion co-mutated immune microenvironment in Non-small cell lung cancer",
        "link": "https://vivli.org/an-exploratory-study-of-the-fusion-co-mutated-immune-microenvironment-in-non-small-cell-lung-cancer/",
        "year": "2022",
        "study_id": [
            "NCT02366143"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7807",
        "lead_investigator": "Hayato Niiyama",
        "lead_institution": "Yokohama City University",
        "study_title": "A Post-hoc Analysis using Secondary Data of Clinical Trial from M14-033 Study to Evaluate Average Treatment Effect and Heterogeneous Treatment Effect of Adalimumab in Maintenance Phase for Patients with Ulcerative Colitis",
        "link": "https://vivli.org/a-post-hoc-analysis-using-secondary-data-of-clinical-trial-from-m14-033-study-to-evaluate-average-treatment-effect-and-heterogeneous-treatment-effect-of-adalimumab-in-maintenance-phase-for-patients-wi/",
        "year": "2022",
        "study_id": [
            "NCT02065622"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7809",
        "lead_investigator": "David James Pinato",
        "lead_institution": "Imperial College, London",
        "study_title": "The predictive role of concomitant antibiotics in patients treated with immunotherapy or oral treatment for unresectable hepatocellular carcinoma (HCC)",
        "link": "https://vivli.org/the-predictive-role-of-concomitant-antibiotics-in-patients-treated-with-immunotherapy-or-oral-treatment-for-unresectable-hepatocellular-carcinoma-hcc/",
        "year": "2022",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7810",
        "lead_investigator": "Diego Chowell",
        "lead_institution": "Icahn School of Medicine at Mount Sinai",
        "study_title": "Machine learning model to predict cancer immunotherapy response",
        "link": "https://vivli.org/machine-learning-model-to-predict-cancer-immunotherapy-response/",
        "year": "2022",
        "study_id": [
            "NCT02008227",
            "NCT03434379",
            "NCT02763579",
            "NCT02908672",
            "NCT02657434",
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02302807",
            "NCT02420821"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "7811",
        "lead_investigator": "Gustavo Turecki",
        "lead_institution": "McGill University",
        "study_title": "Using Artificial Intelligence to Personalize Treatment Selection and Trajectory Monitoring of Bipolar Disorder",
        "link": "https://vivli.org/using-artificial-intelligence-to-personalize-treatment-selection-and-trajectory-monitoring-of-bipolar-disorder/",
        "year": "2023",
        "study_id": [
            "NCT00618748",
            "NCT00510146",
            "NCT00485771",
            "NCT00191399",
            "NCT00094549",
            "NCT00071253",
            "NCT00060905",
            "NCT01467700",
            "NCT01467713",
            "NCT01677182",
            "NCT00094432"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "7817",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Predictors of Histologic Response using Antibodies Against Interleukin-5 in Eosinophilic Esophagitis",
        "link": "https://vivli.org/predictors-of-histologic-response-using-antibodies-against-interleukin-5-in-eosinophilic-esophagitis/",
        "year": "2022",
        "study_id": [
            "NCT00358449",
            "NCT00358449"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7818",
        "lead_investigator": "Werner Weitschies",
        "lead_institution": "University of Greifswald",
        "study_title": "Development and improvement of an in vitro tool, which simulates the physiological characteristics of the ascending colon",
        "link": "https://vivli.org/development-and-improvement-of-an-in-vitro-tool-which-simulates-the-physiological-characteristics-of-the-ascending-colon",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7819",
        "lead_investigator": "Jeanine Roeters van Lennep",
        "lead_institution": "Erasmus University Medical Center",
        "study_title": "Efficacy & Safety of Proprotein Convertase Subtilisin/Kexin type 9 Inhibitors: a Systematic Review and Meta-analysis of Real-World Data",
        "link": "https://vivli.org/efficacy-safety-of-proprotein-convertase-subtilisin-kexin-type-9-inhibitors-a-systematic-review-and-meta-analysis-of-real-world-data/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7822",
        "lead_investigator": "Linbin Lu",
        "lead_institution": "the 900th Hospital of PLA",
        "study_title": "Trajectories of alpha-fetoprotein and liver cancer outcomes after atezolizumab treatment",
        "link": "https://vivli.org/trajectories-of-alpha-fetoprotein-and-liver-cancer-outcomes-after-atezolizumab-treatment/",
        "year": "2022",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7823",
        "lead_investigator": "Marc Carrier",
        "lead_institution": "University of Ottawa",
        "study_title": "Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Patients with Cancer: A Systematic Review",
        "link": "https://vivli.org/anticoagulation-for-the-prevention-of-arterial-thrombosis-in-ambulatory-patients-with-cancer-a-systematic-review/",
        "year": "2022",
        "study_id": [
            "NCT00312013",
            "NCT00694382"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "7824",
        "lead_investigator": "Feng Sun",
        "lead_institution": "Peking University",
        "study_title": "An individual participant data meta-analysis to evaluate PD1 vs PD-L1 Inhibitors in Asian subgroup Cancer patients",
        "link": "https://vivli.org/an-individual-participant-data-meta-analysis-to-evaluate-pd1-vs-pd-l1-inhibitors-in-asian-subgroup-cancer-patients",
        "year": "2022",
        "study_id": [
            "NCT02452424",
            "NCT03434379",
            "NCT02951767",
            "NCT02924883",
            "NCT02908672",
            "NCT02763579",
            "NCT02420821",
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02322814",
            "NCT02302807",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01984242",
            "NCT01903993",
            "NCT01846416"
        ],
        "number_of_studies": 18
    },
    {
        "request_id": "7828",
        "lead_investigator": "Ramiro Sofia",
        "lead_institution": "Leiden University Medical Center",
        "study_title": "SPondyloarthritis EARly Definition (ASAS-SPEAR) Analysis of Symptom Duration Thresholds Using Pooled Data from Randomized Controlled Trials",
        "link": "https://vivli.org/spondyloarthritis-early-definition-asas-spear-analysis-of-symptom-duration-thresholds-using-pooled-data-from-randomized-controlled-trials",
        "year": "2022",
        "study_id": [
            "NCT03129100",
            "NCT02757352",
            "NCT02696798",
            "NCT02696785",
            "NCT01258738",
            "NCT01087762",
            "NCT00939003",
            "NCT02186873",
            "NCT01248793",
            "NCT01114880",
            "NCT00421915",
            "NCT00265083",
            "NCT00207701",
            "NCT00195819",
            "NCT00085644",
            "NCT02552212",
            "NCT02505542",
            "NCT02509026",
            "NCT01808118"
        ],
        "number_of_studies": 19
    },
    {
        "request_id": "7830",
        "lead_investigator": "Yi-Wen Tsai",
        "lead_institution": "National Yang Ming Chiao Tung University",
        "study_title": "Cost effectiveness analysis of atezolizumab plus chemotherapy for untreated extensive stage small cell lung cancer in Asia",
        "link": "https://vivli.org/cost-effectiveness-analysis-of-atezolizumab-plus-chemotherapy-for-untreated-extensive-stage-small-cell-lung-cancer-in-asia/",
        "year": "2022",
        "study_id": [
            "NCT02763579"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7835",
        "lead_investigator": "Hiroyuki Kusuhara",
        "lead_institution": "University of Tokyo",
        "study_title": "Assessment of the drug-drug interactions risks of drugs based on the clinical data of the plasma biomarkers",
        "link": "https://vivli.org/assessment-of-the-drug-drug-interactions-risks-of-drugs-based-on-the-clinical-data-of-the-plasma-biomarkers",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7840",
        "lead_investigator": "Marco Tagliamento",
        "lead_institution": "IRCCS Ospedale Policlinico San Martino",
        "study_title": "Clinical Effect of Chemotherapy-Immunotherapy Combination in the First-Line Treatment of Older Patients with Non-Small Cell Lung Cancer",
        "link": "https://vivli.org/clinical-effect-of-chemotherapy-immunotherapy-combination-in-the-first-line-treatment-of-older-patients-with-non-small-cell-lung-cancer",
        "year": "2023",
        "study_id": [
            "NCT02366143",
            "NCT02367781",
            "NCT02367794",
            "NCT02657434"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7842",
        "lead_investigator": "Marco Tagliamento",
        "lead_institution": "IRCCS Ospedale Policlinico San Martino",
        "study_title": "Pooled Efficacy and Safety Analysis of the Phase III Studies of Alectinib vs. Crizotinib in Untreated ALK-Positive Non-Small Cell Lung Cancer",
        "link": "https://vivli.org/pooled-efficacy-and-safety-analysis-of-the-phase-iii-studies-of-alectinib-vs-crizotinib-in-untreated-alk-positive-non-small-cell-lung-cancer",
        "year": "2022",
        "study_id": [
            "NCT02075840",
            "NCT02838420",
            "NCT02075840"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7844",
        "lead_investigator": "Linong Ji",
        "lead_institution": "Peking University People's Hospital",
        "study_title": "Risk stratification and responder identification for glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) in Type 2 Diabetes Mellitus (T2DM): a machine learning facilitated post-hoc analysis of clinical trials",
        "link": "https://vivli.org/risk-stratification-and-responder-identification-for-glucagon-like-peptide-1-receptor-agonists-glp-1-ra-and-sodium-glucose-cotransporter-2-inhibitors-sglt2i-in-type-2-diabetes-mellitus-t2dm-a-m/",
        "year": "2022",
        "study_id": [
            "NCT02465515",
            "NCT00000620",
            "NCT02065791",
            "NCT01032629",
            "NCT01989754"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7845",
        "lead_investigator": "Craig Nelson",
        "lead_institution": "University of California San Francisco",
        "study_title": "Change in cognition during antidepressant treatment of late life depression",
        "link": "https://vivli.org/change-in-cognition-during-antidepressant-treatment-of-late-life-depression/",
        "year": "2022",
        "study_id": [
            "NCT00406848",
            "NCT00062673",
            "NCT00811252"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7846",
        "lead_investigator": "Samuele Cortese",
        "lead_institution": "University of Southampton",
        "study_title": "PATIENCE Individual Patient DATa Network Meta-AnalysIs of the Efficacy aNd aCceptability of Attention-Deficit/Hyperactivity Disorder (ADHD) mEdication",
        "link": "https://vivli.org/patience-individual-patient-data-network-meta-analysis-of-the-efficacy-and-acceptability-of-attention-deficit-hyperactivity-disorder-adhd-medication",
        "year": "2025",
        "study_id": [
            "NCT00429091",
            "NCT00528697",
            "NCT00326391",
            "NCT00714688",
            "NCT00937040",
            "NCT00246220",
            "NCT01323192",
            "NCT00962104",
            "NCT00486122",
            "NCT00190879",
            "NCT00190775",
            "NCT00190736",
            "NCT00510276",
            "NCT00190931",
            "NCT00191698",
            "NCT00406354",
            "NCT00191295",
            "NCT00386581",
            "NCT00380692",
            "NCT00607919",
            "NCT00190957",
            "NCT00486083",
            "NCT00763971",
            "NCT00735371",
            "NCT00152022",
            "NCT00150579",
            "NCT02604407",
            "NCT00334880",
            "NCT01101022",
            "NCT00248092",
            "NCT00152009",
            "NCT00367835",
            "NCT01244490",
            "NCT00150592",
            "NCT00997984",
            "NCT00150618",
            "NCT01552915",
            "NCT01552902",
            "NCT01081132"
        ],
        "number_of_studies": 39
    },
    {
        "request_id": "7848",
        "lead_investigator": "Jennifer Lund",
        "lead_institution": "University of North Carolina at Chapel Hill",
        "study_title": "Improving Colon Cancer Therapy Decisions by Extending Trial Representation",
        "link": "https://vivli.org/improving-colon-cancer-therapy-decisions-by-extending-trial-representation/",
        "year": "2022",
        "study_id": [
            "NCT00275210"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7849",
        "lead_investigator": "Igor Stojkov",
        "lead_institution": "Paul-Ehrlich-Institut",
        "study_title": "Determinants of study design for vaccines against opportunistic bacterial infections a proof-of-concept for data-driven, individual patient data (IPD) analyses.",
        "link": "https://vivli.org/determinants-of-study-design-for-vaccines-against-opportunistic-bacterial-infections-a-proof-of-concept-for-data-driven-individual-patient-data-ipd-analyses",
        "year": "2023",
        "study_id": [
            "NCT01887912",
            "NCT00772343",
            "NCT01230957"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7850",
        "lead_investigator": "Vipul Jairath",
        "lead_institution": "University of Western Ontario",
        "study_title": "Impact of concomitant baseline medication on efficacy of biologics and small molecules for Inflammatory Bowel Disease",
        "link": "https://vivli.org/impact-of-concomitant-baseline-medication-on-efficacy-of-biologics-and-small-molecules-for-inflammatory-bowel-disease",
        "year": "2022",
        "study_id": [
            "NCT01369342",
            "NCT01369329",
            "NCT01224171",
            "NCT00552058",
            "NCT00207662",
            "NCT00783692",
            "NCT01465763",
            "NCT01458951",
            "NCT00488774",
            "NCT00487539",
            "NCT00385736",
            "NCT00096655",
            "NCT00036439",
            "NCT02407236",
            "NCT00783718",
            "NCT00408629"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "7854",
        "lead_investigator": "Vipul Jairath",
        "lead_institution": "University of Western Ontario",
        "study_title": "Efficacy of medical therapies for ulcerative colitis according to disease distribution: An individual patient data meta-analysis of randomized controlled trials",
        "link": "https://vivli.org/efficacy-of-medical-therapies-for-ulcerative-colitis-according-to-disease-distribution-an-individual-patient-data-meta-analysis-of-randomized-controlled-trials",
        "year": "2022",
        "study_id": [
            "NCT01465763",
            "NCT01458951",
            "NCT00488774",
            "NCT00487539",
            "NCT00385736",
            "NCT00096655",
            "NCT00036439",
            "NCT02611830",
            "NCT01458574",
            "NCT00488631",
            "NCT02407236",
            "NCT00783718",
            "NCT00408629"
        ],
        "number_of_studies": 13
    },
    {
        "request_id": "7856",
        "lead_investigator": "Evandro de Azambuja",
        "lead_institution": "Institut Jules Bordet",
        "study_title": "Metastatic HER2-positive breast cancer treated with docetaxel, trastuzumab, and pertuzumab: the impact of early response on patient survival",
        "link": "https://vivli.org/metastatic-her2-positive-breast-cancer-treated-with-docetaxel-trastuzumab-and-pertuzumab-the-impact-of-early-response-on-patient-survival/",
        "year": "2022",
        "study_id": [
            "NCT00567190",
            "NCT01491737",
            "NCT00567190",
            "NCT01491737"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7857",
        "lead_investigator": "Rentao Yu",
        "lead_institution": "Chongqing Medical University",
        "study_title": "Cutaneous adverse effects of immunotherapy medications in the treatment of cancers and their associations with overall survival",
        "link": "https://vivli.org/cutaneous-adverse-effects-of-immunotherapy-medications-in-the-treatment-of-cancers-and-their-associations-with-overall-survival",
        "year": "2023",
        "study_id": [
            "NCT03434379",
            "NCT02951767",
            "NCT02924883",
            "NCT02908672",
            "NCT02763579",
            "NCT02452424",
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02322814",
            "NCT02302807",
            "NCT02108652",
            "NCT02031458",
            "NCT02008227",
            "NCT01903993",
            "NCT01846416",
            "NCT02420821",
            "NCT01984242"
        ],
        "number_of_studies": 18
    },
    {
        "request_id": "7858",
        "lead_investigator": "Jie Zha",
        "lead_institution": "Xiamen University",
        "study_title": "Retrospective cohort study with internal and external validation of a predictive tool for progression of disease within 2 years (POD24) risk assessment in follicular lymphoma patients",
        "link": "https://vivli.org/retrospective-cohort-study-with-internal-and-external-validation-of-a-predictive-tool-for-progression-of-disease-within-2-years-pod24-risk-assessment-in-follicular-lymphoma-patients/",
        "year": "2022",
        "study_id": [
            "NCT01200758",
            "NCT01332968",
            "NCT01332968",
            "NCT01200758"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7860",
        "lead_investigator": "Kemi Williams",
        "lead_institution": "54gene",
        "study_title": "Descriptive analysis of UNITY Global study data in Nigeria",
        "link": "https://vivli.org/descriptive-analysis-of-unity-global-study-data-in-nigeria/",
        "year": "2022",
        "study_id": [
            "NCT04626076"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7868",
        "lead_investigator": "Anne-Marie Dingemans",
        "lead_institution": "Erasmus MC University Medical Center",
        "study_title": "Predictive clinical characteristics for weight gain in patients treated with alectinib",
        "link": "https://vivli.org/predictive-clinical-characteristics-for-weight-gain-in-patients-treated-with-alectinib",
        "year": "2022",
        "study_id": [
            "NCT02075840",
            "NCT02604342",
            "NCT02271139"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "7872",
        "lead_investigator": "Dorra Bouazzi",
        "lead_institution": "Zealand University",
        "study_title": "Hidradenitis Suppurativa \u2013 a collaborative study of subtypes",
        "link": "https://vivli.org/hidradenitis-suppurativa-a-collaborative-study-of-subtypes",
        "year": "2023",
        "study_id": [
            "NCT01635764",
            "NCT01468233",
            "NCT01468207",
            "NCT00918255"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "7873",
        "lead_investigator": "Xue Yang",
        "lead_institution": "Beijing Cancer Hospital",
        "study_title": "Crizotinib followed by alectinib vs alectinib alone: analysis of treatment-na\u00efve patients with non-small cell lung cancer (NSCLC) harboring anaplastic lymphoma kinase (ALK) -rearrangement",
        "link": "https://vivli.org/crizotinib-followed-by-alectinib-vs-alectinib-alone-analysis-of-treatment-naive-patients-with-non-small-cell-lung-cancer-nsclc-harboring-anaplastic-lymphoma-kinase-alk-rearrangement/",
        "year": "2022",
        "study_id": [
            "NCT02075840"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "7874",
        "lead_investigator": "Chiara Alessandra Cella",
        "lead_institution": "Istituto Europeo di Oncologia",
        "study_title": "Addressing the synergistic effect of metformin in patients with Pancreatic neuroendocrine tumors treated with sunitinib: a post-hoc analysis from the main pivotal trials.",
        "link": "https://vivli.org/addressing-the-synergistic-effect-of-metformin-in-patients-with-pancreatic-neuroendocrine-tumors-treated-with-sunitinib-a-post-hoc-analysis-from-the-main-pivotal-trials/",
        "year": "2023",
        "study_id": [
            "NCT00056693",
            "NCT00428597",
            "NCT00056693",
            "NCT00428597",
            "NCT01525550"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "7875",
        "lead_investigator": "Marco Valgimigli",
        "lead_institution": "Cardiocentro Ticino, Lugano and Universita della Svizzera ltaliana (USI)",
        "study_title": "P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease: in individual patient data meta-analysis (PANTHER collaborative initiative)",
        "link": "https://vivli.org/p2y12-inhibitor-or-aspirin-monotherapy-as-secondary-prevention-in-patients-with-coronary-artery-disease-in-individual-patient-data-meta-analysis-panther-collaborative-initiative/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "7882",
        "lead_investigator": "Jos\u00e9 Gonz\u00e1lez-Gomariz",
        "lead_institution": "Fundacion para la Investigacion Medica Aplicada (FIMA)",
        "study_title": "Study of the expression of several cytokines related with the survival of advanced melanoma patients",
        "link": "http://vivli.org/study-of-the-expression-of-several-cytokines-related-with-the-survival-of-advanced-melanoma-patients",
        "year": "2023",
        "study_id": [
            "NCT01621490"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8052",
        "lead_investigator": "Wataru Fukuokaya",
        "lead_institution": "The Jikei University School of Medicine",
        "study_title": "Association of serum magnesium levels with effectiveness of atezolizumab in advanced urothelial carcinoma",
        "link": "https://vivli.org/association-of-serum-magnesium-levels-with-effectiveness-of-atezolizumab-in-advanced-urothelial-carcinoma/",
        "year": "2022",
        "study_id": [
            "NCT02302807",
            "NCT02108652"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8053",
        "lead_investigator": "Alexander G Mathioudakis",
        "lead_institution": "Manchester University NHS Foundation Trust",
        "study_title": "ICS-RECODE: Predictors of treatment REsponse to inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease: randomised COntrolled trials individual participant Data re-Evaluation.",
        "link": "https://vivli.org/ics-recode-predictors-of-treatment-response-to-inhaled-corticosteroids-ics-in-chronic-obstructive-pulmonary-disease-randomised-controlled-trials-individual-participant-data-re-evaluation",
        "year": "2023",
        "study_id": [
            "NCT01313676",
            "NCT00975195",
            "NCT00268216",
            "NCT01054885",
            "NCT00115492",
            "NCT00144911",
            "NCT01053988",
            "NCT02105974",
            "NCT01009463",
            "NCT01017952",
            "NCT01110200",
            "NCT01069289",
            "NCT00419744",
            "NCT02157935",
            "NCT02164513",
            "NCT01069289",
            "NCT00419744",
            "NCT02157935",
            "NCT02164513"
        ],
        "number_of_studies": 19
    },
    {
        "request_id": "8056",
        "lead_investigator": "Ashley Hopkins",
        "lead_institution": "Flinders University",
        "study_title": "Summarising the therapeutic and adverse effects of antibody-drug conjugates in older women with breast cancer: A review of clinical trial individual-participant data",
        "link": "https://vivli.org/summarising-the-therapeutic-and-adverse-effects-of-antibody-drug-conjugates-in-older-women-with-breast-cancer-a-review-of-clinical-trial-individual-participant-data/",
        "year": "2022",
        "study_id": [
            "NCT00829166",
            "NCT01772472",
            "NCT01419197",
            "NCT01120184"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8058",
        "lead_investigator": "Howard Smith",
        "lead_institution": "Sheffield Teaching Hospitals",
        "study_title": "An individual patient data meta-analysis of clinical endpoints in pulmonary hypertension with interstitial lung disease (PH-ILD)",
        "link": "https://vivli.org/an-individual-patient-data-meta-analysis-of-clinical-endpoints-in-pulmonary-hypertension-with-interstitial-lung-disease-ph-ild/",
        "year": "2023",
        "study_id": [
            "NCT02802345",
            "NCT00903331",
            "NCT00391443"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8175",
        "lead_investigator": "Guoxing Wan",
        "lead_institution": "Hubei University of Medicine",
        "study_title": "Efficacy and safety of atezolizumab plus bevacizumab for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade",
        "link": "https://vivli.org/efficacy-and-safety-of-atezolizumab-plus-bevacizumab-for-patients-with-advanced-hepatocellular-carcinoma-based-on-albumin-bilirubin-grade",
        "year": "2022",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8180",
        "lead_investigator": "Sheng Luo",
        "lead_institution": "Duke University",
        "study_title": "Clinical and molecular characteristics of human epidermal growth factor receptor 2-positive and human epidermal growth factor receptor 2-negative breast cancer",
        "link": "https://vivli.org/clinical-and-molecular-characteristics-of-human-epidermal-growth-factor-receptor-2-positive-and-human-epidermal-growth-factor-receptor-2-negative-breast-cancer",
        "year": "2022",
        "study_id": [
            "NCT03383692",
            "NCT03248492",
            "NCT02924883",
            "NCT02675231",
            "NCT02340221",
            "NCT02322814",
            "NCT02132949",
            "NCT02131064",
            "NCT01942135",
            "NCT01772472",
            "NCT01740427",
            "NCT01702571",
            "NCT01663727",
            "NCT01641939",
            "NCT01566721",
            "NCT01491737",
            "NCT01419197",
            "NCT01401166",
            "NCT01358877",
            "NCT01152606",
            "NCT01120184",
            "NCT01026142",
            "NCT00976989",
            "NCT00950300",
            "NCT00943670",
            "NCT00934856",
            "NCT00829166",
            "NCT00721409",
            "NCT00703326",
            "NCT00679341",
            "NCT00679211",
            "NCT00567190",
            "NCT00545688",
            "NCT00528567",
            "NCT00509769",
            "NCT00391092",
            "NCT00333775",
            "NCT00045032",
            "NCT00022672"
        ],
        "number_of_studies": 39
    },
    {
        "request_id": "8236",
        "lead_investigator": "Gao-Jun Teng",
        "lead_institution": "Zhongda Hospital, Southeast University",
        "study_title": "The role of prior transarterial chemoembolization in atezolizumab plus bevacizumab in hepatocellular carcinoma",
        "link": "https://vivli.org/the-role-of-prior-transarterial-chemoembolization-in-atezolizumab-plus-bevacizumab-in-hepatocellular-carcinoma/",
        "year": "2022",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8244",
        "lead_investigator": "Frank Doyle",
        "lead_institution": "Royal College of Surgeons Ireland",
        "study_title": "Do psychometrics matter? The effects of advanced psychometric analyses on depression randomised trial outcomes",
        "link": "https://vivli.org/do-psychometrics-matter-the-effects-of-advanced-psychometric-analyses-on-depression-randomised-trial-outcomes",
        "year": "2022",
        "study_id": [
            "NCT02191397",
            "NCT01808612",
            "NCT01432457",
            "NCT00976560",
            "NCT00896363",
            "NCT00887224",
            "NCT00866294",
            "NCT00863798",
            "NCT00824291",
            "NCT00810069",
            "NCT00798707",
            "NCT00735709",
            "NCT00672958",
            "NCT00569062",
            "NCT00536471",
            "NCT00369343",
            "NCT00300378",
            "NCT00073762",
            "NCT00072774",
            "NCT00067444",
            "NCT00063206",
            "NCT00062673",
            "NCT00048204",
            "NCT00494377",
            "NCT00489073",
            "NCT00406848",
            "NCT00042575",
            "NCT00036335",
            "NCT02389816",
            "NCT02371980",
            "NCT01355081",
            "NCT01255787",
            "NCT01163266",
            "NCT00985504",
            "NCT00384033",
            "NCT01138007",
            "NCT01070329",
            "NCT01000805",
            "NCT00035321",
            "NCT01121484"
        ],
        "number_of_studies": 40
    },
    {
        "request_id": "8263",
        "lead_investigator": "George Ntaios",
        "lead_institution": "University of Thesaly",
        "study_title": "Risk of myocardial infarction in patients with paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient data meta-analysis of the ENGAGE-AF and RE-LY trials",
        "link": "https://vivli.org/risk-of-myocardial-infarction-in-patients-with-paroxysmal-vs-non-paroxysmal-atrial-fibrillation-an-individual-patient-data-meta-analysis-of-the-engage-af-and-re-ly-trials",
        "year": "2022",
        "study_id": [
            "NCT00262600",
            "NCT00781391"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8266",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The first affiliated hospital of Sun Yat-sen University",
        "study_title": "The prognostic value of faecal calprotectin for long-term outcomes in ulcerative colitis",
        "link": "https://vivli.org/the-prognostic-value-of-faecal-calprotectin-for-long-term-outcomes-in-ulcerative-colitis",
        "year": "2022",
        "study_id": [
            "NCT01124149",
            "NCT02497469",
            "NCT02611830",
            "NCT00783718"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8287",
        "lead_investigator": "Damian J. Ralser",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Evaluation of the easy-to-implement modified Glasgow prognostic score (mGPS) in patients with previously treated human epidermal growth factor receptor 2-positive advanced breast cancer in the KATE2 clinical trial",
        "link": "https://vivli.org/evaluation-of-the-easy-to-implement-modified-glasgow-prognostic-score-mgps-in-patients-with-previously-treated-human-epidermal-growth-factor-receptor-2-positive-advanced-breast-cancer-in-the-kate2-c",
        "year": "2022",
        "study_id": [
            "NCT02924883"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8294",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Extended Validation of an Ulcerative Colitis Vedolizumab Decision Support Tool for Outcome Prediction with Tofacitinib",
        "link": "https://vivli.org/extended-validation-of-an-ulcerative-colitis-vedolizumab-decision-support-tool-for-outcome-prediction-with-tofacitinib",
        "year": "2022",
        "study_id": [
            "NCT01465763",
            "NCT01458951",
            "NCT01458574"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8315",
        "lead_investigator": "Chiara Tani",
        "lead_institution": "University of Pisa",
        "study_title": "Evaluation of gender differences in the efficacy and safety of belimumab in the treatment of active systemic lupus erythematosus",
        "link": "https://vivli.org/evaluation-of-gender-differences-in-the-efficacy-and-safety-of-belimumab-in-the-treatment-of-active-systemic-lupus-erythematosus",
        "year": "2024",
        "study_id": [
            "NCT00424476",
            "NCT00410384",
            "NCT01484496"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8316",
        "lead_investigator": "Vipul Jairath",
        "lead_institution": "Alimentiv",
        "study_title": "Correlation Between Symptoms and Objective Measures of Disease Activity in Patients with Moderate to Severe Ulcerative Colitis and Crohn\u2019s Disease",
        "link": "https://vivli.org/correlation-between-symptoms-and-objective-measures-of-disease-activity-in-patients-with-moderate-to-severe-ulcerative-colitis-and-crohns-disease",
        "year": "2022",
        "study_id": [
            "NCT01465763",
            "NCT01458951",
            "NCT00783718",
            "NCT02497469",
            "NCT02611830",
            "NCT02407236",
            "NCT00783692",
            "NCT00094458",
            "NCT00348283",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "8324",
        "lead_investigator": "Jeroen Dekervel",
        "lead_institution": "Universitaire Ziekenhuizen Leuven",
        "study_title": "Response Evaluation Criteria in Solid Tumors (RECIST) vs modified RECIST response durability in advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab",
        "link": "https://vivli.org/response-evaluation-criteria-in-solid-tumors-recist-vs-modified-recist-response-durability-in-advanced-hepatocellular-carcinoma-treated-with-atezolizumab-and-bevacizumab",
        "year": "2023",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8325",
        "lead_investigator": "Xiaodan Tang",
        "lead_institution": "Northwestern University",
        "study_title": "Does scoring method impact estimation of significant individual changes using Patient-Reported Outcomes Measurement Information System (PROMIS) measures? Comparing Classical Test Theory versus Item Response Theory",
        "link": "https://vivli.org/does-scoring-method-impact-estimation-of-significant-individual-changes-using-patient-reported-outcomes-measurement-information-system-promis-measures-comparing-classical-test-theory-versus-item-re/",
        "year": "2022",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8327",
        "lead_investigator": "Eva Hoster",
        "lead_institution": "Ludwig-Maximilian University Munich",
        "study_title": "Constructing estimands for overall survival within causal frame work for dynamic treatment schemes in oncology: Simulation and a clinical trial example",
        "link": "https://vivli.org/constructing-estimands-for-overall-survival-within-causal-frame-work-for-dynamic-treatment-schemes-in-oncology-simulation-and-a-clinical-trial-example",
        "year": "2022",
        "study_id": [
            "NCT01059630"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8342, 7444",
        "lead_investigator": "Gus Slotman",
        "lead_institution": "Inspira Health Network",
        "study_title": "IDENTIFYING TOCILIZUMAB-RESPONSIVE COVID-19 PATIENTS FROM COVACTA, EMPACTA, AND REMDACTA RANDOMIZED CLINICAL TRIAL PRE-RANDOMIZATION DATA",
        "link": "https://vivli.org/identifying-tocilizumab-responsive-covid-19-patients-from-covacta-empacta-and-remdacta-randomized-clinical-trial-pre-randomization-data/",
        "year": "2022",
        "study_id": [
            "NCT04372186",
            "NCT04320615",
            "NCT04409262",
            "NCT04320615",
            "NCT04409262",
            "NCT04372186"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8344",
        "lead_investigator": "Xiaoling Shang",
        "lead_institution": "Shandong University",
        "study_title": "A clinical variable based-Nomogram could predict survival for Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide",
        "link": "https://vivli.org/a-clinical-variable-based-nomogram-could-predict-survival-for-extensive-stage-small-cell-lung-cancer-treated-with-atezolizumab-carboplatin-and-etoposide",
        "year": "2023",
        "study_id": [
            "NCT02763579"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8347",
        "lead_investigator": "Hong Jae Chon",
        "lead_institution": "CHA Bundang Medical Center",
        "study_title": "Thyroid immune-related adverse events correlated with favorable clinical outcome in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab",
        "link": "https://vivli.org/thyroid-immune-related-adverse-events-correlated-with-favorable-clinical-outcome-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-atezolizumab-and-bevacizumab",
        "year": "2022",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8349",
        "lead_investigator": "Nqoba Tsabedze",
        "lead_institution": "University of Witwatersrand",
        "study_title": "The efficacy of beta-blockers on morbidity and mortality endpoints in black hypertensive patients: A meta-analysis",
        "link": "https://vivli.org/the-efficacy-of-beta-blockers-on-morbidity-and-mortality-endpoints-in-black-hypertensive-patients-a-meta-analysis/",
        "year": "2022",
        "study_id": [
            "NCT00108082",
            "NCT00123903",
            "NCT00273052"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8377",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Services",
        "study_title": "Estimating Differences in the Comparison of Outcomes in Clinical Trials for Ulcerative Colitis Patients using Patient-Level Data and Aggregated Data Network Meta-Analysis",
        "link": "https://vivli.org/estimating-differences-in-the-comparison-of-outcomes-in-clinical-trials-for-ulcerative-colitis-patients-using-patient-level-data-and-aggregated-data-network-meta-analysis",
        "year": "2022",
        "study_id": [
            "NCT00036439",
            "NCT00096655",
            "NCT00385736",
            "NCT00408629",
            "NCT00783718",
            "NCT02497469",
            "NCT00488631",
            "NCT02407236",
            "NCT01465763",
            "NCT02497469",
            "NCT02407236",
            "NCT01465763",
            "NCT00783718",
            "NCT00488631",
            "NCT00408629",
            "NCT00385736",
            "NCT00096655",
            "NCT00036439"
        ],
        "number_of_studies": 18
    },
    {
        "request_id": "8427",
        "lead_investigator": "Ahmad Abuhelwa",
        "lead_institution": "University of Sharjah",
        "study_title": "Predictors of exposure, therapeutic and adverse effects of medicines used in the treatment of multiple myeloma",
        "link": "https://vivli.org/predictors-of-exposure-therapeutic-and-adverse-effects-of-medicines-used-in-the-treatment-of-multiple-myeloma",
        "year": "2022",
        "study_id": [
            "NCT02252172",
            "NCT02076009",
            "NCT02136134",
            "NCT01985126",
            "NCT00574288",
            "NCT02990338",
            "NCT01564537",
            "NCT02312258",
            "NCT02046070",
            "NCT01850524",
            "NCT00574288",
            "NCT01985126",
            "NCT02136134",
            "NCT02076009",
            "NCT02252172"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "8435",
        "lead_investigator": "Hui Zheng",
        "lead_institution": "Chengdu University of Traditional Chinese Medicine",
        "study_title": "Predictors of galcanezumab in the preventive treatment of migraine",
        "link": "https://vivli.org/predictors-of-galcanezumab-in-the-preventive-treatment-of-migraine",
        "year": "2022",
        "study_id": [
            "NCT03559257",
            "NCT02614287",
            "NCT02614261",
            "NCT02614196",
            "NCT02614183",
            "NCT02163993"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8436",
        "lead_investigator": "David Schade",
        "lead_institution": "NM Non profit Society to Prevent Symptomatic Heart Disease",
        "study_title": "Development of an Atherosclerosis Reversal Calculator",
        "link": "https://vivli.org/development-of-an-atherosclerosis-reversal-calculator",
        "year": "2022",
        "study_id": [
            "NCT00620542",
            "NCT00620542"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8438",
        "lead_investigator": "Sheng Luo",
        "lead_institution": "Duke University",
        "study_title": "Development of novel statistical methods to detect treatment effect in Alzheimer\u2019s disease clinical trials over time",
        "link": "https://vivli.org/development-of-novel-statistical-methods-to-detect-treatment-effect-in-alzheimers-disease-clinical-trials-over-time",
        "year": "2022",
        "study_id": [
            "NCT02880956",
            "NCT02880956",
            "NCT03712787"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8440",
        "lead_investigator": "David Seiffge",
        "lead_institution": "Insel Gruppe AG",
        "study_title": "Andexanet alfa and the risk of haematoma expansion in patients with non-traumatic intracerebral haemorrhage \u2013 a pooled individual patient data analysis of ANNEXA-4 ICH and TICH-NOAC",
        "link": "https://vivli.org/andexanet-alfa-and-the-risk-of-haematoma-expansion-in-patients-with-non-traumatic-intracerebral-haemorrhage-a-pooled-individual-patient-data-analysis-of-annexa-4-ich-and-tich-noac",
        "year": "2023",
        "study_id": [
            "NCT02329327",
            "NCT02866838"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8442",
        "lead_investigator": "Yi Lisa Hwa",
        "lead_institution": "Mayo Clinic",
        "study_title": "Better outcomes among multiple myeloma patients who are taking beta-blockers while receiving chemotherapy.",
        "link": "https://vivli.org/better-outcomes-among-multiple-myeloma-patients-who-are-taking-beta-blockers-while-receiving-chemotherapy",
        "year": "2023",
        "study_id": [
            "NCT02990338"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8443",
        "lead_investigator": "Lane Desborough",
        "lead_institution": "Nudge BG, Inc.",
        "study_title": "Aerobic and Anaerobic Exercise Effects on Blood Glucose and Insulin",
        "link": "https://vivli.org/aerobic-and-anaerobic-exercise-effects-on-blood-glucose-and-insulin",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8445",
        "lead_investigator": "Kelley Kidwell",
        "lead_institution": "University of Michigan",
        "study_title": "Use of external control with longitudinal data for drug evaluation in Duchenne muscular dystrophy a Bayesian small sample, sequential, multiple assignment randomized trial design (snSMART)",
        "link": "https://vivli.org/use-of-external-control-with-longitudinal-data-for-drug-evaluation-in-duchenne-muscular-dystrophy-a-bayesian-small-sample-sequential-multiple-assignment-randomized-trial-design-snsmart",
        "year": "2022",
        "study_id": [
            "NCT01753804"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8446, 7479, 7075",
        "lead_investigator": "Elias Eriksson",
        "lead_institution": "University of Gothenburg",
        "study_title": "Efficacy of serotonin reuptake inhibitors in children and adolescents",
        "link": "https://vivli.org/efficacy-of-serotonin-reuptake-inhibitors-in-children-and-adolescents/",
        "year": "2021",
        "study_id": [
            "NCT00812812",
            "NCT01372150",
            "NCT01371734",
            "NCT02372799",
            "NCT01878292",
            "NCT00849901",
            "NCT00849693"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "8450",
        "lead_investigator": "Dennis McGonagle",
        "lead_institution": "University of Leeds",
        "study_title": "The effect of Body Mass Index (BMI) and Age on Baricitinib efficacy in Covid-19 patients",
        "link": "https://vivli.org/the-effect-of-body-mass-index-bmi-and-age-on-baricitinib-efficacy-in-covid-19-patients",
        "year": "2022",
        "study_id": [
            "NCT04421027"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8542",
        "lead_investigator": "Jo\u00e3o S\u00e9rgio Neves",
        "lead_institution": "Faculty of Medicine of University of Porto",
        "study_title": "Albiglutide and Cardiovascular Outcomes in Type 2 Diabetes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use",
        "link": "https://vivli.org/albiglutide-and-cardiovascular-outcomes-in-type-2-diabetes-with-and-without-concomitant-sodium-glucose-cotransporter-2-inhibition-use/",
        "year": "2022",
        "study_id": [
            "NCT02465515"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8546",
        "lead_investigator": "Alice Adenis",
        "lead_institution": "Diabeloop SA",
        "study_title": "Modeling the impact of physical activity, estimated by sensors such as accelerometers and heart rate, on glycemia of Type 1 Diabetes (T1D) patients",
        "link": "https://vivli.org/modeling-the-impact-of-physical-activity-estimated-by-sensors-such-as-accelerometers-and-heart-rate-on-glycemia-of-type-1-diabetes-t1d-patients",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8555",
        "lead_investigator": "Gijsbert Stoet",
        "lead_institution": "University of Essex",
        "study_title": "Effects of exercise on blood glucose levels, food intake and insulin use in adult T1D patients",
        "link": "https://vivli.org/effects-of-exercise-on-blood-glucose-levels-food-intake-and-insulin-use-in-adult-t1d-patients/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8557",
        "lead_investigator": "Fan Ge",
        "lead_institution": "Guangzhou Medical University",
        "study_title": "Organ-specific metastatic landscape dissects programmed death ligand-1 (PD-L1) blockade efficacy in advanced cancer",
        "link": "https://vivli.org/organ-specific-metastatic-landscape-dissects-programmed-death-ligand-1-pd-l1-blockade-efficacy-in-advanced-cancer/",
        "year": "2023",
        "study_id": [
            "NCT02008227",
            "NCT01903993",
            "NCT02908672",
            "NCT02763579",
            "NCT02420821",
            "NCT02367781",
            "NCT02302807",
            "NCT01183780",
            "NCT01984242",
            "NCT02322814",
            "NCT01491737"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "8558",
        "lead_investigator": "Pablo Guisado Vasco",
        "lead_institution": "Hospital Universitario Quironsalud Madrid",
        "study_title": "Investigating the impact of antibodies against SARS-CoV-2 on the effectiveness of interleukin-6 inhibitors in Covid-19 patients",
        "link": "https://vivli.org/Investigating the impact of antibodies against SARS-CoV-2 on the effectiveness of interleukin-6 inhibitors in Covid-19 patients",
        "year": "2022",
        "study_id": [
            "NCT04320615"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8559",
        "lead_investigator": "Dag Aarsland",
        "lead_institution": "King\u2019s College London",
        "study_title": "Predicting Cognitive Abilities and Treatment Outcome of Major Depressive Disorder in Elderly Patients Using Vortioxetine and Duloxetine Antidepressants",
        "link": "https://vivli.org/predicting-cognitive-abilities-and-treatment-outcome-of-major-depressive-disorder-in-elderly-patients-using-vortioxetine-and-duloxetine-antidepressants",
        "year": "2022",
        "study_id": [
            "NCT00811252"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8561",
        "lead_investigator": "Dale Morrison",
        "lead_institution": "The University of Melbourne",
        "study_title": "IMPROVING EXERCISE WITH TYPE 1 DIABETES",
        "link": "https://vivli.org/improving-exercise-with-type-1-diabetes/",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8562",
        "lead_investigator": "Raquibul Hannan",
        "lead_institution": "UT Southwestern Medical Center",
        "study_title": "Long-term outcomes of renal cell carcinoma patients with stable and progressive disease following treatment with Ipilimumab and Nivolumab in randomized controlled trial",
        "link": "https://vivli.org/long-term-outcomes-of-renal-cell-carcinoma-patients-with-stable-and-progressive-disease-following-treatment-with-ipilimumab-and-nivolumab-in-randomized-controlled-trial/",
        "year": "2023",
        "study_id": [
            "NCT02231749"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8563, 9228",
        "lead_investigator": "Kenta Yoshida",
        "lead_institution": "Genentech, Inc.",
        "study_title": "Tumor Growth Inhibition-Overall Survival (TGI-OS) model development and validation for hormone receptor positive (HR+)human epidermal growth factor receptor 2 negative (HER2-) breast cancer",
        "link": "https://vivli.org/tumor-growth-inhibition-overall-survival-tgi-os-model-development-and-validation-for-hormone-receptor-positive-hrhuman-epidermal-growth-factor-receptor-2-negative-her2-breast-cancer",
        "year": "2023",
        "study_id": [
            "NCT01942135",
            "NCT00099437"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8564",
        "lead_investigator": "SANGWOO KIM",
        "lead_institution": "Yonsei University Health System",
        "study_title": "Development of Immune Phenotype-specific Immune Checkpoint Inhibitor Response (anti-programmed death ligand-1) Prediction Algorithm",
        "link": "https://vivli.org/development-of-immune-phenotype-specific-immune-checkpoint-inhibitor-response-anti-programmed-death-ligand-1-prediction-algorithm/",
        "year": "2023",
        "study_id": [
            "NCT01358721",
            "NCT01358721",
            "NCT01354431",
            "NCT01668784"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8569",
        "lead_investigator": "Gus Slotman",
        "lead_institution": "Inspira Health Network",
        "study_title": "USING PRE-RANDOMIZATION DATA TO IDENTIFY PATIENTS WITH COVID-19 AMONG WHOM FLUVOXAMINE OR IVERMECTIN IMPROVED OUTCOMES",
        "link": "https://vivli.org/using-pre-randomization-data-to-identify-patients-with-covid-19-among-whom-fluvoxamine-or-ivermectin-improved-outcomes",
        "year": "2022",
        "study_id": [
            "NCT04727424"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8576",
        "lead_investigator": "Dafne Capelusnik",
        "lead_institution": "Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands",
        "study_title": "Validating a Personalised Ankylosing Spondylitis Metrology Index",
        "link": "https://vivli.org/validating-a-personalised-ankylosing-spondylitis-metrology-index/",
        "year": "2023",
        "study_id": [
            "NCT00195819",
            "NCT00207701",
            "NCT00247962",
            "NCT02186873",
            "NCT00265083",
            "NCT02505542",
            "NCT01087762",
            "NCT02696785",
            "NCT02696798",
            "NCT02757352",
            "NCT01258738",
            "NCT00939003",
            "NCT02552212",
            "NCT03178487",
            "NCT03502616",
            "NCT03502616"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "8577",
        "lead_investigator": "Yao Zhu",
        "lead_institution": "Fudan University Shanghai Cancer Center",
        "study_title": "The impact of long-term proton pump inhibitors use on the prognosis of patients receiving Androgen-annihilation therapy",
        "link": "https://vivli.org/the-impact-of-long-term-proton-pump-inhibitors-use-on-the-prognosis-of-patients-receiving-androgen-annihilation-therapy",
        "year": "2023",
        "study_id": [
            "NCT02200614"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8581",
        "lead_investigator": "Masahiro Takeuchi",
        "lead_institution": "The University of Tokyo",
        "study_title": "Repositioning of neurological drug Aripiprazole for Amyotrophic lateral sclerosis (ALS) patients",
        "link": "https://vivli.org/repositioning-of-neurological-drug-aripiprazole-for-amyotrophic-lateral-sclerosis-als-patients/",
        "year": "2023",
        "study_id": [
            "NCT01438060",
            "NCT00036114",
            "NCT00041678"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8582",
        "lead_investigator": "David Cherne",
        "lead_institution": "University Health Network",
        "study_title": "Modelling Studies to Assess Sodium-Glucose co-Transporter-2 (SGLT2) Inhibition Effects and Kidney Protection in Type 1 Diabetes",
        "link": "https://vivli.org/modelling-studies-to-assess-sodium-glucose-co-transporter-2-sglt2-inhibition-effects-and-kidney-protection-in-type-1-diabetes/",
        "year": "2023",
        "study_id": [
            "NCT02460978",
            "NCT02268214",
            "NCT02414958",
            "NCT02580591"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8585",
        "lead_investigator": "Daniel Schachter",
        "lead_institution": "Unigranrio",
        "study_title": "Efficacy of Calcitonin gene-related peptide (CGRP) monoclonal antibodies for medication overuse headache in chronic migraine patients A systematic review and meta-analysis",
        "link": "https://vivli.org/efficacy-of-calcitonin-gene-related-peptide-cgrp-monoclonal-antibodies-for-medication-overuse-headache-in-chronic-migraine-patients-a-systematic-review-and-meta-analysis",
        "year": "2023",
        "study_id": [
            "NCT03559257",
            "NCT02614261",
            "NCT02974153"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8588",
        "lead_investigator": "Wenlong Zhong",
        "lead_institution": "Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSU)",
        "study_title": "The influence of antibiotics on survival outcomes for bladder cancer patients being treated with immune checkpoint inhibitor therapy",
        "link": "https://vivli.org/the-influence-of-antibiotics-on-survival-outcomes-for-bladder-cancer-patients-being-treated-with-immune-checkpoint-inhibitor-therapy/",
        "year": "2023",
        "study_id": [
            "NCT02108652"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8591",
        "lead_investigator": "John Reynolds",
        "lead_institution": "University of Birmingham",
        "study_title": "Patterns of skin flare in patients with systemic lupus erythematosus",
        "link": "https://vivli.org/patterns-of-skin-flare-in-patients-with-systemic-lupus-erythematosus",
        "year": "2023",
        "study_id": [
            "NCT02446899",
            "NCT02446912",
            "NCT01438489"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "8593",
        "lead_investigator": "Hyon Choi",
        "lead_institution": "Massachusetts General Hospital",
        "study_title": "Serum urate reduction, gout flares, and risk of major cardiovascular events during urate-lowering therapy initiation target trial emulation and self-controlled case series analysis",
        "link": "https://vivli.org/serum-urate-reduction-gout-flares-and-risk-of-major-cardiovascular-events-during-urate-lowering-therapy-initiation-target-trial-emulation-and-self-controlled-case-series-analysis",
        "year": "2023",
        "study_id": [
            "NCT01101035"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8602",
        "lead_investigator": "Robert Hamilton",
        "lead_institution": "University of Toronto",
        "study_title": "Statin use and prostate cancer outcomes in patients treated in the ARAMIS trial",
        "link": "https://vivli.org/statin-use-and-prostate-cancer-outcomes-in-patients-treated-in-the-aramis-trial",
        "year": "2023",
        "study_id": [
            "NCT02200614"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8603",
        "lead_investigator": "Wencai Jiang",
        "lead_institution": "Chengdu Second People's Hospital",
        "study_title": "Predictive value of high\u2010sensitivity cardiac troponin\u2010T for Major Adverse Cardiovascular Events in patients with Chronic coronary heart disease",
        "link": "https://vivli.org/predictive-value-of-high\u2010sensitivity-cardiac-troponin\u2010t-for-major-adverse-cardiovascular-events-in-patients-with-chronic-coronary-heart-disease",
        "year": "2023",
        "study_id": [
            "NCT00799903"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8606",
        "lead_investigator": "Daria Igudesman",
        "lead_institution": "AdventHealth Translational Research Institute",
        "study_title": "Evaluating the association of eating window duration and timing of calorie distribution with glycemic parameters and body weight",
        "link": "https://vivli.org/evaluating-the-association-of-eating-window-duration-and-timing-of-calorie-distribution-with-glycemic-parameters-and-body-weight",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8609",
        "lead_investigator": "Fredrik Schjesvold",
        "lead_institution": "Oslo University Hospital",
        "study_title": "Personalized prediction of progression-free survival in multiple myeloma patients treated with isatuximab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone only, using combined machine learning and mechanistic modeling.",
        "link": "https://vivli.org/personalized-prediction-of-progression-free-survival-in-multiple-myeloma-patients-treated-with-isatuximab-plus-pomalidomide-and-dexamethasone-versus-pomalidomide-and-dexamethasone-only-using-combined/",
        "year": "2023",
        "study_id": [
            "NCT02990338",
            "NCT03275285"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8611",
        "lead_investigator": "Adam de Havenon",
        "lead_institution": "Yale University",
        "study_title": "Baseline Stroke Severity in Secondary Prevention Trials",
        "link": "https://vivli.org/baseline-stroke-severity-in-secondary-prevention-trials/",
        "year": "2023",
        "study_id": [
            "NCT00153062"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8615",
        "lead_investigator": "Monia Rekik",
        "lead_institution": "Universit\u00e9 Laval",
        "study_title": "Using artificial intelligence to predict and prevent physical activity induced hypoglycemia and hyperglycemia in type 1 diabetes",
        "link": "https://vivli.org/using-artificial-intelligence-to-predict-and-prevent-physical-activity-induced-hypoglycemia-and-hyperglycemia-in-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8656",
        "lead_investigator": "Meg Jardine",
        "lead_institution": "The University of Sydney",
        "study_title": "The RAAS inhibition in COVID-19 Trialists Collaboration (RiCTC)",
        "link": "https://vivli.org/the-raas-inhibition-in-covid-19-trialists-collaboration-rictc",
        "year": "2023",
        "study_id": [
            "NCT04311177",
            "NCT04312009",
            "NCT04328012",
            "NCT04328012"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8684",
        "lead_investigator": "Jos\u00e9 da Silva",
        "lead_institution": "Centro Hospitalar e Universit\u00e1rio de Coimbra",
        "study_title": "Comparing the prevalence of Boolean-based remission based on 3 versus 4 variables and their association with radiographic outcomes in rheumatoid arthritis using data from Tofacitinib studies",
        "link": "https://vivli.org/comparing-the-prevalence-of-boolean-based-remission-based-on-3-versus-4-variables-and-their-association-with-radiographic-outcomes-in-rheumatoid-arthritis-using-data-from-tofacitinib-studies",
        "year": "2024",
        "study_id": [
            "NCT01039688",
            "NCT00413699",
            "NCT01164579",
            "NCT00661661",
            "NCT00847613"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8686",
        "lead_investigator": "Andrea E. van der Meulen - de Jong",
        "lead_institution": "Leiden University Medical Center",
        "study_title": "Anemia and therapy with Janus Kinase Inhibitors in patients with ulcerative colitis",
        "link": "https://vivli.org/anemia-and-therapy-with-janus-kinase-inhibitors-in-patients-with-ulcerative-colitis",
        "year": "2023",
        "study_id": [
            "NCT02914522",
            "NCT01465763",
            "NCT01458951",
            "NCT01458574"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8688",
        "lead_investigator": "Grace Lu-Yao",
        "lead_institution": "Thomas Jefferson University",
        "study_title": "Anemia and therapy with Janus Kinase Inhibitors in patients with ulcerative colitis",
        "link": "https://vivli.org/risk-of-therapy-related-adverse-events-in-men-on-abiraterone-or-enzalutamide-a-meta-analysis-of-clinical-trial-data",
        "year": "2023",
        "study_id": [
            "NCT02215096",
            "NCT02485691",
            "NCT00473512",
            "NCT00473746",
            "NCT00474383",
            "NCT00544440",
            "NCT00638690",
            "NCT00887198",
            "NCT00924469",
            "NCT01088529",
            "NCT01314118",
            "NCT01424930",
            "NCT00485303",
            "NCT01591122",
            "NCT01685983",
            "NCT01695135",
            "NCT01715285",
            "NCT01795703",
            "NCT01867710",
            "NCT02236637",
            "NCT02257736"
        ],
        "number_of_studies": 21
    },
    {
        "request_id": "8699",
        "lead_investigator": "Niklas Kl\u00fcmper",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Evaluation of baseline and on-treatment serum biomarkers to predict immunotherapy response in solid cancers",
        "link": "https://vivli.org/evaluation-of-baseline-and-on-treatment-serum-biomarkers-to-predict-immunotherapy-response-in-solid-cancers",
        "year": "2023",
        "study_id": [
            "NCT03434379",
            "NCT02908672",
            "NCT02763579",
            "NCT02657434",
            "NCT02367794",
            "NCT02031458",
            "NCT02420821",
            "NCT02302807",
            "NCT02951767",
            "NCT02108652",
            "NCT01984242"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "8700",
        "lead_investigator": "Leo Buckley",
        "lead_institution": "Brigham and Women's Hospital",
        "study_title": "Colchicine Adverse Effects Research in people with Covid-19 randomized to colchicine treatment",
        "link": "https://vivli.org/colchicine-adverse-effects-research-in-people-with-covid-19-randomized-to-colchicine-treatment",
        "year": "2023",
        "study_id": [
            "NCT04322682"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8712",
        "lead_investigator": "Amit Manjrekar",
        "lead_institution": "Medtronic Diabetes",
        "study_title": "T1-DEXI Analysis for Exercise Study",
        "link": "https://vivli.org/t1-dexi-analysis-for-exercise-study",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8716",
        "lead_investigator": "Ali Cinar",
        "lead_institution": "Illinois Institute of Technology",
        "study_title": "Data Analysis, Classification and Model Development using Continuous Glucose Monitoring (CGM) and Physical Activity Data of people with Type 1 Diabetes",
        "link": "https://vivli.org/data-analysis-classification-and-model-development-using-continuous-glucose-monitoring-cgm-and-physical-activity-data-of-people-with-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8720",
        "lead_investigator": "George Ntaios",
        "lead_institution": "University of Thessaly",
        "study_title": "Association between statin treatment and cardiovascular outcomes in patients with atrial fibrillation",
        "link": "https://vivli.org/association-between-statin-treatment-and-cardiovascular-outcomes-in-patients-with-atrial-fibrillation",
        "year": "2023",
        "study_id": [
            "NCT00781391",
            "NCT00262600"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8721",
        "lead_investigator": "Jorge Bondia",
        "lead_institution": "Universitat Polit\u00e8cnica de Val\u00e8ncia",
        "study_title": "Modeling of exercise and meal disturbances under free-living conditions for improved performance of single- and dual-hormone artificial pancreas systems",
        "link": "https://vivli.org/modeling-of-exercise-and-meal-disturbances-under-free-living-conditions-for-improved-performance-of-single-and-dual-hormone-artificial-pancreas-systems",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8722",
        "lead_investigator": "Daniele Robesti",
        "lead_institution": "Ospedale San Raffaele",
        "study_title": "Assessing the Androgen indifferent prostate cancer patients reponse to novel antiandrogen-based regimen or taxanes.",
        "link": "https://vivli.org/assessing-the-androgen-indifferent-prostate-cancer-patients-response-to-novel-antiandrogen-based-regimen-or-taxanes",
        "year": "2023",
        "study_id": [
            "NCT01591122",
            "NCT01308580",
            "NCT01254279",
            "NCT00887198",
            "NCT01867710",
            "NCT00638690"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8724",
        "lead_investigator": "Joel Skaistis",
        "lead_institution": "Corewell Health",
        "study_title": "Effect of Tafamidis on Dementia Medication Initiation: A Post-Hoc Analysis of the ATTR-ACT Trial",
        "link": "https://vivli.org/effect-of-tafamidis-on-dementia-medication-initiation-a-post-hoc-analysis-of-the-attr-act-trial/",
        "year": "2023",
        "study_id": [
            "NCT01994889"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8729",
        "lead_investigator": "Octavian Adam",
        "lead_institution": "Albany Medical College",
        "study_title": "Time to Initiation of Symptomatic Treatment in untreated Parkinson Disease",
        "link": "https://vivli.org/time-to-initiation-of-symptomatic-treatment-in-untreated-parkinson-disease/",
        "year": "2023",
        "study_id": [
            "NCT03318523"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8750",
        "lead_investigator": "Manit Srisurapanont",
        "lead_institution": "Chiang Mai University Faculty of Medicine",
        "study_title": "Depressive Symptoms Responding to Bupropion A Differential Item Functioning Approach in Patients with Major Depressive Disorder",
        "link": "https://vivli.org/depressive-symptoms-responding-to-bupropion-a-differential-item-functioning-approach-in-patients-with-major-depressive-disorder",
        "year": "2023",
        "study_id": [
            "NCT01138007",
            "NCT02191397"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8751",
        "lead_investigator": "Diederik Dippel",
        "lead_institution": "Erasmus MC University Medical Center",
        "study_title": "Prediction of the treatment benefit of intravenous alteplase treatment for acute ischemic stroke",
        "link": "https://vivli.org/prediction-of-the-treatment-benefit-of-intravenous-alteplase-treatment-for-acute-ischemic-stroke",
        "year": "2023",
        "study_id": [
            "NCT00153036"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8752",
        "lead_investigator": "Michelle Condren",
        "lead_institution": "University of Oklahoma",
        "study_title": "Type 1 Diabetes and Exercise-Helmsley Trust RFP",
        "link": "https://vivli.org/type-1-diabetes-and-exercise-helmsley-trust-rfp",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8753",
        "lead_investigator": "Yu-Han Chiu",
        "lead_institution": "Harvard T.H. Chan School of Public Health",
        "study_title": "Dabigatran versus Warfarin in Patients with Atrial Fibrillation Extending inference from the RE-LY trial to real world target population",
        "link": "https://vivli.org/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation-extending-inference-from-the-re-ly-trial-to-real-world-target-population/",
        "year": "2023",
        "study_id": [
            "NCT00808067",
            "NCT00262600"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8756",
        "lead_investigator": "Eyal Dassau",
        "lead_institution": "Eli Lilly and Company",
        "study_title": "Assessment of insulin utilization and insulin delivery metrics in people with type 1 diabetes mellitus using blood glucose excursions, combined with nutrition and exercise information from the T1-DEXI dataset",
        "link": "https://vivli.org/assessment-of-insulin-utilization-and-insulin-delivery-metrics-in-people-with-type-1-diabetes-mellitus-using-blood-glucose-excursions-combined-with-nutrition-and-exercise-information-from-the-t1-dexi/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8757",
        "lead_investigator": "Sandra Tessa Hattenhauer",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Baseline immune signature score as predictor for response to atezolizumabbevacizumab in hepatocellular carcinoma",
        "link": "https://vivli.org/baseline-immune-signature-score-as-predictor-for-response-to-atezolizumabbevacizumab-in-hepatocellular-carcinoma",
        "year": "2023",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8758",
        "lead_investigator": "Michael Szarek",
        "lead_institution": "CPC Clinical Research",
        "study_title": "Comparison of RGX-202-01 with ramucirumab or aflibercept in the treatment of patients with recurrent colorectal cancer harboring a RAS mutation",
        "link": "https://vivli.org/comparison-of-rgx-202-01-with-ramucirumab-or-aflibercept-in-the-treatment-of-patients-with-recurrent-colorectal-cancer-harboring-a-ras-mutation",
        "year": "2023",
        "study_id": [
            "NCT01183780",
            "NCT00561470",
            "NCT03597581",
            "NCT03597581"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8760, 4112",
        "lead_investigator": "Florian Naudet",
        "lead_institution": "CHU de Rennes",
        "study_title": "Tolerability of duloxetine in the elderly and in younger adults: a systematic review and individual patient data meta-analysis of randomized controlled trials versus placebo.",
        "link": "https://vivli.org/tolerability-of-duloxetine-in-the-elderly-and-in-adults-a-systematic-review-and-individual-patient-data-meta-analysis-of-randomized-controlled-trials-versus-placebo",
        "year": "2020",
        "study_id": [
            "NCT00036335",
            "NCT00073411",
            "NCT00105989",
            "NCT00406848",
            "NCT01000805",
            "NCT01070329",
            "NCT00475969",
            "NCT00122850",
            "NCT00122863",
            "NCT00122837",
            "NCT00122824",
            "NCT00489073",
            "NCT00965081",
            "NCT00058968",
            "NCT00408993",
            "NCT01179672",
            "NCT00424593",
            "NCT00408876",
            "NCT00767806",
            "NCT00408421",
            "NCT00433290",
            "NCT00945945",
            "NCT00635219",
            "NCT01140906",
            "NCT00672620",
            "NCT01153009",
            "NCT01564862",
            "NCT01931475",
            "NCT00384033",
            "NCT00190866",
            "NCT00673452",
            "NCT00233025",
            "NCT01018680",
            "NCT00190814",
            "NCT01000805",
            "NCT00507936",
            "NCT00507936",
            "NCT00191919",
            "NCT00191919"
        ],
        "number_of_studies": 39
    },
    {
        "request_id": "8764",
        "lead_investigator": "Giuseppe Cabibbo",
        "lead_institution": "University of Palermo",
        "study_title": "Competing risk factors in survival analyses for advanced hepatocellular carcinoma outcomes. The key role of liver function and impact of drug class",
        "link": "https://vivli.org/competing-risk-factors-in-survival-analyses-for-advanced-hepatocellular-carcinoma-outcomes-the-key-role-of-liver-function-and-impact-of-drug-class/",
        "year": "2023",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8765",
        "lead_investigator": "Amit Etkin",
        "lead_institution": "Alto Neuroscience",
        "study_title": "Understanding individual differences in response to roflumilast in schizophrenia",
        "link": "https://vivli.org/understanding-individual-differences-in-response-to-roflumilast-in-schizophrenia",
        "year": "2023",
        "study_id": [
            "NCT02079844"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8766",
        "lead_investigator": "Catherine Russon",
        "lead_institution": "University of Exeter",
        "study_title": "Using machine learning methods to predict the risk of exercise-induced hypoglycemia in people with Type 1 diabetes",
        "link": "https://vivli.org/using-machine-learning-methods-to-predict-the-risk-of-exercise-induced-hypoglycemia-in-people-with-type-1-diabetes",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8767",
        "lead_investigator": "Armando Turchetta",
        "lead_institution": "McGill University",
        "study_title": "Forecasting recruitments in multicenter clinical trials via the time-dependent Poisson-Gamma model",
        "link": "https://vivli.org/forecasting-recruitments-in-multicenter-clinical-trials-via-the-time-dependent-poisson-gamma-model/",
        "year": "2023",
        "study_id": [
            "NCT00045032",
            "NCT01358877",
            "NCT00106548",
            "NCT00106574"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8768",
        "lead_investigator": "Ryan Mizell",
        "lead_institution": "Advent Health",
        "study_title": "Predicting progression in Primary Progressive Multiple Sclerosis with Machine Learning",
        "link": "https://vivli.org/predicting-progression-in-primary-progressive-multiple-sclerosis-with-machine-learning",
        "year": "2023",
        "study_id": [
            "NCT01194570"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8769",
        "lead_investigator": "Hyung Seok Park",
        "lead_institution": "Yonsei University Health System",
        "study_title": "A novel prediction model of poly ADP ribose polymerase (PARP) inhibitor sensitivity using genomic analyses",
        "link": "https://vivli.org/a-novel-prediction-model-of-poly-adp-ribose-polymerase-parp-inhibitor-sensitivity-using-genomic-analyses",
        "year": "2023",
        "study_id": [
            "NCT01945775"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8773, 6118",
        "lead_investigator": "Roxana Mehran",
        "lead_institution": "Icahn School of Medicine at Mount Sinai",
        "study_title": "Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.",
        "link": "https://vivli.org/antithrombotic-therapy-in-patients-with-atrial-fibrillation-after-percutaneous-coronary-intervention-a-systematic-review-and-individual-patient-data-network-meta-analysis/",
        "year": "2021",
        "study_id": [
            "NCT02164864",
            "NCT02866175",
            "NCT01830543",
            "NCT01830543",
            "NCT00769938",
            "NCT00769938",
            "NCT00776633",
            "NCT00776633",
            "NCT02415400",
            "NCT02415400",
            "NCT03023020",
            "NCT03023020"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "8774",
        "lead_investigator": "Paco Welsing",
        "lead_institution": "University Medical Center Utrecht",
        "study_title": "Using the \u201cpotential-outcomes framework\u201d to predict added value of more intensive initial therapy for individual early Rheumatoid Arthritis (RA) patients",
        "link": "https://vivli.org/using-the-potential-outcomes-framework-to-predict-added-value-of-more-intensive-initial-therapy-for-individual-early-rheumatoid-arthritis-ra-patients",
        "year": "2023",
        "study_id": [
            "NCT01007435"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8775",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The first affiliated hospital of Sun Yat-sen University",
        "study_title": "Predictors for therapeutic outcomes in patients of ulcerative colitis receiving Janus kinase inhibitors",
        "link": "https://vivli.org/predictors-for-therapeutic-outcomes-in-patients-of-ulcerative-colitis-receiving-janus-kinase-inhibitors",
        "year": "2023",
        "study_id": [
            "NCT01465763",
            "NCT01458951",
            "NCT01458574",
            "NCT02914522"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8802",
        "lead_investigator": "Zhi Xiao",
        "lead_institution": "Xiangya Hospital, Central-South University",
        "study_title": "Roles of neutrophil/lymphocyte ratio (NLR) in prognosis in early HER2-positive breast cancer with neuadjuvent trastuzumab and pertuzumab therapy",
        "link": "https://vivli.org/roles-of-neutrophil-lymphocyte-ratio-nlr-in-prognosis-in-early-her2-positive-breast-cancer-with-neuadjuvent-trastuzumab-and-pertuzumab-therapy",
        "year": "2023",
        "study_id": [
            "NCT01358877",
            "NCT00545688",
            "NCT02586025",
            "NCT00976989",
            "NCT02132949"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8803",
        "lead_investigator": "Temiloluwa Prioleau",
        "lead_institution": "Dartmouth College",
        "study_title": "T1-DEXI Analytics",
        "link": "https://vivli.org/t1-dexi-analytics",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8806",
        "lead_investigator": "Timothy Gaulton",
        "lead_institution": "Massachusetts General Hospital",
        "study_title": "Understanding the impact of body mass index on the effectiveness of baricitinib as a treatment for individuals hospitalized with COVID-19",
        "link": "https://vivli.org/understanding-the-impact-of-body-mass-index-on-the-effectiveness-of-baricitinib-as-a-treatment-for-individuals-hospitalized-with-covid-19",
        "year": "2023",
        "study_id": [
            "NCT04421027",
            "NCT04401579"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8807, 10039",
        "lead_investigator": "Lena Friberg",
        "lead_institution": "Uppsala University",
        "study_title": "Evaluation of dose individualization strategies in optimizing survival and patient-reported outcomes of sunitinib treatment in patients with metastatic renal cell carcinoma",
        "link": "https://vivli.org/evaluation-of-dose-individualization-strategies-in-optimizing-survival-and-patient-reported-outcomes-of-sunitinib-treatment-in-patients-with-metastatic-renal-cell-carcinoma/",
        "year": "2023",
        "study_id": [
            "NCT00083889",
            "NCT00338884",
            "NCT00254540",
            "NCT00267748",
            "NCT00137423",
            "NCT00054886",
            "NCT00077974"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "8809",
        "lead_investigator": "Jing Yu",
        "lead_institution": "Sichuan University",
        "study_title": "Constructing a predictive model for lung cancer immunotherapy",
        "link": "https://vivli.org/constructing-a-predictive-model-for-lung-cancer-immunotherapy",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8815",
        "lead_investigator": "Rayid Abdulqawi",
        "lead_institution": "King Faisal Specialist Hospital and Research Centre",
        "study_title": "Effect of Calcium Channel Blocker Therapy in Idiopathic Pulmonary Fibrosis",
        "link": "https://vivli.org/effect-of-calcium-channel-blocker-therapy-in-idiopathic-pulmonary-fibrosis/",
        "year": "2024",
        "study_id": [
            "NCT01366209",
            "NCT00287729",
            "NCT00287716",
            "NCT01335477",
            "NCT01335464"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8828",
        "lead_investigator": "Christopher Moxon",
        "lead_institution": "University of Glasgow",
        "study_title": "Comparison of histophathology in fatal Covid-19 in Malawi with fatal cases in other settings",
        "link": "https://vivli.org/comparison-of-histophathology-in-fatal-covid-19-in-malawi-with-fatal-cases-in-other-settings",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8833",
        "lead_investigator": "Derek Dinart",
        "lead_institution": "Institut Bergoni\u00e9",
        "study_title": "Optimal estimation of the number of subjects in clinical trials to improve the quality of clinical research and the development of new treatments for cancer patients",
        "link": "https://vivli.org/optimal-estimation-of-the-number-of-subjects-in-clinical-trials-to-improve-the-quality-of-clinical-research-and-the-development-of-new-treatments-for-cancer-patients/",
        "year": "2023",
        "study_id": [
            "NCT00561470",
            "NCT03674112",
            "NCT00403403",
            "NCT00022672",
            "NCT00762034",
            "NCT02928224",
            "NCT01183780",
            "NCT02149108",
            "NCT00484939",
            "NCT00109070",
            "NCT00700102",
            "NCT00112918"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "8834",
        "lead_investigator": "Xiaohua Douglas Zhang",
        "lead_institution": "University of Kentucky",
        "study_title": "Markers derived from continuous glucose monitoring data to guide exercise for T1DM",
        "link": "https://vivli.org/markers-derived-from-continuous-glucose-monitoring-data-to-guide-exercise-for-t1dm/",
        "year": "2025",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8837",
        "lead_investigator": "Erin Tallon",
        "lead_institution": "Children's Mercy Kansas City",
        "study_title": "Development of an mHealth-Based Just-In-Time Adaptive Intervention (JITAI) for Promoting Physical Activity in Individuals with Type 1 Diabetes",
        "link": "https://vivli.org/development-of-an-mhealth-based-just-in-time-adaptive-intervention-jitai-for-promoting-physical-activity-in-individuals-with-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8839",
        "lead_investigator": "Florencia Tettamanti",
        "lead_institution": "AstraZeneca",
        "study_title": "Predicting survival in chronic lymphocytic leukaemia from measurable residual disease (MRD) kinetics",
        "link": "https://vivli.org/predicting-survival-in-chronic-lymphocytic-leukaemia-from-measurable-residual-disease-mrd-kinetics",
        "year": "2024",
        "study_id": [
            "NCT02005471",
            "NCT02242942"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8842",
        "lead_investigator": "Sheng Luo",
        "lead_institution": "Duke University",
        "study_title": "Clinical and molecular characteristics of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) breast cancer a meta-analysis",
        "link": "https://vivli.org/clinical-and-molecular-characteristics-of-hormone-receptor-positive-hr-and-human-epidermal-growth-factor-receptor-2-negative-her2-breast-cancer-a-meta-analysis/",
        "year": "2024",
        "study_id": [
            "NCT02340221",
            "NCT01942135",
            "NCT00721409",
            "NCT00313170",
            "NCT00305448",
            "NCT01740427"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8845",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The first affiliated hospital of Sun Yat-sen University",
        "study_title": "Biomarkers for predicting long-term outcomes in ulcerative colitis",
        "link": "https://vivli.org/biomarkers-for-predicting-long-term-outcomes-in-ulcerative-colitis",
        "year": "2023",
        "study_id": [
            "NCT00783718",
            "NCT02497469",
            "NCT00385736",
            "NCT00408629",
            "NCT00790933",
            "NCT02611830",
            "NCT00036439",
            "NCT00487539",
            "NCT00488631",
            "NCT02407236",
            "NCT00488774"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "8846",
        "lead_investigator": "Charles Horsburgh",
        "lead_institution": "Boston University School of Public Health",
        "study_title": "Predictors of emergence of drug resistance while on treatment for multidrug-resistant tuberculosis: a meta-analysis",
        "link": "https://vivli.org/predictors-of-emergence-of-drug-resistance-while-on-treatment-for-multidrug-resistant-tuberculosis-a-meta-analysis/",
        "year": "2023",
        "study_id": [
            "NCT01424670"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8848",
        "lead_investigator": "Wenrui Hao",
        "lead_institution": "Penn State University",
        "study_title": "Develop a mathematical model for Alzheimer's disease treatment study.",
        "link": "https://vivli.org/develop-a-mathematical-model-for-alzheimers-disease-treatment-study",
        "year": "2023",
        "study_id": [
            "NCT02791191",
            "NCT00594568",
            "NCT01900665",
            "NCT01127633",
            "NCT00905372",
            "NCT00904683"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8850",
        "lead_investigator": "Changsheng Ma",
        "lead_institution": "Beijing Anzhen Hospital",
        "study_title": "The impact of malnutrition on the Efficacy and Safety of empagliflozin for heart failure With reduced ejection fraction",
        "link": "https://vivli.org/the-impact-of-malnutrition-on-the-efficacy-and-safety-of-empagliflozin-for-heart-failure-with-reduced-ejection-fraction",
        "year": "2024",
        "study_id": [
            "NCT03057977"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8853",
        "lead_investigator": "Guang Sheng Ling",
        "lead_institution": "University of Hong Kong",
        "study_title": "Using clinical characteristics of hepatocellular carcinoma (HCC) patients as predictors of their immunotherapy response",
        "link": "https://vivli.org/using-clinical-characteristics-of-hepatocellular-carcinoma-hcc-patients-as-predictors-of-their-immunotherapy-response/",
        "year": "2023",
        "study_id": [
            "NCT02715531",
            "NCT03434379",
            "NCT02715531",
            "NCT03434379"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "8856",
        "lead_investigator": "Fei Ma",
        "lead_institution": "Peking Union Medical College",
        "study_title": "The impact of human epidermal growth factor receptor 2-low (HER2-low) Expression on the Efficacy of endocrine therapy in Hormone Receptor-positiveHER2-Negative (HR+HER2-) Breast Cancer",
        "link": "https://vivli.org/the-impact-of-human-epidermal-growth-factor-receptor-2-low-her2-low-expression-on-the-efficacy-of-endocrine-therapy-in-hormone-receptor-positive-her2-negative-hr-her2-breast-cancer",
        "year": "2023",
        "study_id": [
            "NCT00754845",
            "NCT00265759",
            "NCT00003857",
            "NCT01942135",
            "NCT00305448",
            "NCT00601900",
            "NCT00313170",
            "NCT00022672",
            "NCT01491737",
            "NCT00721409",
            "NCT01740427"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "8857",
        "lead_investigator": "Zachary Epstein-Peterson",
        "lead_institution": "Memorial Sloan Kettering Cancer Center",
        "study_title": "A phase 2 study of Cerdulatinib in treating Cutaneous T-cell Lymphomas (CTCL)",
        "link": "https://vivli.org/a-phase-2-study-of-cerdulatinib-in-treating-cutaneous-t-cell-lymphomas-ctcl/",
        "year": "2023",
        "study_id": [
            "NCT01994382"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8860",
        "lead_investigator": "Yutaka Shimazu",
        "lead_institution": "Kyoto University Hospital",
        "study_title": "Pretreatment lymphocyte counts and free light chain ratio predict the efficacy of elotuzumab against relapsed refractory multiple myeloma",
        "link": "https://vivli.org/pretreatment-lymphocyte-counts-and-free-light-chain-ratio-predict-the-efficacy-of-elotuzumab-against-relapsed-refractory-multiple-myeloma",
        "year": "2024",
        "study_id": [
            "NCT01239797",
            "NCT01239797"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8864",
        "lead_investigator": "Lisa Chow",
        "lead_institution": "University of Minnesota",
        "study_title": "Machine Learning to evaluate glycemic variation with exercise",
        "link": "https://vivli.org/machine-learning-to-evaluate-glycemic-variation-with-exercise",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8865",
        "lead_investigator": "Erin Tallon",
        "lead_institution": "Children\u2019s Mercy Kansas City",
        "study_title": "Data driven approaches to inform the development of eating behavior patterns that promote glycemic management in youth with type 1 diabetes",
        "link": "https://vivli.org/data-driven-approaches-to-inform-the-development-of-eating-behavior-patterns-that-promote-glycemic-management-in-youth-with-type-1-diabetes",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8873",
        "lead_investigator": "Cristina Soguero Ruiz",
        "lead_institution": "King Juan Carlos University",
        "study_title": "Multimodal data-driven analysis of T1D in pediatrics and adults with machine learning",
        "link": "https://vivli.org/multimodal-data-driven-analysis-of-t1d-in-pediatrics-and-adults-with-machine-learning",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8874",
        "lead_investigator": "Nicola Dalbeth",
        "lead_institution": "University of Auckland",
        "study_title": "An investigation of remission in patients with gout - efficacy of treatments, prediction of remission and outcomes",
        "link": "https://vivli.org/an-investigation-of-remission-in-patients-with-gout-efficacy-of-treatments-prediction-of-remission-and-outcomes",
        "year": "2023",
        "study_id": [
            "NCT01101035",
            "NCT00102440",
            "NCT00175019",
            "NCT01078389",
            "NCT00174941"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8877",
        "lead_investigator": "Cinzia Del Giovane",
        "lead_institution": "University Hospital of Modena and Reggio Emilia",
        "study_title": "Antithrombotic therapies for secondary prevention in patients with cryptogenic stroke a systematic review and network meta-analysis with individual participant data",
        "link": "https://vivli.org/antithrombotic-therapies-for-secondary-prevention-in-patients-with-cryptogenic-stroke-a-systematic-review-and-network-meta-analysis-with-individual-participant-data",
        "year": "2024",
        "study_id": [
            "NCT02239120",
            "NCT00153062",
            "NCT00311402",
            "NCT00562289",
            "NCT03824691"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8879",
        "lead_investigator": "Micaela Morettini",
        "lead_institution": "Universit\u00e0 Poiltecnica delle Marche",
        "study_title": "Development of a decision support solution to prevent hypoglycemia during and after exercise in T1D",
        "link": "https://vivli.org/development-of-a-decision-support-solution-to-prevent-hypoglycemia-during-and-after-exercise-in-t1d",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8884",
        "lead_investigator": "Haotian Zou",
        "lead_institution": "Duke University School of Medicine",
        "study_title": "Risk stratification model for predicting risk of recurrence in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients with pathological complete response after neoadjuvant therapy",
        "link": "https://vivli.org/risk-stratification-model-for-predicting-risk-of-recurrence-in-human-epidermal-growth-factor-receptor-2-her2-positive-breast-cancer-patients-with-pathological-complete-response-after-neoadjuvant-the",
        "year": "2023",
        "study_id": [
            "NCT00976989",
            "NCT02131064",
            "NCT01196052",
            "NCT02132949",
            "NCT01358877"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "8885",
        "lead_investigator": "Giacomo Cappon",
        "lead_institution": "University of Padova",
        "study_title": "ReplayBG-E: Expansion of the ReplayBG software to assess exercise-aware treatments of type 1 diabetes",
        "link": "https://vivli.org/replaybg-e-expansion-of-the-replaybg-software-to-assess-exercise-aware-treatments-of-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8889",
        "lead_investigator": "Fabricio Garelli",
        "lead_institution": "National University of La Plata",
        "study_title": "Modelling short and long-term exercise effect on glucose levels from wearable devices\u2019 signal patterns",
        "link": "https://vivli.org/modelling-short-and-long-term-exercise-effect-on-glucose-levels-from-wearable-devices-signal-patterns",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8890",
        "lead_investigator": "Konrad Mulrennan",
        "lead_institution": "Atlantic Technological University",
        "study_title": "DEXTER - Diabetes Exercise Training for Enhanced Regulation",
        "link": "https://vivli.org/dexter-diabetes-exercise-training-for-enhanced-regulation",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8893",
        "lead_investigator": "Eleonora Manzoni",
        "lead_institution": "University of Padova",
        "study_title": "Detection and prediction of physical activity in type 1 diabetic subjects.",
        "link": "https://vivli.org/detection-and-prediction-of-physical-activity-in-type-1-diabetic-subjects/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8896",
        "lead_investigator": "Bin Cao",
        "lead_institution": "China-Japan Friendship Hospital",
        "study_title": "Treatment of baloxavir marboxil in immunocompromised patients with influenza infection",
        "link": "https://vivli.org/treatment-of-baloxavir-marboxil-in-immunocompromised-patients-with-influenza-infection/",
        "year": "2023",
        "study_id": [
            "NCT02949011",
            "NCT03684044"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8897",
        "lead_investigator": "Rebecca Dean",
        "lead_institution": "University of Sussex",
        "study_title": "The impact of interventions for depression on self-perceptions in young people: A systematic review and meta-analysis",
        "link": "https://vivli.org/the-impact-of-interventions-for-depression-on-self-perceptions-in-young-people-a-systematic-review-and-meta-analysis",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8903",
        "lead_investigator": "Daniel DeSalvo",
        "lead_institution": "Baylor College of Medicine",
        "study_title": "A Counterfactual Data-Driven Approach to Carbohydrate Intake with Exercise in T1D: a Novel Application for Optimizing Time-In-Range",
        "link": "https://vivli.org/a-counterfactual-data-driven-approach-to-carbohydrate-intake-with-exercise-in-t1d-a-novel-application-for-optimizing-time-in-range",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8913",
        "lead_investigator": "Thomas Hawke",
        "lead_institution": "McMaster University",
        "study_title": "T1-DEXi-T Study: Does exercise training improve the time in range following acute bouts of exercise?",
        "link": "https://vivli.org/t1-dexi-t-study-does-exercise-training-improve-the-time-in-range-following-acute-bouts-of-exercise",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8921",
        "lead_investigator": "Hongliang Liu",
        "lead_institution": "Duke University",
        "study_title": "The efficacy of programmed cell death protein 1 (PD-1)programmed death-ligand 1 (PD-L1) inhibitors in solid tumor patients with different clinicopathological characteristics a meta-analysis",
        "link": "https://vivli.org/the-efficacy-of-programmed-cell-death-protein-1-pd-1programmed-death-ligand-1-pd-l1-inhibitors-in-solid-tumor-patients-with-different-clinicopathological-characteristics-a-meta-analysis/",
        "year": "2023",
        "study_id": [
            "NCT02452424",
            "NCT02031458",
            "NCT02108652",
            "NCT02008227",
            "NCT02951767",
            "NCT02322814",
            "NCT02908672",
            "NCT02924883",
            "NCT02367794",
            "NCT02367781",
            "NCT02302807",
            "NCT01375842",
            "NCT01903993",
            "NCT03434379",
            "NCT02763579",
            "NCT02420821",
            "NCT02366143",
            "NCT01984242",
            "NCT01846416",
            "NCT02657434",
            "NCT02715531"
        ],
        "number_of_studies": 21
    },
    {
        "request_id": "8922",
        "lead_investigator": "Tomas Koutny",
        "lead_institution": "University of West Bohemia",
        "study_title": "In-Silico modelling",
        "link": "https://vivli.org/in-silico-modelling",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8924",
        "lead_investigator": "Prajakta Belsare",
        "lead_institution": "Dartmouth College",
        "study_title": "Analyzing exercise settings and the impact of various intensities, durations, and types of exercise on people with Type 1 diabetes.",
        "link": "https://vivli.org/analyzing-exercise-settings-and-the-impact-of-various-intensities-durations-and-types-of-exercise-on-people-with-type-1-diabetes",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8926",
        "lead_investigator": "Alessio Cortellini",
        "lead_institution": "Imperial College London",
        "study_title": "The putative differential impact of opioids exposure in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy or chemotherapy: a post-hoc analysis of the randomized phase 2 POPLAR and phase 3 OAK trials.",
        "link": "https://vivli.org/the-putative-differential-impact-of-opioids-exposure-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-treated-with-immunotherapy-or-chemotherapy-a-post-hoc-analysis-of-the-randomized-phas/",
        "year": "2023",
        "study_id": [
            "NCT02008227",
            "NCT01903993"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8933",
        "lead_investigator": "Jo\u00e3o Pedro Ferreira",
        "lead_institution": "University of Porto",
        "study_title": "Non cardiovascular hospitalizations in heart failure and preserved ejection fraction (HFpEF) and the effect of empagliflozin",
        "link": "https://vivli.org/non-cardiovascular-hospitalizations-in-heart-failure-and-preserved-ejection-fraction-hfpef-and-the-effect-of-empagliflozin/",
        "year": "2023",
        "study_id": [
            "NCT03057951"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "8937, 6024",
        "lead_investigator": "Cosima Locher",
        "lead_institution": "University Hospital Zurich",
        "study_title": "Predictors of placebo response in opioid trials for patients with Chronic Primary Pain \u2013 An individual-patient data meta-analysis",
        "link": "https://vivli.org/predictors-of-placebo-response-in-opioid-trials-for-patients-with-chronic-primary-pain-an-individual-patient-data-meta-analysis",
        "year": "2021",
        "study_id": [
            "NCT01364922",
            "NCT00325949",
            "NCT00761150",
            "NCT00763321",
            "NCT02528253",
            "NCT02528253"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8944",
        "lead_investigator": "Wesley Kerr",
        "lead_institution": "University of Pittsburgh",
        "study_title": "Evaluation of Time to Event endpoints in randomized controlled trials of multiple antiseizure medications for uncontrolled epilepsy",
        "link": "https://vivli.org/evaluation-of-time-to-event-endpoints-in-randomized-controlled-trials-of-multiple-antiseizure-medications-for-uncontrolled-epilepsy/",
        "year": "2023",
        "study_id": [
            "NCT01648101",
            "NCT00044278",
            "NCT00236730",
            "NCT00310388",
            "NCT01921205",
            "NCT00504881",
            "NCT00236873",
            "NCT00236847",
            "NCT00236860",
            "NCT00104416",
            "NCT00231556",
            "NCT00310375",
            "NCT00136019",
            "NCT01229735",
            "NCT01243177",
            "NCT00043875",
            "NCT00490035",
            "NCT00236418",
            "NCT00235755",
            "NCT00113165",
            "NCT01261325",
            "NCT00938431",
            "NCT00464269",
            "NCT00160550",
            "NCT00232596",
            "NCT00043901",
            "NCT00236704",
            "NCT01405508",
            "NCT00761774",
            "NCT00220415",
            "NCT00419393",
            "NCT01336621",
            "NCT00530855",
            "NCT00699283",
            "NCT00520741",
            "NCT01777139",
            "NCT00236756"
        ],
        "number_of_studies": 37
    },
    {
        "request_id": "8946",
        "lead_investigator": "Stuart Pocock",
        "lead_institution": "London School of Hygiene and Tropical Medicine",
        "study_title": "Patterns of heart failure hospitalisations and cardiovascular death in EMPEROR studies",
        "link": "https://vivli.org/patterns-of-heart-failure-hospitalisations-and-cardiovascular-death-in-emperor-studies",
        "year": "2023",
        "study_id": [
            "NCT03057977",
            "NCT03057951"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8953",
        "lead_investigator": "Wilson Lin",
        "lead_institution": "Santa Clara University",
        "study_title": "Drivers of Algorithm/Technology Use In Type 1 Diabetes Self-Management",
        "link": "https://vivli.org/drivers-of-algorithm-technology-use-in-type-1-diabetes-self-management",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "8956",
        "lead_investigator": "Sheng Luo",
        "lead_institution": "Duke University",
        "study_title": "A Novel Machine Learning-Based Prediction Model for Outcomes in Patients with Untreated Diffuse Large B Cell Lymphoma",
        "link": "https://vivli.org/a-novel-machine-learning-based-prediction-model-for-outcomes-in-patients-with-untreated-diffuse-large-b-cell-lymphoma",
        "year": "2024",
        "study_id": [
            "NCT01287741",
            "NCT01649856",
            "NCT00118209",
            "NCT00301821",
            "NCT00719472",
            "NCT01724021"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "8957",
        "lead_investigator": "Dean Bodenham",
        "lead_institution": "Imperial College London",
        "study_title": "Two-sample testing for clinical trials data with missing values",
        "link": "https://vivli.org/two-sample-testing-for-clinical-trials-data-with-missing-values",
        "year": "2023",
        "study_id": [
            "NCT01874431",
            "NCT01874431"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8966",
        "lead_investigator": "Alberico L. Catapano",
        "lead_institution": "IRCCS MultiMedica",
        "study_title": "Effect of lipid-lowering therapies on lipoprotein(a) levels: a meta-analysis of randomized controlled trials",
        "link": "https://vivli.org/effect-of-lipid-lowering-therapies-on-lipoproteina-levels-a-meta-analysis-of-randomized-controlled-trials/",
        "year": "2023",
        "study_id": [
            "NCT01507831",
            "NCT01623115",
            "NCT02585778",
            "NCT02642159",
            "NCT01617655",
            "NCT01644175",
            "NCT02023879",
            "NCT02107898",
            "NCT02584504",
            "NCT02289963"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "8985",
        "lead_investigator": "Joel Skaistis",
        "lead_institution": "Corewell Health",
        "study_title": "Effect of tafamidis treatment on total cardiovascular and cerebrovascular events in Transthyretin (TTR) cardiac amyloidosis",
        "link": "https://vivli.org/effect-of-tafamidis-treatment-on-total-cardiovascular-and-cerebrovascular-events-in-transthyretin-ttr-cardiac-amyloidosis",
        "year": "2025",
        "study_id": [
            "NCT01994889",
            "NCT01994889"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "8997",
        "lead_investigator": "Lewis Carpenter",
        "lead_institution": "Arcturis",
        "study_title": "The integration of clinical trial data, real-world evidence, and novel statistical methods to optimise control arm recruitment in relapsed and refractory multiple myeloma",
        "link": "https://vivli.org/the-integration-of-clinical-trial-data-real-world-evidence-and-novel-statistical-methods-to-optimise-control-arm-recruitment-in-relapsed-and-refractory-multiple-myeloma",
        "year": "2023",
        "study_id": [
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338",
            "NCT02990338"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "9004",
        "lead_investigator": "Limin Zhao",
        "lead_institution": "Nan Chang University",
        "study_title": "Exploring the relationship between paboxib treatment and age-related gene expression differences in breast cancer patients",
        "link": "https://vivli.org/exploring-the-relationship-between-paboxib-treatment-and-age-related-gene-expression-differences-in-breast-cancer-patients",
        "year": "2025",
        "study_id": [
            "NCT01942135",
            "NCT01740427"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9007",
        "lead_investigator": "Zhao Xingwang",
        "lead_institution": "Jilin University",
        "study_title": "Prediction of hypoglycemia during and after exercise",
        "link": "https://vivli.org/prediction-of-hypoglycemia-during-and-after-exercise",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9012",
        "lead_investigator": "Barry Greenberg",
        "lead_institution": "University of California, San Diego",
        "study_title": "Development of a Machine Learning Score to Predict Risk of Sudden Cardiac Death in Patients with Heart Failure with Preserved Ejection Fraction",
        "link": "https://vivli.org/development-of-a-machine-learning-score-to-predict-risk-of-sudden-cardiac-death-in-patients-with-heart-failure-with-preserved-ejection-fraction",
        "year": "2024",
        "study_id": [
            "NCT03057951"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9016",
        "lead_investigator": "Alane Izu",
        "lead_institution": "WITS-VIDA",
        "study_title": "Evaluation of Immune Response of 10-valent Pneumococcal Conjugate Vaccine (PCV-10) in HIV infected and uninfected children",
        "link": "https://vivli.org/evaluation-of-immune-response-of-10-valent-pneumococcal-conjugate-vaccine-pcv-10-in-hiv-infected-and-uninfected-children/",
        "year": "2023",
        "study_id": [
            "NCT00829010"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9018",
        "lead_investigator": "Alessio Cortellini",
        "lead_institution": "Imperial College London (UK)",
        "study_title": "Differential effect of systemic antibiotics and proton pump inhibitors on clinical outcomes from immunotherapy or placebo as sequential therapy in patients with locally advanced, unresectable non-small cell lung cancer (stage III) who have not progressed following chemoradiation therapy A post-hoc analysis of the PACIFIC trial",
        "link": "https://vivli.org/differential-effect-of-systemic-antibiotics-and-proton-pump-inhibitors-on-clinical-outcomes-from-immunotherapy-or-placebo-as-sequential-therapy-in-patients-with-locally-advanced-unresectable-non-smal/",
        "year": "2023",
        "study_id": [
            "NCT02125461"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9019",
        "lead_investigator": "Philip Johnson",
        "lead_institution": "University of Liverpool",
        "study_title": "Assessing the validity of progression free survival in patients with hepatocellular carcinoma as an endpoint in clinical trials",
        "link": "https://vivli.org/assessing-the-validity-of-progression-free-survival-in-patients-with-hepatocellular-carcinoma-as-an-endpoint-in-clinical-trials",
        "year": "2023",
        "study_id": [
            "NCT03434379",
            "NCT01004003",
            "NCT01258608",
            "NCT00508001",
            "NCT01009593",
            "NCT01009593"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9024",
        "lead_investigator": "Alain Amstutz",
        "lead_institution": "University Hospital Basel",
        "study_title": "Effectiveness and safety of janus kinase inhibitors in hospitalized patients with COVID-19: Systematic review and individual patient data meta-analysis of randomized trials",
        "link": "https://vivli.org/effectiveness-and-safety-of-janus-kinase-inhibitors-in-hospitalized-patients-with-covid-19-systematic-review-and-individual-patient-data-meta-analysis-of-randomized-trials/",
        "year": "2023",
        "study_id": [
            "NCT04421027",
            "NCT04381936",
            "NCT04401579"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9053",
        "lead_investigator": "Johanna Elin Gehin",
        "lead_institution": "Oslo University Hospital",
        "study_title": "Personalised dosing of certolizumab pegol based on serum concentration in rheumatoid arthritis patients",
        "link": "https://vivli.org/personalised-dosing-of-certolizumab-pegol-based-on-serum-concentration-in-rheumatoid-arthritis-patients",
        "year": "2023",
        "study_id": [
            "NCT00152386",
            "NCT00160602",
            "NCT00175877",
            "NCT00160641"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9076",
        "lead_investigator": "Alexander Tolmach",
        "lead_institution": "MakeSense Digital Health Ltd.",
        "study_title": "Automatic nutrition assessment based on continuous glucose and insulin data for improvement of carbs counting and investigation of glycemia episodes",
        "link": "https://vivli.org/automatic-nutrition-assessment-based-on-continuous-glucose-and-insulin-data-for-improvement-of-carbs-counting-and-investigation-of-glycemia-episodes",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9077",
        "lead_investigator": "Anne-Marie Wills",
        "lead_institution": "Massachusetts General Hospital",
        "study_title": "Predictors of Progressive Supranuclear Palsy (PSP) disease progression using \u201cA Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)\u201d (ClinicalTrials.gov ID NCT02985879)",
        "link": "https://vivli.org/predictors-of-progressive-supranuclear-palsy-psp-disease-progression-using-a-study-to-assess-efficacy-safety-tolerability-and-pharmacokinetics-of-abbv-8e12-in-subjects-with-progressive-s",
        "year": "2023",
        "study_id": [
            "NCT02985879",
            "NCT03391765",
            "NCT02985879"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9081",
        "lead_investigator": "Kyle Greenway",
        "lead_institution": "McGill University",
        "study_title": "Antidepressant effects of bupropion, varenicline, nicotine replacement therapy, and placebo in tobacco users.",
        "link": "https://vivli.org/antidepressant-effects-of-bupropion-varenicline-nicotine-replacement-therapy-and-placebo-in-tobacco-users",
        "year": "2023",
        "study_id": [
            "NCT01456936"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9090",
        "lead_investigator": "Lena Friberg",
        "lead_institution": "Uppsala University",
        "study_title": "Dose-exposure-response relationships for ceftazidime-avibactam of value to explore dose individualization strategies",
        "link": "https://vivli.org/dose-exposure-response-relationships-for-ceftazidime-avibactam-of-value-to-explore-dose-individualization-strategies",
        "year": "2024",
        "study_id": [
            "NCT01499290",
            "NCT01499290",
            "NCT01726023",
            "NCT01726023",
            "NCT01644643",
            "NCT01644643",
            "NCT01595438",
            "NCT01595438",
            "NCT01599806",
            "NCT01599806",
            "NCT00690378",
            "NCT00690378",
            "NCT00752219",
            "NCT00752219",
            "NCT01808092",
            "NCT01808092"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "9093",
        "lead_investigator": "Ewan Goligher",
        "lead_institution": "University of Toronto",
        "study_title": "Secondary analysis for estimating heterogeneous treatment effects for the \u201cDrotrecogin Alfa (Activated) in Adults with Septic Shock\u201d trial",
        "link": "https://vivli.org/secondary-analysis-for-estimating-heterogeneous-treatment-effects-for-the-drotrecogin-alfa-activated-in-adults-with-septic-shock-trial",
        "year": "2023",
        "study_id": [
            "NCT00604214"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9098",
        "lead_investigator": "St\u00e9phane Oudard",
        "lead_institution": "Assitance Publique des H\u00f4pitaux de Paris",
        "study_title": "External validation of a prognostic score for survival in patients with metastatic castration-resistant prostate cancer (CABASCORE) treated with Cabazitaxel.",
        "link": "https://vivli.org/external-validation-of-a-prognostic-score-for-survival-in-patients-with-metastatic-castration-resistant-prostate-cancer-cabascore-treated-with-cabazitaxel/",
        "year": "2023",
        "study_id": [
            "NCT02485691",
            "NCT01308580",
            "NCT01308567",
            "NCT00417079"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9099",
        "lead_investigator": "Andrew Sims",
        "lead_institution": "Newcastle upon Tyne Hospitals NHS Trust",
        "study_title": "An exploration of UK real world evidence and comparison with clinical trial data in supporting evaluation of 4 drugs that have exited the United Kingdom\u2019s Cancer Drugs Fund (CDF)",
        "link": "https://vivli.org/an-exploration-of-uk-real-world-evidence-and-comparison-with-clinical-trial-data-in-supporting-evaluation-of-4-drugs-that-have-exited-the-united-kingdoms-cancer-drugs-fund-cdf/",
        "year": "2025",
        "study_id": [
            "NCT02231749",
            "NCT02231749",
            "NCT01564537"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9102",
        "lead_investigator": "Joel Skaistis",
        "lead_institution": "Corewell Health East",
        "study_title": "Effect of Tafamidis Across the Range of Systolic Function: A Post-Hoc Analysis of the ATTR-ACT Trial",
        "link": "https://vivli.org/effect-of-tafamidis-across-the-range-of-systolic-function-a-post-hoc-analysis-of-the-attr-act-trial/",
        "year": "2023",
        "study_id": [
            "NCT01994889"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9103",
        "lead_investigator": "JOSE GARCIA-TIRADO",
        "lead_institution": "University of Bern",
        "study_title": "Automatic Recognition of Main Glycemic Disturbances in Type 1 Diabetes (T1D)",
        "link": "https://vivli.org/automatic-recognition-of-main-glycemic-disturbances-in-type-1-diabetes-t1d/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9104",
        "lead_investigator": "Mark Woodward",
        "lead_institution": "January AI",
        "study_title": "Improving Blood Glucose Predictions for Patients with Type 1 Diabetes",
        "link": "https://vivli.org/improving-blood-glucose-predictions-for-patients-with-type-1-diabetes/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9105",
        "lead_investigator": "Nate Kowahl",
        "lead_institution": "Verily Life Sciences",
        "study_title": "Verily Analysis of Jaeb data",
        "link": "https://vivli.org/verily-analysis-of-jaeb-data/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9106",
        "lead_investigator": "Nima Aghaeepour",
        "lead_institution": "Stanford University",
        "study_title": "Identifying Subgroups of Patients with Improved Outcomes in Clinical Trials",
        "link": "https://vivli.org/identifying-subgroups-of-patients-with-improved-outcomes-in-clinical-trials",
        "year": "2024",
        "study_id": [
            "NCT02016482",
            "NCT01452750",
            "NCT02079805",
            "NCT01496469",
            "NCT00829933",
            "NCT01642602",
            "NCT01760954",
            "NCT00408876",
            "NCT01621178",
            "NCT00475397",
            "NCT01687998",
            "NCT01088412",
            "NCT01088399",
            "NCT04516746",
            "NCT00781391",
            "NCT01358877",
            "NCT00670319",
            "NCT01887912",
            "NCT01101035",
            "NCT01456936",
            "NCT04322682",
            "NCT00986154",
            "NCT00949910",
            "NCT00045032",
            "NCT00448383",
            "NCT02689531",
            "NCT00968708",
            "NCT00694382",
            "NCT02474355",
            "NCT01346293",
            "NCT01931566",
            "NCT01712984",
            "NCT01788163",
            "NCT01152606",
            "NCT00112918",
            "NCT00625898",
            "NCT00388206",
            "NCT00306384"
        ],
        "number_of_studies": 38
    },
    {
        "request_id": "9121",
        "lead_investigator": "Vitalay Fomin",
        "lead_institution": "Y-AI inc.",
        "study_title": "Biomarkers associated with response to monotherapy compared to combination therapy in cancers",
        "link": "https://vivli.org/biomarkers-associated-with-response-to-monotherapy-compared-to-combination-therapy-in-cancers",
        "year": "2024",
        "study_id": [
            "NCT02008227",
            "NCT02108652",
            "NCT02951767",
            "NCT02908672",
            "NCT03434379",
            "NCT02367794",
            "NCT02302807",
            "NCT02420821",
            "NCT02366143"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "9128",
        "lead_investigator": "Pierluigi Navarra",
        "lead_institution": "Catholic University Medical School",
        "study_title": "A comparison between the assessments of overall response rate carried out by local assessors and a blinded independent central review in oncology trials. Analysis of differences in the assessment conducted at single-patient level.",
        "link": "https://vivli.org/a-comparison-between-the-assessments-of-overall-response-rate-carried-out-by-local-assessors-and-a-blinded-independent-central-review-in-oncology-trials-analysis-of-differences-in-the-assessment-cond",
        "year": "2024",
        "study_id": [
            "NCT01026142"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9129",
        "lead_investigator": "Yi-Wen Tsai",
        "lead_institution": "National Yang Ming Chiao Tung University",
        "study_title": "Cost-effectiveness analysis of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma subgroup analyses",
        "link": "https://vivli.org/cost-effectiveness-analysis-of-atezolizumab-plus-bevacizumab-in-unresectable-hepatocellular-carcinoma-subgroup-analyses",
        "year": "2024",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9130, 6488",
        "lead_investigator": "Feng Sun",
        "lead_institution": "Peking University",
        "study_title": "An individual participant data meta-analysis to evaluate new hypoglycemic drugs (SGLT-2i and DPP-4i) on type 2 diabetes mellitus patient sub-groups",
        "link": "https://vivli.org/an-individual-participant-data-meta-analysis-to-evaluate-a-new-category-of-hypoglycemic-drugs-sglt-2is-on-type-2-diabetes-mellitus-patient-sub-groups/",
        "year": "2021",
        "study_id": [
            "NCT00881530",
            "NCT01368081",
            "NCT00789035",
            "NCT00749190",
            "NCT01890122",
            "NCT01289119",
            "NCT01381900",
            "NCT00968812",
            "NCT01081834"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "9132",
        "lead_investigator": "Viola Pongratz",
        "lead_institution": "Technical University Munich",
        "study_title": "Monitoring of upper extremity motor function in Multiple Sclerosis the nine-hole-peg-test in MS revisited",
        "link": "https://vivli.org/monitoring-of-upper-extremity-motor-function-in-multiple-sclerosis-the-nine-hole-peg-test-in-ms-revisited",
        "year": "2024",
        "study_id": [
            "NCT00451451",
            "NCT01247324",
            "NCT00548405",
            "NCT01797965",
            "NCT00530348",
            "NCT01412333"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9137",
        "lead_investigator": "Ly-Mee Yu",
        "lead_institution": "University of Oxford",
        "study_title": "Loop Diuretics and Weight Change in Heart Failure A Meta-Analysis",
        "link": "https://vivli.org/loop-diuretics-and-weight-change-in-heart-failure-a-meta-analysis",
        "year": "2024",
        "study_id": [
            "NCT03057977",
            "NCT03057951",
            "NCT01951625",
            "NCT03547583"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9141",
        "lead_investigator": "Shujie Yang",
        "lead_institution": "University of Iowa",
        "study_title": "Fatty Acid Metabolism, Oxidative phosphorylation, and cholesterol homeostasis pathways in endometrial cancer organoids",
        "link": "https://vivli.org/fatty-acid-metabolism-oxidative-phosphorylation-and-cholesterol-homeostasis-pathways-in-endometrial-cancer-organoids",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9229",
        "lead_investigator": "Andreas Meid",
        "lead_institution": "Heidelberg University Hospital",
        "study_title": "MAGIC-BULLET - Model-based support of translational steps throughout drug development of antibody-drug conjugates (ADCs) in breast cancer",
        "link": "https://vivli.org/magic-bullet-model-based-support-of-translational-steps-throughout-drug-development-of-antibody-drug-conjugates-adcs-in-breast-cancer",
        "year": "2024",
        "study_id": [
            "NCT00679341",
            "NCT03248492",
            "NCT03383692",
            "NCT00829166",
            "NCT01419197",
            "NCT01772472",
            "NCT02131064",
            "NCT01966471",
            "NCT01120184",
            "NCT00509769",
            "NCT00943670",
            "NCT00679211",
            "NCT01702571"
        ],
        "number_of_studies": 13
    },
    {
        "request_id": "9230",
        "lead_investigator": "Erinne Wasalski",
        "lead_institution": "Rutgers University",
        "study_title": "Health-Related Quality of Life in Breast Cancer Clinical Trials Through the Lens of Race and Ethnicity: The Importance of Understanding the Patient Experience",
        "link": "https://vivli.org/health-related-quality-of-life-in-breast-cancer-clinical-trials-through-the-lens-of-race-and-ethnicity-the-importance-of-understanding-the-patient-experience",
        "year": "2024",
        "study_id": [
            "NCT01945775",
            "NCT01250379",
            "NCT01966471",
            "NCT01942135",
            "NCT01120184",
            "NCT02131064",
            "NCT01491737",
            "NCT02441946",
            "NCT02102490",
            "NCT01572038",
            "NCT03674112",
            "NCT00829166",
            "NCT00567190",
            "NCT00703326",
            "NCT01419197",
            "NCT01358877",
            "NCT02747004",
            "NCT01772472",
            "NCT02340221",
            "NCT02322814",
            "NCT01427933",
            "NCT02569801",
            "NCT00006459",
            "NCT02246621",
            "NCT01271725",
            "NCT03248492",
            "NCT00950742",
            "NCT01125566",
            "NCT03366428",
            "NCT02675231",
            "NCT00721409",
            "NCT02107703",
            "NCT01325428",
            "NCT01740427",
            "NCT01441596",
            "NCT00241449"
        ],
        "number_of_studies": 36
    },
    {
        "request_id": "9234",
        "lead_investigator": "Matthew Chersich",
        "lead_institution": "Wits Reproductive Health Institute at University of the Witwatersrand",
        "study_title": "Developing data science solutions to mitigate the health impacts of climate change in Africa: The Heat and Health African Transdisciplinary Center (HE\u00b2AT Center)",
        "link": "https://vivli.org/developing-data-science-solutions-to-mitigate-the-health-impacts-of-climate-change-in-africa-the-heat-and-health-african-transdisciplinary-center-he%c2%b2at-center/",
        "year": "2024",
        "study_id": [
            "NCT00144183",
            "NCT00069784",
            "NCT00069784"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9235",
        "lead_investigator": "Christian Lood",
        "lead_institution": "University of Washington",
        "study_title": "Neutrophil Lymphocyte Ratio as predictor of treatment response in malignancy",
        "link": "https://vivli.org/neutrophil-lymphocyte-ratio-as-predictor-of-treatment-response-in-malignancy",
        "year": "2024",
        "study_id": [
            "NCT00762034",
            "NCT00917384",
            "NCT01183780",
            "NCT00789373",
            "NCT01168973",
            "NCT01170663"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9236",
        "lead_investigator": "Christian Dansereau",
        "lead_institution": "Perceiv AI",
        "study_title": "Validation of prognostic machine learning tools for forecasting clinical progression to enrich Alzheimer\u2019s disease trials",
        "link": "https://vivli.org/validation-of-prognostic-machine-learning-tools-for-forecasting-clinical-progression-to-enrich-alzheimers-disease-trials",
        "year": "2023",
        "study_id": [
            "NCT01900665",
            "NCT01127633",
            "NCT00904683",
            "NCT00905372",
            "NCT00762411",
            "NCT00594568",
            "NCT02880956",
            "NCT01931566"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "9240",
        "lead_investigator": "Michael Kreissl",
        "lead_institution": "University Hospital Magdeburg",
        "study_title": "Parameters of Body Composition as prognostic biomarkers in patients with RET-altered thyroid cancer treated with selpercatinib Post-hoc analysis of the LIBRETTO-001 trial",
        "link": "https://vivli.org/parameters-of-body-composition-as-prognostic-biomarkers-in-patients-with-ret-altered-thyroid-cancer-treated-with-selpercatinib-post-hoc-analysis-of-the-libretto-001-trial",
        "year": "2024",
        "study_id": [
            "NCT03157128",
            "NCT03157128"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9241",
        "lead_investigator": "Amit Garg",
        "lead_institution": "Northwell Health",
        "study_title": "Association between skin-related quality of life and race in patients with hidradenitis suppurativa, and Repeatability/Intra-rater agreement of lesion counts in hidradenitis suppurativa",
        "link": "https://vivli.org/association-between-skin-related-quality-of-life-and-race-in-patients-with-hidradenitis-suppurativa-and-repeatability-intra-rater-agreement-of-lesion-counts-in-hidradenitis-suppurativa/",
        "year": "2023",
        "study_id": [
            "NCT01468207",
            "NCT01468233"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9244",
        "lead_investigator": "Kazuki Takada",
        "lead_institution": "Saiseikai Fukuoka General Hospital, Fukuoka, Japan",
        "study_title": "Impact of Probiotics on Clinical Outcomes in Patients with Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Atezolizumab Combination Therapy A Post Hoc Analysis of IMpower133",
        "link": "https://vivli.org/impact-of-probiotics-on-clinical-outcomes-in-patients-with-extensive-stage-small-cell-lung-cancer-treated-with-first-line-atezolizumab-combination-therapy-a-post-hoc-analysis-of-impower133",
        "year": "2024",
        "study_id": [
            "NCT02763579"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9247",
        "lead_investigator": "Giovanni Sebastiani",
        "lead_institution": "Italian National Council of Research, Institute for Applied Mathematics \"Mauro Picone\"",
        "study_title": "Hypoglicaemic events risk prediction for type 1 diabetes subjects during physical activity",
        "link": "https://vivli.org/hypoglicaemic-events-risk-prediction-for-type-1-diabetes-subjects-during-physical-activity",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9250",
        "lead_investigator": "Nan Hu",
        "lead_institution": "Florida International University",
        "study_title": "Machine learning augmented decision support system for myocardial revascularization treatment plan selection",
        "link": "https://vivli.org/machine-learning-augmented-decision-support-system-for-myocardial-revascularization-treatment-plan-selection",
        "year": "2025",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9252",
        "lead_investigator": "Danny Volkaerts",
        "lead_institution": "University Colleges Leuven-Limburg",
        "study_title": "Developing a personalized, data-driven diabetes application which assists persons with type 1 diabetes before and during physical activity regarding insulin administration and carbohydrate intake.",
        "link": "https://vivli.org/developing-a-personalized-data-driven-diabetes-application-which-assists-persons-with-type-1-diabetes-before-and-during-physical-activity-regarding-insulin-administration-and-carbohydrate-intake/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9253",
        "lead_investigator": "Jiajun Yan",
        "lead_institution": "McMaster University",
        "study_title": "Statistical Methods for Analyzing EuroQol 5 Dimension 5 (EQ-5D) in Randomized Clinical Trials",
        "link": "https://vivli.org/statistical-methods-for-analyzing-euroqol-5-dimension-5-eq-5d-in-randomized-clinical-trials",
        "year": "2024",
        "study_id": [
            "NCT00125918",
            "NCT02611830",
            "NCT00783718",
            "NCT01711359",
            "NCT01721044",
            "NCT01721057",
            "NCT03255382",
            "NCT02757352",
            "NCT01064401",
            "NCT00530348",
            "NCT00548405",
            "NCT02485691",
            "NCT00083889"
        ],
        "number_of_studies": 13
    },
    {
        "request_id": "9274",
        "lead_investigator": "Kazuki Takada",
        "lead_institution": "Saiseikai Fukuoka General Hospital, Fukuoka, Japan",
        "study_title": "Prognostic Impact of Probiotic Supplementation on the Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Atezolizumab Pooled Analyses of Five Randomized Control Trials",
        "link": "https://vivli.org/prognostic-impact-of-probiotic-supplementation-on-the-outcomes-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-first-line-atezolizumab-pooled-analyses-of-five-randomized-control-tria",
        "year": "2024",
        "study_id": [
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02657434",
            "NCT02409342"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "9275",
        "lead_investigator": "Kazuki Takada",
        "lead_institution": "Saiseikai Fukuoka General Hospital, Fukuoka, Japan",
        "study_title": "Influence of Acetaminophen on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer Pooled Data Analyses from Five Randomized Control Trials of First-Line Atezolizumab",
        "link": "https://vivli.org/influence-of-acetaminophen-on-treatment-outcomes-in-advanced-non-small-cell-lung-cancer-pooled-data-analyses-from-five-randomized-control-trials-of-first-line-atezolizumab",
        "year": "2024",
        "study_id": [
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02657434",
            "NCT02409342"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "9280",
        "lead_investigator": "Nuno Filipe de Sousa Vale",
        "lead_institution": "University of Porto",
        "study_title": "Population Pharmacokinetic Study involving different formulations of Salbutamol",
        "link": "https://vivli.org/population-pharmacokinetic-study-involving-different-formulations-of-salbutamol",
        "year": "2023",
        "study_id": [
            "NCT01984086"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9284",
        "lead_investigator": "Jiro McKinnis",
        "lead_institution": "Virror Health",
        "study_title": "Associative Analysis of Comorbidities and Clinical Variables with Concomitant Presence of CHF in Patients Undergoing Cardiac Catheterization.",
        "link": "https://vivli.org/associative-analysis-of-comorbidities-and-clinical-variables-with-concomitant-presence-of-chf-in-patients-undergoing-cardiac-catheterization",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9285",
        "lead_investigator": "Mengyi Lu",
        "lead_institution": "Nanjing Medical University",
        "study_title": "Association of Body Mass Index (BMI) with Prognosis and Safety Profile of Atezolizumab",
        "link": "https://vivli.org/association-of-body-mass-index-bmi-with-prognosis-and-safety-profile-of-atezolizumab",
        "year": "2024",
        "study_id": [
            "NCT02031458",
            "NCT01903993",
            "NCT02763579",
            "NCT01846416",
            "NCT02657434",
            "NCT02367794",
            "NCT02367781",
            "NCT02366143",
            "NCT02008227",
            "NCT02108652",
            "NCT02951767",
            "NCT02908672",
            "NCT02322814",
            "NCT02924883",
            "NCT02302807",
            "NCT03434379",
            "NCT02420821",
            "NCT01984242"
        ],
        "number_of_studies": 18
    },
    {
        "request_id": "9286",
        "lead_investigator": "Jo\u00e3o S\u00e9rgio Neves",
        "lead_institution": "Faculdade de Medicina da Universidade do Porto",
        "study_title": "Effect of Exenatide Across the Spectrum of Ejection Fraction: An analysis from the EXSCEL trial",
        "link": "https://vivli.org/effect-of-exenatide-across-the-spectrum-of-ejection-fraction-an-analysis-from-the-exscel-trial/",
        "year": "2023",
        "study_id": [
            "NCT01144338"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9328",
        "lead_investigator": "Sebastian Polak",
        "lead_institution": "Jagiellonian University Medical College in Poland",
        "study_title": "Developing a quantitative base for more effective and individualized ropinirole dosing regimen",
        "link": "https://vivli.org/developing-a-quantitative-base-for-more-effective-and-individualized-ropinirole-dosing-regimen/",
        "year": "2023",
        "study_id": [
            "NCT00381472"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9332",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Outcomes from Induction Using Ustekinumab or Vedolizumab Among Patients Who Have Prior Biologic Intolerance vs Biologic Failure in Ulcerative colitis and Crohn's disease",
        "link": "https://vivli.org/outcomes-from-induction-using-ustekinumab-or-vedolizumab-among-patients-who-have-prior-biologic-intolerance-vs-biologic-failure-in-ulcerative-colitis-and-crohns-disease",
        "year": "2024",
        "study_id": [
            "NCT00783718",
            "NCT01369329",
            "NCT01369342",
            "NCT02407236",
            "NCT02407236",
            "NCT00783718",
            "NCT01369329",
            "NCT01369342"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "9350",
        "lead_investigator": "Lucy Vivash",
        "lead_institution": "Monash University",
        "study_title": "Evaluation of epilepsy-DOOR (Desirability of outcome ranking) as an outcome measure for therapeutic trials in drug resistant epilepsy",
        "link": "https://vivli.org/evaluation-of-epilepsy-door-desirability-of-outcome-ranking-as-an-outcome-measure-for-therapeutic-trials-in-drug-resistant-epilepsy",
        "year": "2024",
        "study_id": [
            "NCT00504881",
            "NCT00490035",
            "NCT00464269"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9352",
        "lead_investigator": "Sangwoo Kim",
        "lead_institution": "Yonsei University",
        "study_title": "Conventional genomic predictive markers to immune checkpoint inhibitors are deteriorated in metastatic clear cell renal cell carcinoma",
        "link": "https://vivli.org/conventional-genomic-predictive-markers-to-immune-checkpoint-inhibitors-are-deteriorated-in-metastatic-clear-cell-renal-cell-carcinoma",
        "year": "2024",
        "study_id": [
            "NCT01358721",
            "NCT01668784"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9354",
        "lead_investigator": "Li-Xuan Qin",
        "lead_institution": "Memorial Sloan Kettering Cancer Center",
        "study_title": "Tumor Mutational Burden (TMB) Dichotomization for Immunotherapy Outcome Prediction",
        "link": "https://vivli.org/tumor-mutational-burden-tmb-dichotomization-for-immunotherapy-outcome-prediction",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9360",
        "lead_investigator": "Guilherme Polanczyk",
        "lead_institution": "University of Sao Paulo (USP)",
        "study_title": "Moderators of treatment response to stimulants in preschoolers with attention-deficithyperactivity disorder an individual patient data meta-analysis",
        "link": "https://vivli.org/moderators-of-treatment-response-to-stimulants-in-preschoolers-with-attention-deficit-hyperactivity-disorder-an-individual-patient-data-meta-analysis/",
        "year": "2023",
        "study_id": [
            "NCT03260205"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9373",
        "lead_investigator": "Amit Etkin",
        "lead_institution": "Alto Neuroscience, Inc.",
        "study_title": "Cognitive factors as predictors of treatment outcomes in patients with Schizophrenia",
        "link": "https://vivli.org/cognitive-factors-as-predictors-of-treatment-outcomes-in-patients-with-schizophrenia",
        "year": "2024",
        "study_id": [
            "NCT02281773"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9377",
        "lead_investigator": "Benjamin Haibe-Kains",
        "lead_institution": "University Health Network",
        "study_title": "Biomarker discovery for immunotherapy response via pan-cancer and cancer-specific analyses",
        "link": "https://vivli.org/biomarker-discovery-for-immunotherapy-response-via-pan-cancer-and-cancer-specific-analyses",
        "year": "2024",
        "study_id": [
            "NCT01783938",
            "NCT01783938",
            "NCT01927419",
            "NCT01927419"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9383",
        "lead_investigator": "Jo\u00e3o Pedro Ferreira",
        "lead_institution": "Faculty of Medicine of Porto University",
        "study_title": "Anemia and the Effect of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) findings from EMPEROR-Preserved",
        "link": "https://vivli.org/anemia-and-the-effect-of-empagliflozin-in-heart-failure-with-preserved-ejection-fraction-hfpef-findings-from-emperor-preserved/",
        "year": "2023",
        "study_id": [
            "NCT03057951",
            "NCT03057951"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9384",
        "lead_investigator": "Evyn Peters",
        "lead_institution": "University Of Saskatchewan",
        "study_title": "Episode duration and severity as predictors of response to desvenlafaxine and placebo in patients with major depressive disorder",
        "link": "https://vivli.org/episode-duration-and-severity-as-predictors-of-response-to-desvenlafaxine-and-placebo-in-patients-with-major-depressive-disorder",
        "year": "2024",
        "study_id": [
            "NCT00277823",
            "NCT00384033",
            "NCT00300378",
            "NCT01432457",
            "NCT00863798",
            "NCT00072774",
            "NCT00798707"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "9388",
        "lead_investigator": "Ritu Lal",
        "lead_institution": "GEn1E Lifesciences Inc.",
        "study_title": "A Prospective Machine Learning Model for the Identification of Sepsis Endotypes",
        "link": "https://vivli.org/a-prospective-machine-learning-model-for-the-identification-of-sepsis-endotypes",
        "year": "2024",
        "study_id": [
            "NCT00604214"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9389",
        "lead_investigator": "Sinbad Xia",
        "lead_institution": "Zhejiang University School of Medicine",
        "study_title": "Predictors of survival in patients with extensive-stage small-cell lung cancer",
        "link": "https://vivli.org/predictors-of-survival-in-patients-with-extensive-stage-small-cell-lung-cancer",
        "year": "2024",
        "study_id": [
            "NCT02763579"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9390",
        "lead_investigator": "Joseph Merola",
        "lead_institution": "The International Dermatology Outcome Measures Group (IDEOM)",
        "study_title": "Musculoskeletal Symptoms in Hidradenitis Suppurativa",
        "link": "https://vivli.org/musculoskeletal-symptoms-in-hidradenitis-suppurativa",
        "year": "2024",
        "study_id": [
            "NCT01468207",
            "NCT01468233",
            "NCT00918255",
            "NCT01635764"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9399",
        "lead_investigator": "Philip Johnson",
        "lead_institution": "University of Liverpool",
        "study_title": "A novel, evidence-based approach to clinical trial design in patients with advanced liver cancer (hepatocellular carcinoma); single arm studies with a virtual control group",
        "link": "https://vivli.org/a-novel-evidence-based-approach-to-clinical-trial-design-in-patients-with-advanced-liver-cancer-hepatocellular-carcinoma-single-arm-studies-with-a-virtual-control-group",
        "year": "2024",
        "study_id": [
            "NCT02715531",
            "NCT03434379",
            "NCT00987935",
            "NCT01004003",
            "NCT01774344",
            "NCT00508001",
            "NCT01258608"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "9407",
        "lead_investigator": "Josep Vehi",
        "lead_institution": "University of Girona",
        "study_title": "Validation of New Exercise Models and Therapy Optimization",
        "link": "https://vivli.org/validation-of-new-exercise-models-and-therapy-optimization/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9410",
        "lead_investigator": "Abhinav Sharma",
        "lead_institution": "The Research Institute of the McGill University Health Centre",
        "study_title": "Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibitors on Cardiovascular and Heart Failure Outcomes",
        "link": "https://vivli.org/proprotein-convertase-subtilisinkexin-type-9-pcsk9-inhibitors-on-cardiovascular-and-heart-failure-outcomes",
        "year": "2024",
        "study_id": [
            "NCT01975376",
            "NCT01975376",
            "NCT01975389",
            "NCT01975389"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9417",
        "lead_investigator": "Vipul Jairath",
        "lead_institution": "Alimentiv Inc.",
        "study_title": "Determining Endoscopic Treatment Response in Ulcerative Colitis and Crohn\u2019s Disease using the Win Probability Approach",
        "link": "https://vivli.org/determining-endoscopic-treatment-response-in-ulcerative-colitis-and-crohns-disease-using-the-win-probability-approach",
        "year": "2024",
        "study_id": [
            "NCT01551290",
            "NCT00036439",
            "NCT00096655",
            "NCT00853099",
            "NCT00385736",
            "NCT00408629",
            "NCT01863771",
            "NCT00488631",
            "NCT00488774",
            "NCT00487539",
            "NCT00783718",
            "NCT02039505",
            "NCT02407236",
            "NCT01458574",
            "NCT01458951",
            "NCT00348283",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355"
        ],
        "number_of_studies": 19
    },
    {
        "request_id": "9422",
        "lead_investigator": "James Salsbury",
        "lead_institution": "University of Sheffield",
        "study_title": "Developing methodology for a delayed treatment effect present in a survival trial",
        "link": "https://vivli.org/developing-methodology-for-a-delayed-treatment-effect-present-in-a-survival-trial/",
        "year": "2024",
        "study_id": [
            "NCT02409342",
            "NCT01673867",
            "NCT01673867",
            "NCT01642004",
            "NCT01642004",
            "NCT02105636",
            "NCT02105636",
            "NCT02477826",
            "NCT02477826",
            "NCT01844505",
            "NCT01668784",
            "NCT01668784",
            "NCT01721772",
            "NCT01721772"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "9433",
        "lead_investigator": "Yang Li",
        "lead_institution": "School of Statistics, Renmin University of China",
        "study_title": "A new Statistical method to balance Social Network Effect and Covariate Effect in Response Adaptive Design",
        "link": "https://vivli.org/a-new-statistical-method-to-balance-social-network-effect-and-covariate-effect-in-response-adaptive-design",
        "year": "2024",
        "study_id": [
            "NCT01051661"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9434",
        "lead_investigator": "Victor Moreno",
        "lead_institution": "START Madrid-Fundacion Jimenez Diaz (FJD)",
        "study_title": "Retrospective analysis of different doses of atezolizumab in patients with advanced solid tumors",
        "link": "https://vivli.org/retrospective-analysis-of-different-doses-of-atezolizumab-in-patients-with-advanced-solid-tumors",
        "year": "2024",
        "study_id": [
            "NCT01375842"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9462",
        "lead_investigator": "Chandra Kanth Nagesh",
        "lead_institution": "University of Colorado Boulder",
        "study_title": "Analysis-of-Type-1-Diabetes",
        "link": "https://vivli.org/analysis-of-type-1-diabetes/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9470",
        "lead_investigator": "Joseph Cafazzo",
        "lead_institution": "Toronto General Hospitable Research Institute, University Health Network",
        "study_title": "Can we trust GPT-4 Turbo Vision to estimate carbohydrate and caloric content from food images within the broad context of diabetes?",
        "link": "https://vivli.org/can-we-trust-gpt-4-turbo-vision-to-estimate-carbohydrate-and-caloric-content-from-food-images-within-the-broad-context-of-diabetes/",
        "year": "2023",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9474",
        "lead_investigator": "Daniel Adam Blanco",
        "lead_institution": "Inari Medical, Inc.",
        "study_title": "Comparative Analysis of Health-Related Quality of Life in Pulmonary Embolism Survivors: Pulmonary Embolism Quality of Life Questionnaire (PEmb-QoL) versus EuroQol five-dimension questionnaire (EQ-5D) Instruments",
        "link": "https://vivli.org/comparative-analysis-of-health-related-quality-of-life-in-pulmonary-embolism-survivors-pulmonary-embolism-quality-of-life-questionnaire-pemb-qol-versus-euroqol-five-dimension-questionnaire-eq-5d-i",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9478",
        "lead_investigator": "Lena Friberg",
        "lead_institution": "Uppsala University",
        "study_title": "Study on impact of scanning intervals of follow up tumor assessments on Progression Free Survival (PFS) and median PFS for Non-Small Cell Lung Cancer (NSCLC) patients treated with Atezolizumab and Docetaxel",
        "link": "https://vivli.org/study-on-impact-of-scanning-intervals-of-follow-up-tumor-assessments-on-progression-free-survival-pfs-and-median-pfs-for-non-small-cell-lung-cancer-nsclc-patients-treated-with-atezolizumab-and-doc",
        "year": "2024",
        "study_id": [
            "NCT02008227",
            "NCT01903993"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9480, 6629",
        "lead_investigator": "Jian-Guo Zhou",
        "lead_institution": "The Second Affiliated Hospital of Zunyi Medical University",
        "study_title": "Longitudinal peripheral blood markers and patient reported outcomes(PROs) as dynamic predictors to identify efficacy and safety of non\u2013small-cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)",
        "link": "https://vivli.org/longitudinal-peripheral-blood-markers-and-patient-reported-outcomespros-as-dynamic-predictors-to-identify-efficacy-and-safety-of-non-small-cell-lung-cancer-nsclc-patients-treated-with-epid",
        "year": "2024",
        "study_id": [
            "NCT02774278",
            "NCT01544179",
            "NCT01203917",
            "NCT01017874",
            "NCT00447057",
            "NCT00259064",
            "NCT00130728",
            "NCT00252759",
            "NCT00252759",
            "NCT00242801",
            "NCT00242801",
            "NCT00034879",
            "NCT00034879",
            "NCT00478049",
            "NCT00478049",
            "NCT00256711",
            "NCT00256711"
        ],
        "number_of_studies": 17
    },
    {
        "request_id": "9481",
        "lead_investigator": "Nathalie Germain",
        "lead_institution": "Universite Laval",
        "study_title": "Melatonin and melatonin receptor agonists for the treatment of sleep disturbances associated with neurocognitive disorders",
        "link": "https://vivli.org/melatonin-and-melatonin-receptor-agonists-for-the-treatment-of-sleep-disturbances-associated-with-neurocognitive-disorders",
        "year": "2024",
        "study_id": [
            "NCT00325728"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9492, 8697",
        "lead_investigator": "David McAllister",
        "lead_institution": "University of Glasgow",
        "study_title": "Understanding frailty, multimorbidity and renal failure in clinical trials Attrition, retention and heterogeneity of treatment effects in trials for diabetes, cancer and a heterogenous set of index conditions",
        "link": "https://vivli.org/understanding-frailty-multimorbidity-and-renal-failure-in-clinical-trials-attrition-retention-and-heterogeneity-of-treatment-effects-in-trials-for-diabetes-cancer-and-a-heterogenous-set-of-index-co",
        "year": "2023",
        "study_id": [
            "NCT01772134",
            "NCT02683746",
            "NCT02681094",
            "NCT02597049",
            "NCT02489968",
            "NCT02471404",
            "NCT02465515",
            "NCT02284893",
            "NCT02229227",
            "NCT01792518",
            "NCT01778049",
            "NCT01769378",
            "NCT01734785",
            "NCT01733758",
            "NCT01719003",
            "NCT01708902",
            "NCT01624259",
            "NCT01621178",
            "NCT01606007",
            "NCT01438814",
            "NCT01422876",
            "NCT01370005",
            "NCT01368081",
            "NCT01306214",
            "NCT01217892",
            "NCT01215097",
            "NCT01214239",
            "NCT01210001",
            "NCT01204294",
            "NCT01191268",
            "NCT01177813",
            "NCT01167881",
            "NCT01164501",
            "NCT01159600",
            "NCT01128894",
            "NCT01126580",
            "NCT01098539",
            "NCT01075282",
            "NCT01064687",
            "NCT00976391",
            "NCT00954447",
            "NCT00915772",
            "NCT00849056",
            "NCT00849017",
            "NCT00839527",
            "NCT00838916",
            "NCT00838903",
            "NCT00798161",
            "NCT00654381",
            "NCT00641043",
            "NCT00622284",
            "NCT00621140",
            "NCT00602472",
            "NCT00601250",
            "NCT02242318",
            "NCT02200653",
            "NCT02183064",
            "NCT02200640",
            "NCT02181998",
            "NCT02177461",
            "NCT02177396",
            "NCT02177344",
            "NCT02175355",
            "NCT02172287",
            "NCT02172586",
            "NCT01694771",
            "NCT01646177",
            "NCT01597245",
            "NCT01474512",
            "NCT01335477",
            "NCT01335464",
            "NCT01292473",
            "NCT01287117",
            "NCT01264939",
            "NCT01232569",
            "NCT01209702",
            "NCT01191944",
            "NCT01126437",
            "NCT01119859",
            "NCT01087788",
            "NCT01087762",
            "NCT01007435",
            "NCT00975195",
            "NCT00970632",
            "NCT00926289",
            "NCT00861757",
            "NCT00848081",
            "NCT00855582",
            "NCT00827242",
            "NCT00793624",
            "NCT00782509",
            "NCT00782210",
            "NCT00772538",
            "NCT00776984",
            "NCT00734474",
            "NCT00670501",
            "NCT00670319",
            "NCT00563381",
            "NCT00552058",
            "NCT00525512",
            "NCT00490035",
            "NCT00479401",
            "NCT00472199",
            "NCT00466167",
            "NCT00464269",
            "NCT00402233",
            "NCT00384930",
            "NCT00321854",
            "NCT00277264",
            "NCT00274612",
            "NCT00274599",
            "NCT00274573",
            "NCT00274560",
            "NCT00274547",
            "NCT00274079",
            "NCT00274053",
            "NCT00274014",
            "NCT00239421",
            "NCT00239408",
            "NCT00168857",
            "NCT00168844",
            "NCT00168831",
            "NCT00153088",
            "NCT00153023",
            "NCT00125918",
            "NCT00106535",
            "NCT00034840",
            "NCT00152984",
            "NCT01106690",
            "NCT01106625",
            "NCT01381900",
            "NCT01081834",
            "NCT01106651",
            "NCT01137812",
            "NCT01809327",
            "NCT01106677",
            "NCT00968812",
            "NCT01032629",
            "NCT01989754",
            "NCT00885378",
            "NCT01619059",
            "NCT02551874",
            "NCT00740051",
            "NCT00819091",
            "NCT00800683",
            "NCT00996658",
            "NCT01084005",
            "NCT01087502",
            "NCT01194830",
            "NCT02240680",
            "NCT01131676",
            "NCT02182830",
            "NCT02453555",
            "NCT01648582",
            "NCT01558271",
            "NCT02750410",
            "NCT03495102",
            "NCT02025907",
            "NCT00763451",
            "NCT02065791",
            "NCT00976937",
            "NCT00975286",
            "NCT00866658",
            "NCT01169779",
            "NCT01632163",
            "NCT01768559",
            "NCT01798706",
            "NCT00712673",
            "NCT00713830",
            "NCT00715624",
            "NCT00763815",
            "NCT00688701",
            "NCT00707031",
            "NCT01117350",
            "NCT00051558",
            "NCT00381472",
            "NCT00314860",
            "NCT00197080",
            "NCT00363857",
            "NCT01957163",
            "NCT02119286",
            "NCT02236611",
            "NCT00348140",
            "NCT00348309",
            "NCT00428090",
            "NCT00116831",
            "NCT01181895",
            "NCT00123903",
            "NCT00273052",
            "NCT00064428",
            "NCT01316900",
            "NCT01916226",
            "NCT01316913",
            "NCT01159912",
            "NCT01436110",
            "NCT00289198",
            "NCT00115622",
            "NCT00117325",
            "NCT00118703",
            "NCT00609674",
            "NCT00410384",
            "NCT00424476",
            "NCT01691521",
            "NCT00139815",
            "NCT00118729",
            "NCT00329602",
            "NCT00856284",
            "NCT00968708",
            "NCT00286455",
            "NCT00286429",
            "NCT00707993",
            "NCT00286494",
            "NCT00286468",
            "NCT01289119",
            "NCT00286442",
            "NCT01890122",
            "NCT00395512",
            "NCT01023581",
            "NCT00432276",
            "NCT00328627",
            "NCT00306384",
            "NCT00655863",
            "NCT01521962",
            "NCT02512068",
            "NCT01632007",
            "NCT02324569",
            "NCT03231709",
            "NCT01544179",
            "NCT00322452",
            "NCT00076388",
            "NCT00076388",
            "NCT00478049",
            "NCT00478049",
            "NCT02152371"
        ],
        "number_of_studies": 234
    },
    {
        "request_id": "9731, 7826",
        "lead_investigator": "Carl Turesson",
        "lead_institution": "Lund University",
        "study_title": "Efficacy and safety of tumor necrosis factor inhibitors (TNFi) in seronegative rheumatoid arthritis patients who are inadequate responders to conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). A systematic literature review with meta-analysis.",
        "link": "https://vivli.org/efficacy-and-safety-of-tumor-necrosis-factor-inhibitors-tnfi-in-seronegative-rheumatoid-arthritis-patients-who-are-inadequate-responders-to-conventional-synthetic-disease-modifying-anti-rheumatic-dr/",
        "year": "2022",
        "study_id": [
            "NCT00269867",
            "NCT01710358",
            "NCT00538902",
            "NCT00195702",
            "NCT00152386",
            "NCT00647491",
            "NCT00647920",
            "NCT00264550",
            "NCT00853385",
            "NCT00853385",
            "NCT00235859",
            "NCT00207714",
            "NCT01225393"
        ],
        "number_of_studies": 13
    },
    {
        "request_id": "9734",
        "lead_investigator": "James Brorson",
        "lead_institution": "The University of Chicago",
        "study_title": "Merging data from acute stroke secondary prevention trials for analysis of stroke recurrence risks",
        "link": "https://vivli.org/merging-data-from-acute-stroke-secondary-prevention-trials-for-analysis-of-stroke-recurrence-risks",
        "year": "2024",
        "study_id": [
            "NCT01994720",
            "NCT01994720",
            "NCT03354429",
            "NCT03354429",
            "NCT00991029",
            "NCT00991029"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9735",
        "lead_investigator": "Edouard Auclin",
        "lead_institution": "Assistance Publique des H\u00f4pitaux de Paris",
        "study_title": "Prognostic and predictive value of the lung immune prognostic index in patients with advanced small cell lung cancers treated with immune checkpoint inhibitors",
        "link": "https://vivli.org/prognostic-and-predictive-value-of-the-lung-immune-prognostic-index-in-patients-with-advanced-small-cell-lung-cancers-treated-with-immune-checkpoint-inhibitors",
        "year": "2024",
        "study_id": [
            "NCT03043872",
            "NCT02763579"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9736",
        "lead_investigator": "Stefan Leucht",
        "lead_institution": "Klinikum rechts der Isar",
        "study_title": "Sex differences in antipsychotic side-effects and efficacy in adults with acute exacerbations of schizophrenia: an individual-participant network meta-analysis",
        "link": "https://vivli.org/sex-differences-in-antipsychotic-side-effects-and-efficacy-in-adults-with-acute-exacerbations-of-schizophrenia-an-individual-participant-network-meta-analysis/",
        "year": "2025",
        "study_id": [
            "NCT00073164",
            "NCT00259870",
            "NCT00103727",
            "NCT00034749",
            "NCT00236457",
            "NCT00297388",
            "NCT01662310",
            "NCT00061802",
            "NCT00085748",
            "NCT00299702",
            "NCT00077714",
            "NCT00074477",
            "NCT00078039",
            "NCT00083668",
            "NCT00086320",
            "NCT00088075",
            "NCT00101634",
            "NCT00105326",
            "NCT00111189",
            "NCT00119756",
            "NCT00210548",
            "NCT00210717",
            "NCT00216476",
            "NCT00216671",
            "NCT00236379",
            "NCT00249132",
            "NCT00249223",
            "NCT00253136",
            "NCT00334126",
            "NCT00397033",
            "NCT00412373",
            "NCT00495118",
            "NCT00518323",
            "NCT00524043",
            "NCT00526877",
            "NCT00589914",
            "NCT00590577",
            "NCT00604279",
            "NCT00645099",
            "NCT00645307",
            "NCT00650793",
            "NCT00668837",
            "NCT00992407",
            "NCT01009047",
            "NCT01193153",
            "NCT01299389",
            "NCT01515423",
            "NCT01529515",
            "NCT03345342",
            "NCT01559272",
            "NCT00088478",
            "NCT00036088",
            "NCT00051298",
            "NCT00320489"
        ],
        "number_of_studies": 54
    },
    {
        "request_id": "9738",
        "lead_investigator": "Onyekachukwu Illoh",
        "lead_institution": "University of Maryland",
        "study_title": "Translating Causal Inferences from Randomized and Single-Arm Trials to Externally-Controlled Trials",
        "link": "https://vivli.org/translating-causal-inferences-from-randomized-and-single-arm-trials-to-externally-controlled-trials",
        "year": "2024",
        "study_id": [
            "NCT03057951",
            "NCT02197416",
            "NCT03057977"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9739",
        "lead_investigator": "David Auerbach",
        "lead_institution": "SUNY Upstate Medical University",
        "study_title": "Assessment of cardiac electrical function and prevalence of electrocardiographic abnormalities in patients diagnosed with Dravet Syndrome and Lennox-Gastaut Syndrome",
        "link": "https://vivli.org/assessment-of-cardiac-electrical-function-and-prevalence-of-electrocardiographic-abnormalities-in-patients-diagnosed-with-dravet-syndrome-and-lennox-gastaut-syndrome",
        "year": "2024",
        "study_id": [
            "NCT02682927"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9743",
        "lead_investigator": "Howard Scher",
        "lead_institution": "Memorial Sloan Kettering Cancer Center",
        "study_title": "Evaluating the association between radiographic progression free survival and overall survival using the ELMPC4 and ELMPC5 randomized clinical trial data",
        "link": "https://vivli.org/evaluating-the-association-between-radiographic-progression-free-survival-and-overall-survival-using-the-elmpc4-and-elmpc5-randomized-clinical-trial-data",
        "year": "2024",
        "study_id": [
            "NCT01193257",
            "NCT01193244"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9746",
        "lead_investigator": "Mar\u00eda Elena Hernando P\u00e9rez",
        "lead_institution": "Universidad Polit\u00e9cnica de Madrid",
        "study_title": "PROPHECY: Preprandial Optimized Glucose Prediction with Objective Physical Exercise and Carbohydrate Estimation for Insulin Calculation in Do-it-Yourself Systems",
        "link": "https://vivli.org/prophecy-preprandial-optimized-glucose-prediction-with-objective-physical-exercise-and-carbohydrate-estimation-for-insulin-calculation-in-do-it-yourself-systems",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9748",
        "lead_investigator": "Ho So",
        "lead_institution": "The Chinese University of Hong Kong",
        "study_title": "Causal inference in restrospective rheumatoid arthritis clinical studies",
        "link": "https://vivli.org/causal-inference-in-restrospective-rheumatoid-arthritis-clinical-studies",
        "year": "2024",
        "study_id": [
            "NCT01194414",
            "NCT01119859",
            "NCT00195663",
            "NCT00531817",
            "NCT00106548",
            "NCT00109408",
            "NCT00106574"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "9764",
        "lead_investigator": "Wenjun Yi",
        "lead_institution": "The Second Xiangya Hospital of Central South University",
        "study_title": "Assessing the Efficacy of Trastuzumab Emtansine (T-DM1) in Human Epidermal Growth Factor Receptor 2 (HER2)+ Breast Cancer Across Varying Hormone Receptor Statuses",
        "link": "https://vivli.org/assessing-the-efficacy-of-trastuzumab-emtansine-t-dm1-in-human-epidermal-growth-factor-receptor-2-her2-breast-cancer-across-varying-hormone-receptor-statuses",
        "year": "2024",
        "study_id": [
            "NCT00829166",
            "NCT02924883",
            "NCT01419197",
            "NCT00679341",
            "NCT02131064",
            "NCT01120184",
            "NCT00679211",
            "NCT01702571",
            "NCT00943670",
            "NCT00509769",
            "NCT01772472",
            "NCT00934856"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "9767",
        "lead_investigator": "Rohan Khera",
        "lead_institution": "Yale School of Medicine",
        "study_title": "A computational phenomapping approach to personalize the cardiometabolic benefits of novel glucagon-like peptide-1 receptor and glucose-dependent insulinotropic polypeptide agonists in patients with type 2 diabetes mellitus.",
        "link": "https://vivli.org/a-computational-phenomapping-approach-to-personalize-the-cardiometabolic-benefits-of-novel-glucagon-like-peptide-1-receptor-and-glucose-dependent-insulinotropic-polypeptide-agonists-in-patients-with-t",
        "year": "2024",
        "study_id": [
            "NCT03987919",
            "NCT03730662",
            "NCT03861039",
            "NCT03954834",
            "NCT04039503",
            "NCT03882970",
            "NCT03861052",
            "NCT04093752",
            "NCT03311724",
            "NCT03131687"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "9770",
        "lead_investigator": "Massimo Gentile",
        "lead_institution": "Azienda Ospedaliera Di Cosenza",
        "study_title": "Comparison between Eloquent-3 data (arm EloPd) with real-life data",
        "link": "https://vivli.org/comparison-between-eloquent-3-data-arm-elopd-with-real-life-data",
        "year": "2024",
        "study_id": [
            "NCT02654132",
            "NCT02654132",
            "NCT02654132"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9771",
        "lead_investigator": "Li Yang",
        "lead_institution": "Renmin University of China",
        "study_title": "Covariate selection and adaptive randomization for sequential experiments",
        "link": "https://vivli.org/covariate-selection-and-adaptive-randomization-for-sequential-experiments",
        "year": "2024",
        "study_id": [
            "NCT03057951"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9774",
        "lead_investigator": "Aristeidis Katsanos",
        "lead_institution": "Hamilton Health Sciences Corporation",
        "study_title": "Individual Participant Data Meta-Analysis of Randomized Trials of Anticoagulation compared to Antiplatelet Therapy in Patients with Embolic Strokes of Undetermined Source",
        "link": "https://vivli.org/individual-participant-data-meta-analysis-of-randomized-trials-of-anticoagulation-compared-to-antiplatelet-therapy-in-patients-with-embolic-strokes-of-undetermined-source",
        "year": "2024",
        "study_id": [
            "NCT02239120"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9787",
        "lead_investigator": "Hongmei Zheng",
        "lead_institution": "Huazhong University of Science and Technology",
        "study_title": "Clinical and molecular characteristics of human epidermal growth factor receptor 2-positive breast cancers: a meta-analysis",
        "link": "https://vivli.org/clinical-and-molecular-characteristics-of-human-epidermal-growth-factor-receptor-2-positive-breast-cancers-a-meta-analysis",
        "year": "2024",
        "study_id": [
            "NCT00545688",
            "NCT02586025",
            "NCT00976989",
            "NCT02132949",
            "NCT02131064",
            "NCT01358877",
            "NCT01772472",
            "NCT00045032",
            "NCT00950300",
            "NCT01401166",
            "NCT01566721"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "9792",
        "lead_investigator": "Maria Pia Sormani",
        "lead_institution": "University of Genoa",
        "study_title": "Defining responders to teriflunomide treatment in Multiple Sclerosis",
        "link": "https://vivli.org/defining-responders-to-teriflunomide-treatment-in-multiple-sclerosis",
        "year": "2024",
        "study_id": [
            "NCT00134563",
            "NCT00134563",
            "NCT00622700",
            "NCT00622700",
            "NCT00751881",
            "NCT00751881"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9793",
        "lead_investigator": "Lea Dousset",
        "lead_institution": "Translational Research Institute, The University of Queensland",
        "study_title": "Immunotherapy as Prophylaxis: Exploring the Potential Impact on Hyper-Chronic Non-Melanoma Skin Cancers in Retrospective Melanoma Cohorts",
        "link": "https://vivli.org/immunotherapy-as-prophylaxis-exploring-the-potential-impact-on-hyper-chronic-non-melanoma-skin-cancers-in-retrospective-melanoma-cohorts",
        "year": "2024",
        "study_id": [
            "NCT01927419",
            "NCT01927419",
            "NCT01721746",
            "NCT01721746"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9797",
        "lead_investigator": "Julian Stiels",
        "lead_institution": "OneTwenty AG",
        "study_title": "Advanced blood glucose prediction modelling",
        "link": "https://vivli.org/advanced-blood-glucose-prediction-modelling",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9809",
        "lead_investigator": "Emma Fr\u00f6ling",
        "lead_institution": "Universit\u00e4tsmedizin Charit\u00e9 Berlin",
        "study_title": "Systematic Review and Meta-Analysis of Adverse Events During Levetiracetam Therapy",
        "link": "https://vivli.org/systematic-review-and-meta-analysis-of-adverse-events-during-levetiracetam-therapy",
        "year": "2024",
        "study_id": [
            "NCT00150735",
            "NCT01498822",
            "NCT00160550",
            "NCT00419094",
            "NCT01229735",
            "NCT00419393",
            "NCT01506882",
            "NCT01228747"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "9813",
        "lead_investigator": "Sameer Jauhar",
        "lead_institution": "King\u2019s College London",
        "study_title": "Conducting a systematic review and meta-analysis to assess the incidence and severity of withdrawal symptoms following discontinuation of antidepressants",
        "link": "https://vivli.org/conducting-a-systematic-review-and-meta-analysis-to-assess-the-incidence-and-severity-of-withdrawal-symptoms-following-discontinuation-of-antidepressants",
        "year": "2024",
        "study_id": [
            "NCT01140906",
            "NCT01163266",
            "NCT01153009",
            "NCT00300378",
            "NCT00277823"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "9815",
        "lead_investigator": "Tim Greten",
        "lead_institution": "Center for Cancer Research, National Cancer Institute, NIH",
        "study_title": "Locoregional therapy impact on immunotherapy",
        "link": "https://vivli.org/locoregional-therapy-impact-on-immunotherapy",
        "year": "2025",
        "study_id": [
            "NCT02821754",
            "NCT03434379"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9817",
        "lead_investigator": "Marco Gerlinger",
        "lead_institution": "Queen Mary University of London",
        "study_title": "To determine whether Programmed Cell Death Ligand 1 (PDL1) expression in oesophago-gastric cancer differs depending on the tumour site from which the biopsy was taken from",
        "link": "https://vivli.org/to-determine-whether-programmed-cell-death-ligand-1-pdl1-expression-in-oesophago-gastric-cancer-differs-depending-on-the-tumour-site-from-which-the-biopsy-was-taken-from",
        "year": "2024",
        "study_id": [
            "NCT02872116",
            "NCT02872116"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9821",
        "lead_investigator": "Richard Franzese",
        "lead_institution": "GlaxoSmithKline",
        "study_title": "Assessment of the predictive value of longitudinal circulating tumour deoxyribonucleic acid (ctDNA) dynamics for survival outcomes in non-small-cell lung cancer (NSCLC)",
        "link": "https://vivli.org/assessment-of-the-predictive-value-of-longitudinal-circulating-tumour-deoxyribonucleic-acid-ctdna-dynamics-for-survival-outcomes-in-non-small-cell-lung-cancer-nsclc",
        "year": "2024",
        "study_id": [
            "NCT02366143"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9822",
        "lead_investigator": "Shuhua Yi",
        "lead_institution": "Peking Union Medical College",
        "study_title": "Clinical and molecular characteristics of Non-Hodgkin Lymphoma.",
        "link": "https://vivli.org/clinical-and-molecular-characteristics-of-non-hodgkin-lymphoma",
        "year": "2025",
        "study_id": [
            "NCT00719472",
            "NCT01724021",
            "NCT01287741",
            "NCT01649856",
            "NCT00281918",
            "NCT00090051",
            "NCT02242942",
            "NCT02053610",
            "NCT02005471",
            "NCT01414205",
            "NCT01292603",
            "NCT01200758",
            "NCT01059630",
            "NCT01332968",
            "NCT00576758",
            "NCT01939899"
        ],
        "number_of_studies": 16
    },
    {
        "request_id": "9824",
        "lead_investigator": "Martin Okun",
        "lead_institution": "Fort HealthCare",
        "study_title": "Using Patient-Level Data from Psoriasis Clinical Trials to Evaluate the Relationship between Changes in Skin and Nail Psoriasis",
        "link": "https://vivli.org/using-patient-level-data-from-psoriasis-clinical-trials-to-evaluate-the-relationship-between-changes-in-skin-and-nail-psoriasis",
        "year": "2024",
        "study_id": [
            "NCT01597245",
            "NCT01646177"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9826",
        "lead_investigator": "Lorna Wheaton",
        "lead_institution": "University of Leicester",
        "study_title": "Development and application of new statistical methods for meta-analysis to evaluate treatment effectiveness and surrogate relationships in biomarker subgroups",
        "link": "https://vivli.org/development-and-application-of-new-statistical-methods-for-meta-analysis-to-evaluate-treatment-effectiveness-and-surrogate-relationships-in-biomarker-subgroups",
        "year": "2024",
        "study_id": [
            "NCT02125461",
            "NCT01903993",
            "NCT02409342",
            "NCT02367794",
            "NCT02008227",
            "NCT02366143",
            "NCT02367781",
            "NCT02395172",
            "NCT01673867",
            "NCT03302234",
            "NCT01642004",
            "NCT02041533",
            "NCT02578680",
            "NCT02785952",
            "NCT01285609",
            "NCT02477826",
            "NCT02591615",
            "NCT01905657",
            "NCT03656094",
            "NCT02039674",
            "NCT03057106",
            "NCT00527735",
            "NCT02220894",
            "NCT01633970",
            "NCT02775435",
            "NCT03215706",
            "NCT02352948",
            "NCT02142738",
            "NCT02453282",
            "NCT03088540",
            "NCT03117049",
            "NCT02613507",
            "NCT03607539",
            "NCT03134872",
            "NCT03629925",
            "NCT03728556",
            "NCT03789604"
        ],
        "number_of_studies": 37
    },
    {
        "request_id": "9829",
        "lead_investigator": "Yuanyuan Kong",
        "lead_institution": "Beijing Friendship Hospital",
        "study_title": "Clinical and molecular profiles of Hepatocellular Carcinoma (HCC) treated with combination immunotherapy",
        "link": "https://vivli.org/clinical-and-molecular-profiles-of-hepatocellular-carcinoma-hcc-treated-with-combination-immunotherapy",
        "year": "2024",
        "study_id": [
            "NCT03434379",
            "NCT02715531"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9834",
        "lead_investigator": "Tao Han",
        "lead_institution": "The First Hospital of China Medical University",
        "study_title": "Clinical and molecular profiles of Hepatocellular Carcinoma (HCC)",
        "link": "https://vivli.org/clinical-and-molecular-profiles-of-hepatocellular-carcinoma-hcc",
        "year": "2024",
        "study_id": [
            "NCT01774344",
            "NCT01004003",
            "NCT00987935",
            "NCT01263587",
            "NCT03434379",
            "NCT00508001"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9835",
        "lead_investigator": "Yuya Matsue",
        "lead_institution": "Juntendo University School of Medicine Graduate School of Medicine",
        "study_title": "Impact of serum hepcidin levels on the efficacy of daprodustat treatment in patients with chronic kidney disease",
        "link": "https://vivli.org/impact-of-serum-hepcidin-levels-on-the-efficacy-of-daprodustat-treatment-in-patients-with-chronic-kidney-disease",
        "year": "2024",
        "study_id": [
            "NCT02876835",
            "NCT02879305"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9841",
        "lead_investigator": "Anke Richters",
        "lead_institution": "The Netherlands Comprehensive Cancer Organisation",
        "study_title": "Estimating heterogeneous treatment effects of immunotherapy combination regimens for treatment of advanced/metastatic clear cell renal cell carcinoma: an individual patient data meta-analysis",
        "link": "https://vivli.org/estimating-heterogeneous-treatment-effects-of-immunotherapy-combination-regimens-for-treatment-of-advanced-metastatic-clear-cell-renal-cell-carcinoma-an-individual-patient-data-meta-analysis",
        "year": "2025",
        "study_id": [
            "NCT03141177",
            "NCT03141177"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "9844, 10137",
        "lead_investigator": "Mariam Khayretdinova",
        "lead_institution": "Brainify.AI",
        "study_title": "Predicting Placebo Response in Major Depressive Disorder on Clinical Trials Data Using Artificial Intelligence (AI)/Machine Learning (ML)",
        "link": "https://vivli.org/predicting-placebo-response-in-major-depressive-disorder-on-clinical-trials-data-using-artificial-intelligence-aimachine-learning-ml",
        "year": "2024",
        "study_id": [
            "NCT00105989"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9845",
        "lead_investigator": "Yao Zhu",
        "lead_institution": "Fudan University Shanghai Cancer Center",
        "study_title": "Serum sodium maintenance levels and outcomes in patients with advanced prostate cancer",
        "link": "https://vivli.org/serum-sodium-maintenance-levels-and-outcomes-in-patients-with-advanced-prostate-cancer",
        "year": "2024",
        "study_id": [
            "NCT02799602",
            "NCT01308567",
            "NCT02200614"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9846",
        "lead_investigator": "Samantha Kleinberg",
        "lead_institution": "Stevens Institute of Technology",
        "study_title": "Examining Effects of Meals on Glucose in Individuals with Type 1 Diabetes",
        "link": "https://vivli.org/examining-effects-of-meals-on-glucose-in-individuals-with-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9848",
        "lead_investigator": "Garrett Ash",
        "lead_institution": "Yale School of Medicine",
        "study_title": "Developing a pre-trainable foundation time series model for blood glucose prediction among people with type 1 diabetes (T1D) and then applying it to a vulnerable, understudied subset of them",
        "link": "https://vivli.org/developing-a-pre-trainable-foundation-time-series-model-for-blood-glucose-prediction-among-people-with-type-1-diabetes-t1d-and-then-applying-it-to-a-vulnerable-understudied-subset-of-them",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9863",
        "lead_investigator": "Yasuhiro Hagiwara",
        "lead_institution": "The University of Tokyo",
        "study_title": "Development of Covariate Adjustment Methods to Improve Efficiency of Randomized Clinical Trials for human immunodeficiency virus Infected Patients",
        "link": "https://vivli.org/development-of-covariate-adjustment-methods-to-improve-efficiency-of-randomized-clinical-trials-for-human-immunodeficiency-virus-infected-patients",
        "year": "2024",
        "study_id": [
            "NCT01449929"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9866",
        "lead_investigator": "Weituo Zhang",
        "lead_institution": "Shanghai Jiao Tong University School of Medicine",
        "study_title": "Comparing methods of selecting and adjusting for confounding factors in clinical trial",
        "link": "https://vivli.org/comparing-methods-of-selecting-and-adjusting-for-confounding-factors-in-clinical-trial",
        "year": "2024",
        "study_id": [
            "NCT00762034"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9870",
        "lead_investigator": "Alexandre Betourne",
        "lead_institution": "Critical Path Institute",
        "study_title": "Integration of Biogen Choroideremia Data (NCT03359551 ; NTCNCT03496012) into the Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP)",
        "link": "https://vivli.org/integration-of-biogen-choroideremia-data-nct03359551-ntcnct03496012-into-the-rare-diseases-cures-accelerator-data-and-analytics-platform-rdca-dap",
        "year": "2024",
        "study_id": [
            "NCT03359551",
            "NCT03496012",
            "NCT03359551",
            "NCT03496012",
            "NCT03496012",
            "NCT03496012",
            "NCT03359551",
            "NCT03359551"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "9890",
        "lead_investigator": "Jasmine Mitchell",
        "lead_institution": "University of California, Los Angeles",
        "study_title": "The Effect of Serotonin Reuptake Inhibitors in Metastatic Colorectal Cancer",
        "link": "https://vivli.org/the-effect-of-serotonin-reuptake-inhibitors-in-metastatic-colorectal-cancer",
        "year": "2024",
        "study_id": [
            "NCT02788279"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9906",
        "lead_investigator": "Alessio Cortellini",
        "lead_institution": "Department of Surgery and Cancer Imperial College London, London",
        "study_title": "The putative role of Proton-Pump Inhibitors in patients with Basal Cell Carcinoma treated with vismodegib",
        "link": "https://vivli.org/the-putative-role-of-proton-pump-inhibitors-in-patients-with-basal-cell-carcinoma-treated-with-vismodegib",
        "year": "2024",
        "study_id": [
            "NCT01201915",
            "NCT01201915",
            "NCT00833417",
            "NCT01201915"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9907",
        "lead_investigator": "Akihiro Hirakawa",
        "lead_institution": "Tokyo Medical and Dental University",
        "study_title": "Developing new statistical methodology harnessing nonconcurrent control data in infectious disease platform trials",
        "link": "https://vivli.org/developing-new-statistical-methodology-harnessing-nonconcurrent-control-data-in-infectious-disease-platform-trials",
        "year": "2024",
        "study_id": [
            "NCT04322682",
            "NCT04421027",
            "NCT04593940"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "9908",
        "lead_investigator": "Haitao Zhao",
        "lead_institution": "Peking Union Medical College Hospital",
        "study_title": "The clinical and prognostic features of acquired resistance to immune-checkpoint inhibitors (ICIs) in Hepatocellular carcinoma (HCC)",
        "link": "https://vivli.org/the-clinical-and-prognostic-features-of-acquired-resistance-to-immune-checkpoint-inhibitors-icis-in-hepatocellular-carcinoma-hcc",
        "year": "2024",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9909",
        "lead_investigator": "John Clemmer",
        "lead_institution": "University of Mississippi Medical Center",
        "study_title": "Improving heart failure with preserved ejection fraction (HFpEF) treatment using a mathematical model of physiology",
        "link": "https://vivli.org/improving-heart-failure-with-preserved-ejection-fraction-hfpef-treatment-using-a-mathematical-model-of-physiology",
        "year": "2024",
        "study_id": [
            "NCT03057951"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9910",
        "lead_investigator": "Yang Li",
        "lead_institution": "Renmin University of China",
        "study_title": "Missing data considerations for patient reported outcome measures in randomized controlled trials",
        "link": "https://vivli.org/missing-data-considerations-for-patient-reported-outcome-measures-in-randomized-controlled-trials",
        "year": "2024",
        "study_id": [
            "NCT01740427"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9911",
        "lead_investigator": "Kazuki Takada",
        "lead_institution": "Saiseikai Fukuoka General Hospital",
        "study_title": "Prognosis of inoperable patients after preoperative atezolizumab administration: A post hoc analysis of Lung Cancer Mutation Consortium (LCMC) 3",
        "link": "https://vivli.org/prognosis-of-inoperable-patients-after-preoperative-atezolizumab-administration-a-post-hoc-analysis-of-lung-cancer-mutation-consortium-lcmc-3",
        "year": "2024",
        "study_id": [
            "NCT02927301"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9912, 9387",
        "lead_investigator": "Soumyajit Roy",
        "lead_institution": "Rush University Medical Center",
        "study_title": "Causal mediation role of prostate-specific antigen (PSA) and pain in metastatic hormone sensitive prostate cancer: a pooled analysis of 3 randomized controlled trials",
        "link": "https://vivli.org/causal-mediation-role-of-prostate-specific-antigen-psa-and-pain-in-metastatic-hormone-sensitive-prostate-cancer-a-pooled-analysis-of-3-randomized-controlled-trials",
        "year": "2024",
        "study_id": [
            "NCT02799602",
            "NCT02489318",
            "NCT01715285",
            "NCT02446405"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "9920",
        "lead_investigator": "Soumyajit Roy",
        "lead_institution": "Rush University Medical Center",
        "study_title": "Does Timing of Metastatic Presentation (Synchronous versus Asynchronous) Affect Outcome in Advanced Urothelial Carcinoma?",
        "link": "https://vivli.org/does-timing-of-metastatic-presentation-synchronous-versus-asynchronous-affect-outcome-in-advanced-urothelial-carcinoma",
        "year": "2024",
        "study_id": [
            "NCT02951767",
            "NCT02302807",
            "NCT02108652",
            "NCT02426125",
            "NCT04052113",
            "NCT02807636"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "9924",
        "lead_investigator": "Thomas B\u00fcttner",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Evaluation of Bellmunt Risk Score as a prognostic score in metastatic-castration resistant prostate cancer",
        "link": "https://vivli.org/evaluation-of-bellmunt-risk-score-as-a-prognostic-score-in-metastatic-castration-resistant-prostate-cancer",
        "year": "2024",
        "study_id": [
            "NCT02257736",
            "NCT01695135",
            "NCT01193257",
            "NCT01308567",
            "NCT00887198"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "9939",
        "lead_investigator": "Xiaoyu Yan",
        "lead_institution": "The Chinese University of Hong Kong",
        "study_title": "Organ specific tumor dynamic predict survival in patients with metastatic breast cancer",
        "link": "https://vivli.org/organ-specific-tumor-dynamic-predict-survival-in-patients-with-metastatic-breast-cancer/",
        "year": "2024",
        "study_id": [
            "NCT01419197",
            "NCT00829166",
            "NCT00262067",
            "NCT00281697",
            "NCT02425891",
            "NCT01942135",
            "NCT02747004"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "9960",
        "lead_investigator": "Zhengfei Zhu",
        "lead_institution": "Fudan University Shanghai Cancer Center",
        "study_title": "Organ-specific response to atezolizumab and radiotherapy in advanced non-small cell lung cancer patients: a pooled analysis",
        "link": "https://vivli.org/organ-specific-response-to-atezolizumab-and-radiotherapy-in-advanced-non-small-cell-lung-cancer-patients-a-pooled-analysis",
        "year": "2024",
        "study_id": [
            "NCT02409342",
            "NCT03285763",
            "NCT02657434",
            "NCT02367781",
            "NCT02367794",
            "NCT02366143",
            "NCT02008227",
            "NCT01903993",
            "NCT01846416",
            "NCT02031458"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "9963",
        "lead_investigator": "Hanna Suominen",
        "lead_institution": "The Australian National University",
        "study_title": "Develop Type 1 Diabetes Simulators/Models for Exercise in Type 1 Diabetes",
        "link": "https://vivli.org/develop-type-1-diabetes-simulators-models-for-exercise-in-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "9964",
        "lead_investigator": "Jo\u00e3o S\u00e9rgio Neves",
        "lead_institution": "Universidade do Porto",
        "study_title": "Effects of tirzepatide versus semaglutide on cardiovascular risk in patients with type 2 diabetes",
        "link": "https://vivli.org/effects-of-tirzepatide-versus-semaglutide-on-cardiovascular-risk-in-patients-with-type-2-diabetes",
        "year": "2024",
        "study_id": [
            "NCT03987919"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "9966",
        "lead_investigator": "Luis Farhat",
        "lead_institution": "University of S\u00e3o Paulo",
        "study_title": "An evaluation of lack early of improvement and later non-response in early-onset schizophrenia: a systematic review and meta-analysis of randomized controlled trials",
        "link": "https://vivli.org/an-evaluation-of-lack-early-of-improvement-and-later-non-response-in-early-onset-schizophrenia-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/",
        "year": "2025",
        "study_id": [
            "NCT00088075",
            "NCT00034749",
            "NCT00518323",
            "NCT01009047",
            "NCT00051298",
            "NCT00102063"
        ],
        "number_of_studies": 6
    },
    {
        "request_id": "10028",
        "lead_investigator": "Hanne Vanluchene",
        "lead_institution": "AZ Delta",
        "study_title": "Development of an Inflammatory Bowel Disease (IBD) patient population dashboard to monitor and improve care through machine learning",
        "link": "https://vivli.org/development-of-an-inflammatory-bowel-disease-ibd-patient-population-dashboard-to-monitor-and-improve-care-through-machine-learning/",
        "year": "2024",
        "study_id": [
            "NCT00036439",
            "NCT00096655",
            "NCT00488631",
            "NCT00487539",
            "NCT00488774",
            "NCT00408629",
            "NCT00385736",
            "NCT02407236",
            "NCT00771667",
            "NCT01369342",
            "NCT01369355",
            "NCT01369329",
            "NCT00409617",
            "NCT00553176"
        ],
        "number_of_studies": 14
    },
    {
        "request_id": "10030",
        "lead_investigator": "Lihi Eder",
        "lead_institution": "Women's College Hospital",
        "study_title": "Exploring Sex-related Mechanisms of Psoriatic Arthritis (PSA) response to advanced therapies (EXSEMP): Individual participant data (IPD) meta-analysis of randomized controlled trials of advanced therapies",
        "link": "https://vivli.org/exploring-sex-related-mechanisms-of-psoriatic-arthritis-psa-response-to-advanced-therapies-exsemp-individual-participant-data-ipd-meta-analysis-of-randomized-controlled-trials-of-advanced-thera",
        "year": "2025",
        "study_id": [
            "NCT02814175",
            "NCT00195689",
            "NCT00646178",
            "NCT00646386",
            "NCT00265096",
            "NCT02181673",
            "NCT01009086",
            "NCT01077362",
            "NCT00267956",
            "NCT00051623",
            "NCT00367237",
            "NCT03796858",
            "NCT02319759",
            "NCT03158285",
            "NCT03162796",
            "NCT03151551",
            "NCT01695239",
            "NCT02349295",
            "NCT00245960",
            "NCT01877668",
            "NCT01877668",
            "NCT01882439",
            "NCT01882439"
        ],
        "number_of_studies": 23
    },
    {
        "request_id": "10032",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The First Affiliated Hospital of Sun Yat-Sen University",
        "study_title": "Dynamics of Disease Activity in Monitoring Therapeutic Outcomes and Predicting Prognosis for Ulcerative Colitis",
        "link": "https://vivli.org/dynamics-of-disease-activity-in-monitoring-therapeutic-outcomes-and-predicting-prognosis-for-ulcerative-colitis",
        "year": "2024",
        "study_id": [
            "NCT02407236",
            "NCT00487539",
            "NCT00488774",
            "NCT00488631",
            "NCT00036439",
            "NCT02497469",
            "NCT00783718"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "10036",
        "lead_investigator": "Akihiro Hirakawa",
        "lead_institution": "Tokyo Medical and Dental University",
        "study_title": "Development of statistical methodology considering placebo response in randomized controlled trials targeting Alzheimer's disease",
        "link": "https://vivli.org/development-of-statistical-methodology-considering-placebo-response-in-randomized-controlled-trials-targeting-alzheimers-disease",
        "year": "2024",
        "study_id": [
            "NCT01900665",
            "NCT00904683",
            "NCT00905372",
            "NCT00594568",
            "NCT00762411"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "10037",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The first affiliated hospital of Sun Yat-sen University",
        "study_title": "Dynamics of Disease Activity in Monitoring Therapeutic Outcomes and Predicting Prognosis for Crohn's disease",
        "link": "https://vivli.org/dynamics-of-disease-activity-in-monitoring-therapeutic-outcomes-and-predicting-prognosis-for-crohns-disease",
        "year": "2024",
        "study_id": [
            "NCT02425111",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT00348283",
            "NCT02425111",
            "NCT01369329",
            "NCT01369355",
            "NCT00348283",
            "NCT01369342"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "10038",
        "lead_investigator": "Linong Ji",
        "lead_institution": "Peking University People\u00e2\u20ac\u2122s Hospital",
        "study_title": "Identify treatment responders in patients with type 2 diabetes using a machine learning based dynamic cardiovascular risk assessment tool (ML-CVD) in clinical trials",
        "link": "https://vivli.org/identify-treatment-responders-in-patients-with-type-2-diabetes-using-a-machine-learning-based-dynamic-cardiovascular-risk-assessment-tool-ml-cvd-in-clinical-trials",
        "year": "2024",
        "study_id": [
            "NCT02065791",
            "NCT01032629",
            "NCT01989754",
            "NCT00968708",
            "NCT01394952",
            "NCT02545049",
            "NCT01147250",
            "NCT02540993"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "10046",
        "lead_investigator": "Matthew Galsky",
        "lead_institution": "Icahn School of Medicine at Mount Sinai",
        "study_title": "Exploring C-reactive protein (CRP) dynamics and resistance to immunotherapy in bladder cancer",
        "link": "https://vivli.org/exploring-c-reactive-protein-crp-dynamics-and-resistance-to-immunotherapy-in-bladder-cancer",
        "year": "2024",
        "study_id": [
            "NCT02108652",
            "NCT02302807",
            "NCT02807636",
            "NCT02951767"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "10047",
        "lead_investigator": "Ramona Belfiore-Oshan",
        "lead_institution": "Critical Path Institute",
        "study_title": "Bayesian item response theory model for the North Star Ambulatory Assessment (NSAA) rating scale",
        "link": "https://vivli.org/bayesian-item-response-theory-model-for-the-north-star-ambulatory-assessment-nsaa-rating-scale",
        "year": "2024",
        "study_id": [
            "NCT01753804",
            "NCT01254019",
            "NCT01153932",
            "NCT01462292"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "10049",
        "lead_investigator": "Dag Aarsland",
        "lead_institution": "King\u2019s College London",
        "study_title": "Neutrophil to Lymphocyte Ratio Decrease and Its Association with Clinical Changes in Late-Life Depression Treated with Vortioxetine (Lu AA21004)",
        "link": "https://vivli.org/neutrophil-to-lymphocyte-ratio-decrease-and-its-association-with-clinical-changes-in-late-life-depression-treated-with-vortioxetine-lu-aa21004",
        "year": "2024",
        "study_id": [
            "NCT00811252"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10052",
        "lead_investigator": "Yasuhiro Hagiwara",
        "lead_institution": "The University of Tokyo",
        "study_title": "Adjusting for treatment switching in Oncology Trials: Sensitivity Analysis for Rank-Preserving Structural Failure Time Model",
        "link": "https://vivli.org/adjusting-for-treatment-switching-in-oncology-trials-sensitivity-analysis-for-rank-preserving-structural-failure-time-model",
        "year": "2024",
        "study_id": [
            "NCT00022672",
            "NCT01154140",
            "NCT00428597"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10054",
        "lead_investigator": "Lisa Koch",
        "lead_institution": "University of Bern",
        "study_title": "Foundational machine learning models for large scale robust modelling of continuous glucose monitoring and activity data",
        "link": "https://vivli.org/foundational-machine-learning-models-for-large-scale-robust-modelling-of-continuous-glucose-monitoring-and-activity-data",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10055",
        "lead_investigator": "Christian Torp-Peteresen",
        "lead_institution": "North Zealand Hospital",
        "study_title": "Reanalyzing Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPAREG) using Longitudinal Targeted Maximum Likelihood Estimation (LTMLE) analysis",
        "link": "https://vivli.org/reanalyzing-empagliflozin-cardiovascular-outcome-event-trial-in-type-2-diabetes-mellitus-patients-empareg-using-longitudinal-targeted-maximum-likelihood-estimation-ltmle-analysis",
        "year": "2024",
        "study_id": [
            "NCT01131676"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10090",
        "lead_investigator": "David Baker",
        "lead_institution": "Queen Mary University of London",
        "study_title": "Monitoring white blood cells as an indicator to assess the risks of treatment failure in multiple sclerosis",
        "link": "https://vivli.org/monitoring-white-blood-cells-as-an-indicator-to-assess-the-risks-of-treatment-failure-in-multiple-sclerosis/",
        "year": "2024",
        "study_id": [
            "NCT05418010",
            "NCT00027300"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10091",
        "lead_investigator": "Jonas Saal",
        "lead_institution": "University Hospital Bonn",
        "study_title": "Establishing a risk score for Skeletal Related Events (SRE) in patients with cancer",
        "link": "https://vivli.org/establishing-a-risk-score-for-skeletal-related-events-sre-in-patients-with-cancer",
        "year": "2025",
        "study_id": [
            "NCT02200614",
            "NCT01715285",
            "NCT00869206",
            "NCT00079001",
            "NCT00089674",
            "NCT00321620",
            "NCT00365105",
            "NCT00519285"
        ],
        "number_of_studies": 8
    },
    {
        "request_id": "10094",
        "lead_investigator": "Sabatina Criscuolo",
        "lead_institution": "University of Naples Federico II",
        "study_title": "Machine Learning approach for glycemia prediction in type 1 diabetes",
        "link": "https://vivli.org/machine-learning-approach-for-glycemia-prediction-in-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10095",
        "lead_investigator": "Michael Greicius",
        "lead_institution": "Stanford University",
        "study_title": "Repurposing clinical trial data to understand potential effects of functional unblinding on outcome measures in Gantenerumab trials",
        "link": "https://vivli.org/repurposing-clinical-trial-data-to-understand-potential-effects-of-functional-unblinding-on-outcome-measures-in-gantenerumab-trials",
        "year": "2024",
        "study_id": [
            "NCT01224106"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10106",
        "lead_investigator": "Mehmet Fatih Ozbay",
        "lead_institution": "Kirsehir Training and Research Hospital",
        "study_title": "Exploring the Correlation between Programmed Death-Ligand 1 (PD-L1) Levels and Eosinophilia in Advanced Lung Cancer Patients Treated with Atezolizumab",
        "link": "https://vivli.org/exploring-the-correlation-between-programmed-death-ligand-1-pd-l1-levels-and-eosinophilia-in-advanced-lung-cancer-patients-treated-with-atezolizumab",
        "year": "2024",
        "study_id": [
            "NCT02657434"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10112",
        "lead_investigator": "Alessio Cortellini",
        "lead_institution": "Imperial College London",
        "study_title": "TP53 missense and truncating mutations may be linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer: a post hoc analysis of the OAK and POPLAR trials",
        "link": "https://vivli.org/tp53-missense-and-truncating-mutations-may-be-linked-to-differential-response-to-checkpoint-blockade-in-patients-with-advanced-non-small-cell-lung-cancer-a-post-hoc-analysis-of-the-oak-and-poplar-tri",
        "year": "2024",
        "study_id": [
            "NCT01903993",
            "NCT02008227"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10116",
        "lead_investigator": "Jean-Pierre Fauvel",
        "lead_institution": "University Claude Bernard Lyon 1",
        "study_title": "Development and validation of clinical prediction tools to estimate all-cause mortality, cardiovascular and renal risk in non-dialysis chronic kidney disease (CKD) patients using machine learning",
        "link": "https://vivli.org/development-and-validation-of-clinical-prediction-tools-to-estimate-all-cause-mortality-cardiovascular-and-renal-risk-in-non-dialysis-chronic-kidney-disease-ckd-patients-using-machine-learning",
        "year": "2025",
        "study_id": [
            "NCT02876835"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10118",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Assessing Outcomes from the EXTEND Clinical Trial Using the Modified Multiplier of the Simple Endoscopic Score for Crohn's disease (MM-SES-CD)",
        "link": "https://vivli.org/assessing-outcomes-from-the-extend-clinical-trial-using-the-modified-multiplier-of-the-simple-endoscopic-score-for-crohns-disease-mm-ses-cd",
        "year": "2024",
        "study_id": [
            "NCT00348283",
            "NCT00348283"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10120",
        "lead_investigator": "Pablo Bonangelino",
        "lead_institution": "US Food and Drug Administration",
        "study_title": "A Bayesian borrowing-by-parts method integrated with propensity score stratification for borrowing adult data for pediatrics",
        "link": "https://vivli.org/a-bayesian-borrowing-by-parts-method-integrated-with-propensity-score-stratification-for-borrowing-adult-data-for-pediatrics",
        "year": "2024",
        "study_id": [
            "NCT01649765",
            "NCT00424476",
            "NCT00410384"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10121",
        "lead_investigator": "Itsuki Osawa",
        "lead_institution": "Columbia University Irving Medical Center",
        "study_title": "Optimized timing of empagliflozin use for cardiorenal protection: a post-hoc analysis of the EMPA-REG OUTCOME, EMPEROR-REDUCED, and EMPEROR-PRESERVED clinical trials",
        "link": "https://vivli.org/optimized-timing-of-empagliflozin-use-for-cardiorenal-protection-a-post-hoc-analysis-of-the-empa-reg-outcome-emperor-reduced-and-emperor-preserved-clinical-trials/",
        "year": "2024",
        "study_id": [
            "NCT01131676",
            "NCT03057951",
            "NCT03057977"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10126",
        "lead_investigator": "Wataru Fukuokaya",
        "lead_institution": "The Jikei University School of Medicine",
        "study_title": "Heterogeneous treatment effects of cabazitaxel in patients with castration-resistant prostate cancer",
        "link": "https://vivli.org/heterogeneous-treatment-effects-of-cabazitaxel-in-patients-with-castration-resistant-prostate-cancer",
        "year": "2024",
        "study_id": [
            "NCT00417079",
            "NCT01308580"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10137",
        "lead_investigator": "Mariam Khayretdinova",
        "lead_institution": "Brainify.ai",
        "study_title": "Predicting Placebo Response in Major Depressive Disorder on Clinical Trials Data Using Artificial Intelligence (AI)/Machine Learning (ML) on Clinical Data",
        "link": "https://vivli.org/predicting-placebo-response-in-major-depressive-disorder-on-clinical-trials-data-using-artificial-intelligence-ai-machine-learning-ml-on-clinical-data/",
        "year": "2025",
        "study_id": [
            "NCT02417064",
            "NCT02418585",
            "NCT02422186",
            "NCT03039192",
            "NCT03097133",
            "NCT00073411",
            "NCT00105989",
            "NCT01140906",
            "NCT00635219",
            "NCT00863798",
            "NCT00369343",
            "NCT00672620"
        ],
        "number_of_studies": 12
    },
    {
        "request_id": "10138",
        "lead_investigator": "Issa Dahabreh",
        "lead_institution": "Harvard T.H. Chan School of Public Health",
        "study_title": "Development of statistical methods for comparison of the efficacy of anticoagulants in non-valvular atrial fibrillation",
        "link": "https://vivli.org/development-of-statistical-methods-for-comparison-of-the-efficacy-of-anticoagulants-in-non-valvular-atrial-fibrillation",
        "year": "2024",
        "study_id": [
            "NCT00781391",
            "NCT00262600"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10146",
        "lead_investigator": "Yuki Miyai",
        "lead_institution": "Nagoya University Hospital",
        "study_title": "Impact of Body Mass Index on Survival and Response in Cancer Patients Treated with Immune Checkpoint Inhibitors",
        "link": "https://vivli.org/impact-of-body-mass-index-on-survival-and-response-in-cancer-patients-treated-with-immune-checkpoint-inhibitors",
        "year": "2025",
        "study_id": [
            "NCT03043872",
            "NCT02453282",
            "NCT02542293",
            "NCT02352948",
            "NCT02125461",
            "NCT02569242",
            "NCT02785952",
            "NCT02788279",
            "NCT02807636",
            "NCT02425891",
            "NCT02008227",
            "NCT02409342",
            "NCT02908672",
            "NCT03434379",
            "NCT03285763",
            "NCT02367794",
            "NCT02302807",
            "NCT02367781",
            "NCT02420821",
            "NCT02763579",
            "NCT02366143",
            "NCT02657434"
        ],
        "number_of_studies": 22
    },
    {
        "request_id": "10151",
        "lead_investigator": "Anthony Willems",
        "lead_institution": "University of Ghent",
        "study_title": "The Impact of Sex, Age and Race on the Immunogenicity of Meningococcal Serogroup B Vaccination in Healthy Infants, Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis",
        "link": "https://vivli.org/the-impact-of-sex-age-and-race-on-the-immunogenicity-of-meningococcal-serogroup-b-vaccination-in-healthy-infants-children-adolescents-and-young-adults-a-systematic-review-and-meta-analysis",
        "year": "Unknown",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10155",
        "lead_investigator": "Brian Gillette",
        "lead_institution": "Droice Labs",
        "study_title": "Developing approaches to accelerate clinical trials using real world data (RWD) from electronic health records (EHR)",
        "link": "https://vivli.org/developing-approaches-to-accelerate-clinical-trials-using-real-world-data-rwd-from-electronic-health-records-ehr",
        "year": "2024",
        "study_id": [
            "NCT01769378",
            "NCT01126580",
            "NCT01624259",
            "NCT02597049",
            "NCT00734474",
            "NCT02152371",
            "NCT01064687",
            "NCT01621178",
            "NCT03882970",
            "NCT03987919",
            "NCT00395512",
            "NCT01023581",
            "NCT00432276",
            "NCT03730662",
            "NCT00286468",
            "NCT00707993",
            "NCT00286442",
            "NCT00328627",
            "NCT04039503",
            "NCT00630825",
            "NCT02866175",
            "NCT00504556",
            "NCT00781391"
        ],
        "number_of_studies": 23
    },
    {
        "request_id": "10158",
        "lead_investigator": "Si-Cong Ma",
        "lead_institution": "The First Affiliated Hospital of Sun Yat-Sen University",
        "study_title": "Biomarker-based strategies to enhance efficacy and reduce toxicity in lung cancer immunotherapy",
        "link": "https://vivli.org/biomarker-based-strategies-to-enhance-efficacy-and-reduce-toxicity-in-lung-cancer-immunotherapy",
        "year": "2024",
        "study_id": [
            "NCT02008227",
            "NCT01903993"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10200",
        "lead_investigator": "Dafne Capelusnik",
        "lead_institution": "Care and Public Health Research Institute (CAPHRI), Maastricht University",
        "study_title": "Assessment of peripheral arthritis and related disease activity measurement instruments in spondyloarthritis",
        "link": "https://vivli.org/assessment-of-peripheral-arthritis-and-related-disease-activity-measurement-instruments-in-spondyloarthritis",
        "year": "2025",
        "study_id": [
            "NCT01064856",
            "NCT03178487",
            "NCT01453725",
            "NCT00207701",
            "NCT00265083",
            "NCT02186873",
            "NCT02696785",
            "NCT02696798",
            "NCT02757352",
            "NCT01258738",
            "NCT00247962",
            "NCT03502616",
            "NCT03502616",
            "NCT02552212",
            "NCT01087762"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "10204",
        "lead_investigator": "Yanguang Cao",
        "lead_institution": "University of North Carolina at Chapel Hill",
        "study_title": "Identifying Prognostic and Predictive Factors for Causal Exposure-Response Analysis of Imatinib in Treatment of Chronic Myeloid Leukemia",
        "link": "https://vivli.org/identifying-prognostic-and-predictive-factors-for-causal-exposure-response-analysis-of-imatinib-in-treatment-of-chronic-myeloid-leukemia",
        "year": "2024",
        "study_id": [
            "NCT00574873",
            "NCT01650805"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10290",
        "lead_investigator": "Jeffrey Bower",
        "lead_institution": "Sana Health, Inc.",
        "study_title": "Anchor Based Minimal Clinical Important Difference Calculation for the Neuropathic Pain Inventory Scale",
        "link": "https://vivli.org/anchor-based-minimal-clinical-important-difference-calculation-for-the-neuropathic-pain-inventory-scale",
        "year": "2024",
        "study_id": [
            "NCT00599638"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10293",
        "lead_investigator": "Joao Pedro Ferreira",
        "lead_institution": "Porto University",
        "study_title": "Effect of Empagliflozin on Blood Pressure in Acute Heart Failure",
        "link": "https://vivli.org/effect-of-empagliflozin-on-blood-pressure-in-acute-heart-failure",
        "year": "2024",
        "study_id": [
            "NCT04157751"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10313",
        "lead_investigator": "Linsen Ye",
        "lead_institution": "The Third Affiliated Hospital, Sun Yat-Sen University",
        "study_title": "Effect of liver lipid deposition on the treatment of atezolizumab plus bevacizumab: a retrospective study based on the IMBrave150",
        "link": "https://vivli.org/effect-of-liver-lipid-deposition-on-the-treatment-of-atezolizumab-plus-bevacizumab-a-retrospective-study-based-on-the-imbrave150",
        "year": "2024",
        "study_id": [
            "NCT03434379"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10317",
        "lead_investigator": "Kelley Kidwell",
        "lead_institution": "University of Michigan School of Public Health",
        "study_title": "Seamless Design for Multiple Endpoints for Drug Development in Rare Diseases Using Gaussian Copula Model in Bayesian Framework : a case study from Hunter syndrome",
        "link": "https://vivli.org/seamless-design-for-multiple-endpoints-for-drug-development-in-rare-diseases-using-gaussian-copula-model-in-bayesian-framework-a-case-study-from-hunter-syndrome",
        "year": "2024",
        "study_id": [
            "NCT00069641"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10341",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Comparison of Onset of Efficacy of Therapies for Ulcerative Colitis Based on Patient Symptom Diary Data",
        "link": "https://vivli.org/comparison-of-onset-of-efficacy-of-therapies-for-ulcerative-colitis-based-on-patient-symptom-diary-data",
        "year": "2024",
        "study_id": [
            "NCT00408629",
            "NCT00385736",
            "NCT02407236",
            "NCT00488631",
            "NCT00096655",
            "NCT00036439",
            "NCT03524092",
            "NCT03518086",
            "NCT02497469",
            "NCT00783718"
        ],
        "number_of_studies": 10
    },
    {
        "request_id": "10360",
        "lead_investigator": "Javier Calvo",
        "lead_institution": "Universidad de Costa Rica",
        "study_title": "Identifying Clinical Predictors of Weight Loss in Older Adults with Diabetes: Insights from SURPASS Clinical Trials",
        "link": "https://vivli.org/identifying-clinical-predictors-of-weight-loss-in-older-adults-with-diabetes-insights-from-surpass-clinical-trials",
        "year": "2024",
        "study_id": [
            "NCT03730662",
            "NCT03987919",
            "NCT03954834",
            "NCT04093752",
            "NCT03882970"
        ],
        "number_of_studies": 5
    },
    {
        "request_id": "10381",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Impact of Concomitant Steroid Use on Adverse Events in Ulcerative Colitis Clinical Trials",
        "link": "https://vivli.org/impact-of-concomitant-steroid-use-on-adverse-events-in-ulcerative-colitis-clinical-trials",
        "year": "2025",
        "study_id": [
            "NCT00408629",
            "NCT00385736",
            "NCT00036439",
            "NCT02407236",
            "NCT00096655",
            "NCT00488631",
            "NCT01465763",
            "NCT00783718",
            "NCT02497469"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "10391",
        "lead_investigator": "You-Shan Feng",
        "lead_institution": "Universit\u00e4tsklinikum T\u00fcbingen",
        "study_title": "Psychometric properties and scoring approaches for the EuroQol-5 dimension-5 level (EQ-5D-5L) Psoriasis-specific questions",
        "link": "https://vivli.org/psychometric-properties-and-scoring-approaches-for-the-euroqol-5-dimension-5-level-eq-5d-5l-psoriasis-specific-questions",
        "year": "2024",
        "study_id": [
            "NCT02561806",
            "NCT02634801",
            "NCT01646177"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10403",
        "lead_investigator": "Ignacio Leiva-Escobar",
        "lead_institution": "Heidelberg University Hospital",
        "study_title": "TREND-REVIVAL \u00e2\u20ac\u201c Trial result extension and disease course modelling to real world evidence generation in multiple myeloma",
        "link": "https://vivli.org/trend-revival-trial-result-extension-and-disease-course-modelling-to-real-world-evidence-generation-in-multiple-myeloma",
        "year": "2024",
        "study_id": [
            "NCT01863550",
            "NCT01564537",
            "NCT01850524"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10406",
        "lead_investigator": "Toby Pillinger",
        "lead_institution": "King's College London",
        "study_title": "Physiological effects of acute antidepressant treatment in psychiatric disorders: a systematic review and network meta-analysis",
        "link": "https://vivli.org/physiological-effects-of-acute-antidepressant-treatment-in-psychiatric-disorders-a-systematic-review-and-network-meta-analysis",
        "year": "2025",
        "study_id": [
            "NCT00048204",
            "NCT00062673",
            "NCT00067912",
            "NCT00071695",
            "NCT00073411",
            "NCT00406848",
            "NCT00489775",
            "NCT01140906",
            "NCT00839423",
            "NCT02272517",
            "NCT00596817",
            "NCT01488071",
            "NCT00635219",
            "NCT01422213",
            "NCT01571453",
            "NCT02279966",
            "NCT00811252",
            "NCT02709746",
            "NCT02279953",
            "NCT04448431",
            "NCT01121484",
            "NCT00063206",
            "NCT00369343",
            "NCT00824291",
            "NCT00863798",
            "NCT00730691",
            "NCT01364649",
            "NCT01153009",
            "NCT01564862",
            "NCT02932904",
            "NCT02371980",
            "NCT02389816",
            "NCT01179516",
            "NCT00672958",
            "NCT01299805",
            "NCT00731120",
            "NCT00735709",
            "NCT00734071",
            "NCT00744627",
            "NCT01255787",
            "NCT00672620",
            "NCT01163266",
            "NCT01355081"
        ],
        "number_of_studies": 43
    },
    {
        "request_id": "10408",
        "lead_investigator": "Su Syonmez",
        "lead_institution": "Orchard Therapeutics",
        "study_title": "Natural History Study of Patients With Mucopolysaccharidosis type IIIA (MPS IIIA)",
        "link": "https://vivli.org/natural-history-study-of-patients-with-mucopolysaccharidosis-type-iiia-mps-iiia",
        "year": "2024",
        "study_id": [
            "NCT01047306"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10411",
        "lead_investigator": "Joao Pedro Ferreira",
        "lead_institution": "Porto University",
        "study_title": "Non-steroidal anti-inflammatory drugs (NSAIDs) use and kidney outcomes in Heart Failure",
        "link": "https://vivli.org/non-steroidal-anti-inflammatory-drugs-nsaids-use-and-kidney-outcomes-in-heart-failure",
        "year": "2024",
        "study_id": [
            "NCT03057951",
            "NCT03057977"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10443",
        "lead_investigator": "Vitalay Fomin",
        "lead_institution": "YAI, Inc.",
        "study_title": "2024 DataWorks! Prize: Analyzing COVID-19 Drug Approval and Patient Response Using Historical Data",
        "link": "https://vivli.org/2024-dataworks-prize-analyzing-covid-19-drug-approval-and-patient-response-using-historical-data/",
        "year": "2024",
        "study_id": [
            "NCT04322682",
            "NCT04322123",
            "NCT04626076",
            "NCT04444674",
            "NCT04463264",
            "NCT04354428",
            "NCT04328961",
            "NCT04311177",
            "NCT04373460"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "10450",
        "lead_investigator": "Sam Royston",
        "lead_institution": "Replica Health",
        "study_title": "Merging Big Datasets for Training Blood Glucose Prediction Models",
        "link": "https://vivli.org/merging-big-datasets-for-training-blood-glucose-prediction-models/",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10462",
        "lead_investigator": "Nermin Diab",
        "lead_institution": "McMaster University",
        "study_title": "Efficacy and safety of monoclonal antibodies in patients with uncontrolled asthma: a systematic review and network meta-analysis",
        "link": "https://vivli.org/efficacy-and-safety-of-monoclonal-antibodies-in-patients-with-uncontrolled-asthma-a-systematic-review-and-network-meta-analysis-2/",
        "year": "Unknown",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10464",
        "lead_investigator": "Maria Panagiotou",
        "lead_institution": "University of Bern",
        "study_title": "Blood Glucose Prediction",
        "link": "https://vivli.org/blood-glucose-prediction",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10466",
        "lead_investigator": "Mia Jovanova",
        "lead_institution": "University of St. Gallen",
        "study_title": "Temporal dynamics of lifestyle factors and glycemic control among children with Type-1 Diabetes",
        "link": "https://vivli.org/temporal-dynamics-of-lifestyle-factors-and-glycemic-control-among-children-with-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10469",
        "lead_investigator": "Shenghong Zhang",
        "lead_institution": "The first affiliated hospital of Sun Yat-sen University",
        "study_title": "Predictors and prediction model for therapeutic outcomes in patients with ulcerative colitis receiving Mirikizumab",
        "link": "https://vivli.org/predictors-and-prediction-model-for-therapeutic-outcomes-in-patients-with-ulcerative-colitis-receiving-mirikizumab",
        "year": "2024",
        "study_id": [
            "NCT03524092",
            "NCT03518086"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10471",
        "lead_investigator": "Khandan Keyomarsi",
        "lead_institution": "The University of Texas MD Anderson Cancer Center",
        "study_title": "Validation of Predictive Molecular Biomarker for Predicting Response to Cyclin-Dependent Kinase 4 and 6 (CDK4/6) Inhibitors in Breast Cancer Using Data from PALOMA-2 and PALOMA-3 Studies",
        "link": "https://vivli.org/validation-of-predictive-molecular-biomarker-for-predicting-response-to-cyclin-dependent-kinase-4-and-6-cdk4-6-inhibitors-in-breast-cancer-using-data-from-paloma-2-and-paloma-3-studies",
        "year": "2025",
        "study_id": [
            "NCT01942135",
            "NCT01740427"
        ],
        "number_of_studies": 2
    },
    {
        "request_id": "10475",
        "lead_investigator": "Jiabin Cai",
        "lead_institution": "Zhongshan Hospital",
        "study_title": "Clinical and Molecular Characterization of Advanced Hepatocellular Carcinoma: Analysis of Therapeutic Responses Across Multiple Treatment Regimens",
        "link": "https://vivli.org/clinical-and-molecular-characterization-of-advanced-hepatocellular-carcinoma-analysis-of-therapeutic-responses-across-multiple-treatment-regimens",
        "year": "2025",
        "study_id": [
            "NCT01774344",
            "NCT02989922",
            "NCT01015833",
            "NCT00508001"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "10486",
        "lead_investigator": "DongKeon Yon",
        "lead_institution": "Kyung Hee University",
        "study_title": "Validation of Abrocitinib's efficacy and safety in moderate-to-severe atopic dermatitis across racial, ethnic, and skin type subgroups using machine learning models",
        "link": "https://vivli.org/validation-of-abrocitinibs-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-across-racial-ethnic-and-skin-type-subgroups-using-machine-learning-models",
        "year": "2025",
        "study_id": [
            "NCT02780167",
            "NCT03349060",
            "NCT03575871"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10487",
        "lead_investigator": "Surya Bhatt",
        "lead_institution": "RespirAnalytics LLC",
        "study_title": "Response to placebo in patients with chronic obstructive pulmonary disease",
        "link": "https://vivli.org/response-to-placebo-in-patients-with-chronic-obstructive-pulmonary-disease",
        "year": "2025",
        "study_id": [
            "NCT01854645",
            "NCT00387088",
            "NCT00144339",
            "NCT02172287",
            "NCT02173691",
            "NCT00240435",
            "NCT00168831",
            "NCT02006732",
            "NCT01964352",
            "NCT00782509",
            "NCT00796653",
            "NCT00239473",
            "NCT00168844",
            "NCT00782210",
            "NCT00793624"
        ],
        "number_of_studies": 15
    },
    {
        "request_id": "10491",
        "lead_investigator": "Jaeyoun Choi",
        "lead_institution": "UC San Diego",
        "study_title": "The effect of frailty and old age on the efficacy and safety of biologics and small molecules in inflammatory bowel disease : A pooled analysis of individual patient data",
        "link": "https://vivli.org/the-effect-of-frailty-and-old-age-on-the-efficacy-and-safety-of-biologics-and-small-molecules-in-inflammatory-bowel-disease-a-pooled-analysis-of-individual-patient-data",
        "year": "2025",
        "study_id": [
            "NCT00077779",
            "NCT02407236",
            "NCT01369342",
            "NCT01369329",
            "NCT01369355",
            "NCT03524092",
            "NCT03518086",
            "NCT01465763",
            "NCT00787202",
            "NCT00783692",
            "NCT00783718"
        ],
        "number_of_studies": 11
    },
    {
        "request_id": "10492",
        "lead_investigator": "Yongwen Zhou",
        "lead_institution": "The Third Affiliated Hospital of SYSU",
        "study_title": "Reinforcement learning for personlized automated insulin delivery system among type 1 diabetes",
        "link": "https://vivli.org/reinforcement-learning-for-personlized-automated-insulin-delivery-system-among-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10499",
        "lead_investigator": "Stefan Koudstaal",
        "lead_institution": "Erasmus Medical Center Rotterdam",
        "study_title": "Personalized Lifetime Prediction of Survival and Treatment Benefit in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: the LIFE-Preserved Model.",
        "link": "https://vivli.org/personalized-lifetime-prediction-of-survival-and-treatment-benefit-in-patients-with-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction-the-life-preserved-model",
        "year": "2025",
        "study_id": [
            "NCT03057951"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10511",
        "lead_investigator": "Min Hyuk Lim",
        "lead_institution": "UNIST (Ulsan National Institute of Science and Technology)",
        "study_title": "A study of establishing Machine Learning (ML) and Artificial Intelligence (AI) models for glucose dynamics",
        "link": "https://vivli.org/a-study-of-establishing-machine-learning-ml-and-artificial-intelligence-ai-models-for-glucose-dynamics",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10540",
        "lead_investigator": "Alexander Drilon",
        "lead_institution": "Memorial Sloan Kettering Cancer Center (MSKCC)",
        "study_title": "Do patients with lung cancers positive for a RET gene alteration benefit from the addition of immunotherapy to chemotherapy?",
        "link": "https://vivli.org/do-patients-with-lung-cancers-positive-for-a-ret-gene-alteration-benefit-from-the-addition-of-immunotherapy-to-chemotherapy",
        "year": "2025",
        "study_id": [
            "NCT04194944",
            "NCT04194944",
            "NCT04194944"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10549",
        "lead_investigator": "Sumayyah Patel",
        "lead_institution": "University of Leeds",
        "study_title": "Cognition in Multiple Myeloma: A Systematic Review and Meta-Analysis",
        "link": "https://vivli.org/cognition-in-multiple-myeloma-a-systematic-review-and-meta-analysis",
        "year": "2025",
        "study_id": [
            "NCT01564537"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10560",
        "lead_investigator": "Katie Bechman",
        "lead_institution": "King\u2019s College London",
        "study_title": "Effects of obesity on treatment response to Janus kinase inhibitors (JAKi) in rheumatoid arthritis",
        "link": "https://vivli.org/effects-of-obesity-on-treatment-response-to-janus-kinase-inhibitors-jaki-in-rheumatoid-arthritis",
        "year": "2025",
        "study_id": [
            "NCT02706847",
            "NCT02706951",
            "NCT02706873",
            "NCT02675426",
            "NCT03086343",
            "NCT02889796",
            "NCT02873936",
            "NCT02886728",
            "NCT02889796",
            "NCT02889796",
            "NCT02873936",
            "NCT02886728",
            "NCT02873936",
            "NCT02889796",
            "NCT02873936",
            "NCT02886728",
            "NCT02886728",
            "NCT01710358",
            "NCT01721044",
            "NCT01721057",
            "NCT01711359",
            "NCT02265705",
            "NCT00960440",
            "NCT00847613",
            "NCT00814307",
            "NCT00856544",
            "NCT00853385",
            "NCT01039688",
            "NCT02187055"
        ],
        "number_of_studies": 29
    },
    {
        "request_id": "10706",
        "lead_investigator": "Neeraj Narula",
        "lead_institution": "Hamilton Health Sciences",
        "study_title": "Assessing the Impact of Disease Duration on the Likelihood of Healing in the Ileum and Colon in Crohn\u2019s Disease",
        "link": "https://vivli.org/assessing-the-impact-of-disease-duration-on-the-likelihood-of-healing-in-the-ileum-and-colon-in-crohns-disease",
        "year": "2025",
        "study_id": [
            "NCT00348283",
            "NCT03345849",
            "NCT03345836",
            "NCT01369329",
            "NCT01369342",
            "NCT01369355",
            "NCT03464136",
            "NCT02611817",
            "NCT02425111"
        ],
        "number_of_studies": 9
    },
    {
        "request_id": "10707",
        "lead_investigator": "Zisheng Chen",
        "lead_institution": "Guangzhou Medical University",
        "study_title": "The Association between Liver Metastasis of Non-Small Cell Lung Cancer and Prognosis Based on Immunotherapy: A Secondary Summary analysis of Individual Patient Data from Randomized Trials",
        "link": "https://vivli.org/the-association-between-liver-metastasis-of-non-small-cell-lung-cancer-and-prognosis-based-on-immunotherapy-a-secondary-summary-analysis-of-individual-patient-data-from-randomized-trials",
        "year": "2025",
        "study_id": [
            "NCT02453282",
            "NCT02542293",
            "NCT02409342",
            "NCT02366143",
            "NCT02367794",
            "NCT02367781",
            "NCT02657434"
        ],
        "number_of_studies": 7
    },
    {
        "request_id": "10732",
        "lead_investigator": "Bryan Saunders",
        "lead_institution": "University of Sao Paulo",
        "study_title": "Semaglutide for weight loss: Where is the weight loss coming from? A systematic review and meta-analysis",
        "link": "https://vivli.org/semaglutide-for-weight-loss-where-is-the-weight-loss-coming-from-a-systematic-review-and-meta-analysis",
        "year": "2025",
        "study_id": [
            "NCT03951753"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10735",
        "lead_investigator": "Andrew Achaiah",
        "lead_institution": "Gloucestershire Royal Hospital, Gloucestershire Hospitals NHS Foundation Trust",
        "study_title": "Exploration of change in forced expiratory volume:forced vital capacity (FEV1:FVC) ratio from baseline to prognosticate clinical outcomes in idiopathic pulmonary fibrosis and predict treatment response to Nintedanib",
        "link": "https://vivli.org/exploration-of-change-in-forced-expiratory-volumeforced-vital-capacity-fev1fvc-ratio-from-baseline-to-prognosticate-clinical-outcomes-in-idiopathic-pulmonary-fibrosis-and-predict-treatment-respons",
        "year": "2025",
        "study_id": [
            "NCT01335464",
            "NCT01335477",
            "NCT01335477",
            "NCT01335464"
        ],
        "number_of_studies": 4
    },
    {
        "request_id": "10749",
        "lead_investigator": "Dennis Shung",
        "lead_institution": "Yale School of Medicine",
        "study_title": "DT1D: Digital Twin for Type 1 Diabetes",
        "link": "https://vivli.org/dt1d-digital-twin-for-type-1-diabetes",
        "year": "2024",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10752",
        "lead_investigator": "Anna Maria Claudia Wagner",
        "lead_institution": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FCIISC)",
        "study_title": "Exercise in type 1 diabetes",
        "link": "https://vivli.org/exercise-in-type-1-diabetes",
        "year": "2025",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10757",
        "lead_investigator": "Zhaojin Chen",
        "lead_institution": "National University of Singapore",
        "study_title": "Analyzing the Effectiveness of a New Cancer Treatment Using Historical Data in a Phase II Clinical Trial",
        "link": "https://vivli.org/analyzing-the-effectiveness-of-a-new-cancer-treatment-using-historical-data-in-a-phase-ii-clinical-trial",
        "year": "2025",
        "study_id": [
            "NCT02151981"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10783",
        "lead_investigator": "Kathryn Connelly",
        "lead_institution": "Monash University School of Clinical Sciences",
        "study_title": "Can a core set of disease activity domains define response in systemic lupus erythematosus clinical trials? An analysis of two Phase 3 randomised controlled trials of belimumab",
        "link": "https://vivli.org/can-a-core-set-of-disease-activity-domains-define-response-in-systemic-lupus-erythematosus-clinical-trials-an-analysis-of-two-phase-3-randomised-controlled-trials-of-belimumab",
        "year": "2025",
        "study_id": [
            "NCT00410384",
            "NCT00424476",
            "NCT01345253"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "10786",
        "lead_investigator": "Yuan Huang",
        "lead_institution": "Yale University",
        "study_title": "Jointly modeling hypoglycemic event times and longitudinal glucose measurement with Brownian motion",
        "link": "https://vivli.org/jointly-modeling-hypoglycemic-event-times-and-longitudinal-glucose-measurement-with-brownian-motion",
        "year": "2025",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "10827",
        "lead_investigator": "Ben Cowling",
        "lead_institution": "The University of Hong Kong",
        "study_title": "Exploring Viral Shedding, Symptom Dynamics, and Antiviral Efficacy in Influenza Transmission",
        "link": "https://vivli.org/exploring-viral-shedding-symptom-dynamics-and-antiviral-efficacy-in-influenza-transmission",
        "year": "2025",
        "study_id": [
            "NCT03969212"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10832",
        "lead_investigator": "Jay Park",
        "lead_institution": "Core Clinical Sciences",
        "study_title": "Assessing the Potential Effect of a New Diabetes Treatment in Canadian Populations",
        "link": "https://vivli.org/assessing-the-potential-effect-of-a-new-diabetes-treatment-in-canadian-populations",
        "year": "2025",
        "study_id": [
            "NCT03882970"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10852",
        "lead_investigator": "Ramona Belfiore-Oshan",
        "lead_institution": "Critical Path Institute",
        "study_title": "Development of an Artificial Intelligence/Machine Learning (AI/ML) model-based clinical trial simulation platform to better characterize Loss of Ambulation in Duchenne Muscular Dystrophy (DMD)",
        "link": "https://vivli.org/development-of-an-artificial-intelligence-machine-learning-ai-ml-model-based-clinical-trial-simulation-platform-to-better-characterize-loss-of-ambulation-in-duchenne-muscular-dystrophy-dmd",
        "year": "2025",
        "study_id": [
            "NCT01753804"
        ],
        "number_of_studies": 1
    },
    {
        "request_id": "10997",
        "lead_investigator": "Ricky Turgeon",
        "lead_institution": "University of British Columbia",
        "study_title": "Re-analyzing Heart Failure Treatment Outcomes Based on Patient Preferences: A Study Using Data from Multiple Clinical Trials",
        "link": "https://vivli.org/re-analyzing-heart-failure-treatment-outcomes-based-on-patient-preferences-a-study-using-data-from-multiple-clinical-trials",
        "year": "2025",
        "study_id": [
            "NCT04157751",
            "NCT03057951",
            "NCT03057977"
        ],
        "number_of_studies": 3
    },
    {
        "request_id": "11011",
        "lead_investigator": "Zahari Kassabov",
        "lead_institution": "Opificio Ltd",
        "study_title": "Study of diabetes metrics during exercise to understand how to improve glycemic control in patients",
        "link": "https://vivli.org/study-of-diabetes-metrics-during-exercise-to-understand-how-to-improve-glycemic-control-in-patients",
        "year": "2025",
        "study_id": [],
        "number_of_studies": 0
    },
    {
        "request_id": "11038",
        "lead_investigator": "Andrew Strahs",
        "lead_institution": "Wave Life Sciences",
        "study_title": "Analysis of PRO-DMD-01 Functional Data to Inform Endpoints in Wave\u2019s FORWARD-53 Study of WVE-N531 for Duchenne Muscular Dystrophy (DMD) Exon-53 Skipping Therapy",
        "link": "https://vivli.org/analysis-of-pro-dmd-01-functional-data-to-inform-endpoints-in-waves-forward-53-study-of-wve-n531-for-duchenne-muscular-dystrophy-dmd-exon-53-skipping-therapy",
        "year": "2025",
        "study_id": [
            "NCT01753804"
        ],
        "number_of_studies": 1
    }
]